D: 14-11-2014
Code Date Hall Enrollment No Name Thesis_titlename_of_guid
e
COLC
ODEBR_NAME
Subject
code
ZO
NEmicro_name other_micro
1 17-Nov-14 HALL - 01 132150808003Lalwala Shivani
Rajendra
formulation, Development and
evaluation of nasal dosage form
containing Fluticasone dipropionate
and Itraconazole for allergic fungal
rhinosinusitis
Dr.Sanket D.
Gandhi215 PHARMACEUTICS 930202 5
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
2 17-Nov-14 HALL - 01 132540808017
PATEL
NIHARIKAKUMARI
PRADHUMANBHAI
FORMULATION AND EVALUATION OF
EMULGEL CONTAINING AN ANTI-
HISTAMINIC AGENT FOR TOPICAL
DRUG DELIVERY
mR. mANISH
GOYANI254 PHARMACEUTICS 930202 5
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
3 17-Nov-14 HALL - 01 132570808002
GAJJAR
SAMEERKUMAR
LAXMANBHAI
Formulation and development of
buccal drug delivery system of
carvedilol
Mr. B. K. Patel 257 PHARMACEUTICS 930202 2
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
4 17-Nov-14 HALL - 01 132540808008MEHTA PRIYANKI
KISHORBHAI
FORMULATION AND EVALUATION OF
TOPICAL SPRAY CONTAINING
ANTIFUNGAL AGENT
mR. mANISH
GOYANI254 PHARMACEUTICS 930202 5
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
5 17-Nov-14 HALL - 01 132540808010PATEL HETVI
HARIBHAI
FORMULATION AND EVALUATION OF
TOPICAL NANOSPONGE GEL
CONTAINING IMMUNOSUPPRESIVE
AGENT
Dr. bhavesh
akbari254 PHARMACEUTICS 930202 5
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
6 17-Nov-14 HALL - 01 132540808013
PATEL
URVISHKUMAR
BALVANTBHAI
FORMULATION AND EVALUATION OF
IPC BUCCAL FILM OF AN OPIOID
ANALGESIC
mr. adil patel 254 PHARMACEUTICS 930202 5
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
7 17-Nov-14 HALL - 01 132540808018
PATEL
SWETANSHUKUM
AR
JASHWANTBHAI
FORMULATION AND EVALUATION OF
TOPICAL AEROSOL CONTAINING ANTI-
ACNE AGENT
mR. mANISH
GOYANI254 PHARMACEUTICS 930202 5
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
8 17-Nov-14 HALL - 02 132150808002Jain Khyati
Chandraprakash
Formulation and Evaluation of mouth
dissolving film containing
Montelukast sodium and
Levocetirizine for allergic rhinitis
Dr.Sanket D.
Gandhi215 PHARMACEUTICS 930202 5
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
9 17-Nov-14 HALL - 02 132540808002AMLA JUNED
SOAEB
FORMULATION AND EVALUATION OF
ORAL OSMOTIC TABLETS OF ANTI-
HYPERTENSIVE AGENT
mr. dhaval
rawal254 PHARMACEUTICS 930202 5
OTHER (KINDLY
SPECIFY)
Osmotic drug
delivery system
Ref No: GTU/MPH/2014/
GUJARAT TECHNOLOGICAL UNIVERSITY
STUDENT LIST FOR INTRODUCTION TO DISSERTATION (ITD)
M. PHARM SEM III WINETR 2014 EXAMINATION
10 17-Nov-14 HALL - 02 132540808009
PATEL
FENIKUMARI
PRAFULBHAI
MICROWAVE ASSISTED SYNTHESIS
AND EVALUATION OF A MODIFIED
NATURAL POLYSACCHARIDE AS
TABLET DISINTEGRANT
mr. dhaval
rawal254 PHARMACEUTICS 930202 5
CO PROCESSED, DC,
TABLET/CAPSULE
EXCIPIENTS AND
ATTRIBUTES
11 17-Nov-14 HALL - 02 132540808012PATEL NILKUMAR
PARESHBHAI
FORMULATION AND EVALUATION OF
SUSTAINED RELEASE MATRIX
TABLETS OF DOXOFYLLINE
Dr. bhavesh
akbari254 PHARMACEUTICS 930202 5
CO PROCESSED, DC,
TABLET/CAPSULE
EXCIPIENTS AND
ATTRIBUTES
12 17-Nov-14 HALL - 02 132570808004
PATEL SANKET
MAHENDRAKUMA
R
Design and evaluation of fast
dissolving tablet of etoricoxibMr. B. K. Patel 257 PHARMACEUTICS 930202 2
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
13 17-Nov-14 HALL - 02 132540808006
KHENI
MITULKUMAR
RAMESHBHAI
POLYCAPROLACTONE-g-
POLYSACCHARIDE BASED MICELLES:
DEVELOPMENT EVALUATION AND
DRUG DELIVERY APPLICATION
Mr. anand
deshmukh254 PHARMACEUTICS 930202 5
CO PROCESSED, DC,
TABLET/CAPSULE
EXCIPIENTS AND
ATTRIBUTES
polymer
grafting for and
its application
14 17-Nov-14 HALL - 03 132150808004SUMAN PRAKASH
BHANDARI
FORMULATION, DEVELOPMENT AND
EVALUATION OF MICROEMULSION
OF SIMVASTATIN.
Mr. RONAK
DEDANIA215 PHARMACEUTICS 930202 5
NANO
SUSPENSION/EMULSI
ON, SEDDS, LIPID
BASED DDS
15 17-Nov-14 HALL - 03 132540808001kataria payal
thakorbhai
DEVELOPMENT AND EVALUATION OF
ACECLOFENAC LOADED CHITOSAN
MAGNETIC NANOPARTICLES FOR
OSTEOARTHRITIS TREATMENT
Mr. anand
deshmukh254 PHARMACEUTICS 930202 5 MULTIPARTICULATE
16 17-Nov-14 HALL - 03 132570808001PATEL ARATIBEN
RAMESHBHAI
Formulation and evaluation of
floating dosage form of pregabalinMr. B. K. Patel 257 PHARMACEUTICS 930202 2
OTHER (KINDLY
SPECIFY)
Gastro
Retentive drug
delivery system
17 17-Nov-14 HALL - 03 132540808005
KARUJI MARUF
YAKUBBHAI
UMARJI
DEVELOPMENT OF LONG ACTING
PLGA BASED MICROPARTICLES FOR
PROTEIN DRUG DELIVERY
Dr. bhavesh
akbari254 PHARMACEUTICS 930202 5 MULTIPARTICULATE
18 17-Nov-14 HALL - 03 132540808015SHAH ARCHITA
JAYANTKUMAR
FORMULATION AND EVALUATION OF
CARBOXYMETHYL XYLOGLUCAN –
GELLAN GUM INTERPENETRATING
POLYMER NETWORK MICROBEADS
FOR ORAL DRUG DELIVERY
Mr. anand
deshmukh254 PHARMACEUTICS 930202 5 MULTIPARTICULATE
19 17-Nov-14 HALL - 03 132540808016
MODI
SAGARKUMAR
BHARATKUMAR
DEVELOPMENT AND EVALUATION OF
INTERPENETRATING POLYMER
NETWORK MICROBEADS OF
CARBOXYMETHYL XYLOGLUCAN –
SODIUM ALGINATE FOR ORAL DRUG
DELIVERY
Mr. anand
deshmukh254 PHARMACEUTICS 930202 5 MULTIPARTICULATE
20 17-Nov-14 HALL - 04 132390808007PATEL TRIVENIBEN
RAMESHBHAI
FORMULATION, EVALUATION and
optimization OF dual release BILAYER
TABLET OF anti-emetic drug
Tularam Barot 239 PHARMACEUTICS 930202 5
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
21 17-Nov-14 HALL - 04 132390808008VATSALA BHARAT
PATEL
FORMULATION & EVALUATION OF
INSITU GEL OF CILNIDIPINEkomal Parmar 239 PHARMACEUTICS 930202 5
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
22 17-Nov-14 HALL - 04 132390808009ALAKKAL ANJU
DEVANANDHAN
FORMULATION and evaluation of
floating tablet of acyclovir to increase
the Residence Time in the
Gastrointestinal Tract
Dr. hitesh
dalvadi239 PHARMACEUTICS 930202 5
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
Using natural
polymer
23 17-Nov-14 HALL - 04 132390808010PATEL PRITESH
JAYANTILAL
FORMULATION & EVALUATION OF
BILaYER TABLET OF VENLAFAXINE
HYDROCHLORIDE
Dr. hitesh
dalvadi239 PHARMACEUTICS 930202 5
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
Bilayer tablet
24 17-Nov-14 HALL - 04 132390808503THAKUR PRIYA
DILIP
Formulation & Evaluation of
controlled release formulation of
antidepressant drug
komal Parmar 239 PHARMACEUTICS 930202 5
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
sustain release
formulation
25 17-Nov-14 HALL - 04 132540808007KHER NIKUNJSINH
KISHORSINH
DEVELOPMENT AND EVALUATION OF
ENTERIC COATED ILAPRAZOLE
TABLET
Mr. anand
deshmukh254 PHARMACEUTICS 930202 5
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
26 17-Nov-14 HALL - 04 132390808504YAGNESHWRI
NITISHA ANANT
FORMULATION & EVALUATION OF
FLOATING PULSATILE DRUG
DELIVERY SYSTEM OF LAFUTIDINE
komal Parmar 239 PHARMACEUTICS 930202 5
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
Floating
pulsatile drug
delivery
27 17-Nov-14 HALL - 04 132540808003
ANSARI
TABASSUM SHAKIL
AHMED
DEVELOPMENT AND EVALUATION OF
PLGA BASED LONG ACTING
PARENTERAL IN SITU GEL
FORMULATION
Dr. bhavesh
akbari254 PHARMACEUTICS 930202 5
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
28 17-Nov-14 HALL - 04 132540808011
PATEL
KRUSHANGKUMAR
VIJAYBHAI
FORMULATION AND EVALUATION OF
FLOATING PULSATILE DRUG
DELIVERY SYSTEM FOR
CHRONOTHERAPY OF
HYPERTENSION
mR. mANISH
GOYANI254 PHARMACEUTICS 930202 5
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
29 17-Nov-14 HALL - 05 132390808002NITESH JASWANT
SINGH
Development & Characterization of
FAST DISSOLVING SUBLINGUAL
TABLETS of granisetron
HYDROCHLORIDE
Dr. hitesh
Dalvadi239 PHARMACEUTICS 930202 5
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
Fast dissolving
sublingual
tablets
30 17-Nov-14 HALL - 05 132390808003Patel Ankitkumar
Vaichandbhai
Formulation and Characterization of
Fast dissolving film of Tramadol
HydroChloride
dr. hitesh
dalvadi239 PHARMACEUTICS 930202 5
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
31 17-Nov-14 HALL - 05 132390808004PATEL MAYURI
SUMANBHAI
Development and evaluation of fast
dissolving oro-dispersible film of
Metoprolol tartrate
Dr. hitesh
dalvadi239 PHARMACEUTICS 930202 5
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
32 17-Nov-14 HALL - 05 132390808006TANDEL VIJAY
NAROTTAMBHAI
formulation and evaluation of
sublingual tablet of Zotepinebhavya S. Shah 239 PHARMACEUTICS 930202 5
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
33 17-Nov-14 HALL - 05 132390808502THAKOR KAJAL
JAYESHSINH
FORMULATION & EVALUATION OF
LIQUISOLID COMPACTS OF CEFIXIME
TRIHYDRATE
komal Parmar 239 PHARMACEUTICS 930202 5
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
34 17-Nov-14 HALL - 05 132540808004GANGAT SUHEL
ISMAIL
FORMULATION AND IN-VITRO
EVALUATION OF SUBLINGUAL
TABLETS OF ANTI-ANGINAL AGENT
mR. mANISH
GOYANI254 PHARMACEUTICS 930202 5
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
35 17-Nov-14 HALL - 05 132540808014
SAPA
NASRINBANU
ILYAS
FORMULATION AND EVALUATION OF
FAST DISSOLVING SUBLINGUAL FILM
OF ANTI-HISTAMINE DRUG
Dr. bhavesh
akbari254 PHARMACEUTICS 930202 5
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
36 17-Nov-14 HALL - 05 132390808501CHAUHAN MITESH
DHIRUBHAI
SOLUBILITY ENHANCEMENT OF
CILNIDIPINE BY LIQUISOLID
COMPACT
Tularam Barot 239 PHARMACEUTICS 930202 5
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
SOLUBILITY
ENHANCEMENT
37 17-Nov-14 HALL - 08 132080804009PATEL DHARMIKA
BHAILALBHAI
Development and Validation of
Analytical Method for Simultaneous
Estimation of Azithromycin and
Dexamethasone in Eye Drops
Dr. Ragin Shah 208QUALITY
ASSURANCE930204 1
SIMULTENEOUS
ESTIMATION
38 17-Nov-14 HALL - 08 132080804013SHAH CHARMI
KAMLESHKUMAR
Validation of Developed Methods for
Simultaneous Estimation of
Cilnidipine and Valsartan in Synthetic
Mixture
Dr. Hiral
Panchal208
QUALITY
ASSURANCE930204 1
SIMULTENEOUS
ESTIMATION
39 17-Nov-14 HALL - 08 132570804002Patel Sneha
Vishnubhai
Development and Validation of
Analytical Methods for the
Determination of Ranitidine and
Ondansetron in Combined
Pharmaceutical Dosage form
Dr Rajesh k
Patel257
QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
40 17-Nov-14 HALL - 08 132570804007
PATEL
BHOOMIKABAHEN
ARVINDKUMAR
Development and Validation of
Analytical Methods for the
Determination of Nicotinamide and
Salicylic acid in Semi solid dosage
form.
Dr Rajesh k
Patel257
QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
41 17-Nov-14 HALL - 08 132570804008
PATEL
DRASTIKUMARI
KANTILAL
Development and Validation of
Analytical Methods for the
Determination of Amlodipine and
Bisoprolol in Combined
Pharmaceutical Dosage form
Dr Rajesh k
Patel257
QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
42 17-Nov-14 HALL - 08 132570804010
PATEL
JINALBAHEN
RASHIKBHAI
Analytical Method Development and
Validation For Estimation of myo-
Inositol, Folic Acid & Melatonin
Contained In Solid Dosage Form
Using HPLC
mr. ojas patel 257QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
43 17-Nov-14 HALL - 08 132570804012PATEL SOHANIBEN
DASHARATHBHAI
Development and Validation of
Analytical Methods for simultaneous
estimation of diacerein and
aceclofenac in pharmaceutical
formulation
mr. ojas patel 257QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
44 17-Nov-14 HALL - 08 132080804008PATEL BINKAL
BHAGABHAI
Development and Validation of
Stability Indicating RP-HPLC Method
for the Estimation of Dexamethasone
and Atropine Sulphate in Eye Drops
Mrs. Mona
Christian208
QUALITY
ASSURANCE930204 1
SIMULTENEOUS
ESTIMATION
45 17-Nov-14 HALL - 08 132080804001
Katrodiya
Viralkumar
Kalubhai
Method Development and Validation
for Simultaneous Estimation of
Ketorolac and Phenylephrine in
Parenteral Dosage Form
Mr. Hiren
Kadikar208
QUALITY
ASSURANCE930204 1
SIMULTENEOUS
ESTIMATION-
46 17-Nov-14 HALL - 08 132080804004PATEL NIKITA
MUKESHBHAI
Development and Validation of UV
Spectroscopy and HPLC Method for
Simultaneous Estimation of Minoxidil
and Finasteride in Topical Solution
Dr. Hiral
Panchal208
QUALITY
ASSURANCE930204 1
SIMULTENEOUS
ESTIMATION
47 17-Nov-14 HALL - 08 132080804006JOSHI KRUNAL
BHARATKUMAR
Development and Validation of
Analytical Method for Simultanous
Estimation of Metformin and Myo
Inositol in Pharmaceutical Dosage
Form
Mrs. Nisha
Parikh208
QUALITY
ASSURANCE930204 1
SIMULTENEOUS
ESTIMATION
48 17-Nov-14 HALL - 09 132080804002Patel Mittalben
Vinodchandra
Devlopment and Validation of
Stability Indicating RP-HPLC Method
for Estimation of Epalrestat and
Methylcobalamine in Pharmaceutical
Dosage Form
Dr. Ragin Shah 208QUALITY
ASSURANCE930204 1 STABILITY STUDIES
49 17-Nov-14 HALL - 09 132080804005JANI BHOOMI
RAJESHKUMAR
Stability Indicating HPLC Method
Development and Validation for
Estimation of Vilazodone
Dr. Hiral
Panchal208
QUALITY
ASSURANCE930204 1 STABILITY STUDIES
50 17-Nov-14 HALL - 09 132080804007PATEL ANKITA
KIRIT
Stability Indicating HPLC Method for
Simultaneous Estimation of
Pregabalin and Methylcobalamin
from Combined Dosage Form
Mr. Hiren
Kadikar208
QUALITY
ASSURANCE930204 1 STABILITY STUDIES
51 17-Nov-14 HALL - 09 132150804003MUNIM KRISHNA
SANJIVBHAI
DEGRADATION STUDY OF
SIROLIMUS.
Dr. ZARNA
DEDANIA215
QUALITY
ASSURANCE930204 5 STABILITY STUDIES
52 17-Nov-14 HALL - 09 132150804007
DOBARIYA
CHANDRIKA
TULSHIBHAI
STABILITY INDICATING ANALYTICAL
METHOD DEVELOPMENT AND
VALIDATION OF FEXOFENADINE
HYDROCHLORIDE.
Dr. ZARNA
DEDANIA215
QUALITY
ASSURANCE930204 5 STABILITY STUDIES
53 17-Nov-14 HALL - 09 132150804008PATEL BHUMIKA
RASIKBHAI
STRESS STUDIES OF CANDERSARTAN
CILEXITIL BY analytical methods IN
TABLET DOSAGE FORM.
Ms. JASMINA
SURATI215
QUALITY
ASSURANCE930204 5 STABILITY STUDIES
54 17-Nov-14 HALL - 09 132540804007PATEL RUCHA
ACHYUT
Development and Validation of
Stability Indicating Analytical Method
for Olmesartan Medoxomil and
Indapamide in Tablet
Dr.Hasumati
Raj254
QUALITY
ASSURANCE930204 5 STABILITY STUDIES
55 17-Nov-14 HALL - 09 132540804010
SHAIKH
FAEZABANU
MOHAMMEDFARU
QUE
Development and Validation of
Stability Indicating Analytical Method
for Felbinac
mr.gautam
sonara254
QUALITY
ASSURANCE930204 5 STABILITY STUDIES
56 17-Nov-14 HALL - 09 132540804011
TAKOLIYA
KINJALBEN
DILIPSINH
Development and Validation of
Stability Indicating Analytical Method
for Argatroban
Dr.Hasumati
Raj254
QUALITY
ASSURANCE930204 5 STABILITY STUDIES
57 17-Nov-14 HALL - 09 132540804015
PATEL
YESHABAHEN
KANAIYALAL
Stability Study and Characterization
of Base Degradation Product of
Donepezil Hydrochloride
DR.M.N.NOOL
VI254
QUALITY
ASSURANCE930204 5 STABILITY STUDIES
58 17-Nov-14 HALL - 10 132150804004PATEL JUHEE
JITENDRAKUMAR
DEVELOPMENT AND VALIDATION OF
UV SPECTROSCOPIC AND HPTLC
METHOD FOR SIMULTANEOUS
ESTIMATION OF DOXOFYLLINE AND
TERBUTALINE SULPHATE IN TABLET
DOSAGE FORM.
Mrs. HENAL
CHORAWALA215
QUALITY
ASSURANCE930204 5
SIMULTENEOUS
ESTIMATION
59 17-Nov-14 HALL - 10 132150804005Ruchita
Yogeshbhai Naik
ANALYTICAL METHODS
DEVELOPMENT AND VALIDATION
FOR SIMULTANEOUS ESTIMATION OF
ETAMSAYLATE AND TRANEXAMIC
ACID IN TABLET DOSAGE FORM.
Dr. ZARNA
DEDANIA215
QUALITY
ASSURANCE930204 5
SIMULTENEOUS
ESTIMATION
60 17-Nov-14 HALL - 10 132390804001
BHANUSALI
VARSHABEN
MULJIBHAI
Analytical Method development and
validation of chlorthalidone and
Losartan potassium in combined
dosage form
Madhuri
A.Hinge239
QUALITY
ASSURANCE930204 5
SIMULTENEOUS
ESTIMATION
61 17-Nov-14 HALL - 10 132390804003DESAI FORAM
HIRENKUMAR
Analytical method development and
validation of Dextromethorphan
Hydrobromide and
chlorpheniramine maleate in
combined dosage form
K.Jessi Kala
Veni239
QUALITY
ASSURANCE930204 5
SIMULTENEOUS
ESTIMATION
62 17-Nov-14 HALL - 10 132390804004Mayankbhai
Kishorbhai Patel
Analytical method development and
validation of cetirizine HydroChloride
and phenylephrine HYDROCHLORIDE
in combineD dosage form
K.Jessi Kala
Veni239
QUALITY
ASSURANCE930204 5
SIMULTENEOUS
ESTIMATION
63 17-Nov-14 HALL - 10 132390804005
NUPUR
DHANESHBHAI
MISTRY
Determination of content uniformity
in pyridoxine HYDROCHLORIDE and
Doxylamine succinate in
Pharmaceutical dosage form by
different analytical tools
P.Malairajan 239QUALITY
ASSURANCE930204 5
SIMULTENEOUS
ESTIMATION
64 17-Nov-14 HALL - 10 132570804013
PATEL
VAISHALIBEN
GANPATBHAI
Development and Validation of
Analytical Methods for the
Determination of Ranitidine
hydrochloride and Drotaverin in
Combined Pharmaceutical Dosage
form
Dr Rajesh k
Patel257
QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
65 17-Nov-14 HALL - 10 132570804014
PATEL
VAISHALIBEN
GOVINDLAL
Development and Validation of
Analytical Methods for the
Determination of Pantoprazole and
Ondansetron in Combined
Pharmaceutical Dosage form
Dr Rajesh k
Patel257
QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
66 17-Nov-14 HALL - 10 132150804006Vyas Janki
Tejalkumar
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHODS FOR
SIMULTANEOUS ESTIMATION OF
LORNOXICAM AND PARACETAMOL
IN PHARMACEUTICAL DOSAGE
FORM.
Dr. ZARNA
DEDANIA215
QUALITY
ASSURANCE930204 5
SIMULTENEOUS
ESTIMATION
67 17-Nov-14 HALL - 10 132150804009PATEL HONEY
DINESHCHANDRA
SIMULTANEOUS ESTIMATION OF
VOGLIBOSE AND METFORMIN
HYDROCHLORIDE BY VALIDATED
ANALYTICAL METHODS IN TABLET
DOSAGE FORM.
Ms. JASMINA
SURATI215
QUALITY
ASSURANCE930204 5
SIMULTENEOUS
ESTIMATION
68 17-Nov-14 HALL - 10 132080804011SHAH AMI
ASHOKKUMAR
Analytical Method Development
Validation and Simultaneous
Estimation of Ezitimib and
Simvastatin by RP-HPLC Method
Mr. Hiren
Kadikar208
QUALITY
ASSURANCE930204 1
SIMULTENEOUS
ESTIMATION
69 17-Nov-14 HALL - 11 132390804006PATEL ANKITABEN
NAVINBHAI
Analytical method development and
validation of Methocarbamol and
paracetamol in Tablet dosage form
P.Malairajan 239QUALITY
ASSURANCE930204 5
SIMULTENEOUS
ESTIMATION
70 17-Nov-14 HALL - 11 132390804008PATEL APEXA
SUMANBHAI
development and validation of
ANALYTICAL METHOD for
simultaneous estimation of
chlorpheniramine maleate and
PHENYLEPHRINE Hydrochloride in
combined dosage form
Hitendra
Yadav239
QUALITY
ASSURANCE930204 5
SIMULTENEOUS
ESTIMATION
71 17-Nov-14 HALL - 11 132390804009
PATEL
MITALKUMARI
VELAJIBHAI
Analytical method development and
validation of Atenolol and nifedipine
in combined dosage form
Hitendra
Yadav239
QUALITY
ASSURANCE930204 5
SIMULTENEOUS
ESTIMATION
72 17-Nov-14 HALL - 11 132390804010 Patel Nikita Pankaj
Development and validation of
analytical method for simultaneous
estimation of methocarbamol and
Diclofenac sodium in injection dosage
form
Madhuri
A.Hinge239
QUALITY
ASSURANCE930204 5
SIMULTENEOUS
ESTIMATION
73 17-Nov-14 HALL - 11 132540804002
BHIM
MOHMMEDASHIF
IQBAL
Development and Validation of
Analytical Methods for Estimation of
Itopride Hydrochloride and
Lansoprazole in Synthetic Mixture
Dr.Vineet Jain 254QUALITY
ASSURANCE930204 5
SIMULTENEOUS
ESTIMATION
74 17-Nov-14 HALL - 11 132540804005
Patel
Bhavishakumari
Gomanbhai
Development and Validation of
Analytical Methods for Lidocaine
Hydrochloride and Clotrimazole in
Ear Drop
Mr.Nirav
Gheewala254
QUALITY
ASSURANCE930204 5
SIMULTENEOUS
ESTIMATION
75 17-Nov-14 HALL - 11 132540804009savaj bhadresh
vinubhai
Analytical Methods Development and
Validation for Simultaneous
Estimation of Propranolol
Hydrochloride and
Hydrochlorothiazide in Tablet Dosage
Form
Mr.aShutoshku
mar patidar254
QUALITY
ASSURANCE930204 5
SIMULTENEOUS
ESTIMATION
76 17-Nov-14 HALL - 11 132540804012
VARODIYA
PRIYANKABEN
SURESHBHAI
Development and Validation of HPLC
Method for Estimation of Three Drug
Combination (Diacerein,
Glucosamine Sulfate, and Methyl
Sulfonyl Methane)
DR.M.N.NOOL
VI254
QUALITY
ASSURANCE930204 5
SIMULTENEOUS
ESTIMATION
77 17-Nov-14 HALL - 11 132570804001MOCHI NEHABEN
SUDHIRKUMAR
Development and Validation of
Analytical Methods for the
Determination of Nortriptyline and
Pregabalin in Combined
Pharmaceutical Dosage form
Dr Rajesh k
Patel257
QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
78 17-Nov-14 HALL - 11 132570804004shah palak
hemendrabhai
Development and Validation of
Analytical Methods for the
Determination of Levofloxacin and
Ambroxol in Combined
Pharmaceutical Dosage form
Dr Rajesh k
Patel257
QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
79 17-Nov-14 HALL - 12 132390804011
PATEL
SNEHALKUMAR
NAGINBHAI
Analytical method development and
validation of Cilnidipine and
chlorthalidone in combined dosage
form
Madhuri
A.Hinge239
QUALITY
ASSURANCE930204 5
SIMULTENEOUS
ESTIMATION
80 17-Nov-14 HALL - 12 132390804012PATEL UPASNA
DINESHBHAI
Analytical method development and
validation of thiocolchicoside and
lornoxicam in combined dosage form
P.Malairajan 239QUALITY
ASSURANCE930204 5
SIMULTENEOUS
ESTIMATION
81 17-Nov-14 HALL - 12 132390804013
TANDEL
MEHULKUMAR
MAHENDRABHAI
Analytical method development and
validation of Paracetamol and
Diclofenac potassium in combined
dosage form
K.Jessi Kala
Veni239
QUALITY
ASSURANCE930204 5
SIMULTENEOUS
ESTIMATION
82 17-Nov-14 HALL - 12 132390804014Vashi Sneha
Ashokkumar
Analytical method development and
Validation of Loteprednol etabonate
and Tobramycin in combined dosage
form
P.Malairajan 239QUALITY
ASSURANCE930204 5
SIMULTENEOUS
ESTIMATION
83 17-Nov-14 HALL - 12 132390804015ZARNA
RANJITBHAI PATEL
Analytical Method development and
validation for simultaneous
estimation of Ofloxacin and flavoxate
HydroChloride in tablet dosage form
P.Malairajan 239QUALITY
ASSURANCE930204 5
SIMULTENEOUS
ESTIMATION
84 17-Nov-14 HALL - 12 132540804014
ATODARIYA
PRIYANKABAHEN
PRADIPSINH
Development and Validation of
Analytical Methods for Lamotrigine
and Clozapine in Synthetic Mixture
Dr.Vineet Jain 254QUALITY
ASSURANCE930204 5
SIMULTENEOUS
ESTIMATION
85 17-Nov-14 HALL - 12 132540804017
SOJITRA
RAJANITKUMAR
VITTHALBHAI
Development and Validation of
Analytical Methods for Nifedipine
and Metoprolol succinate in
Synthetic Mixture
Dr.Hasumati
Raj254
QUALITY
ASSURANCE930204 5
SIMULTENEOUS
ESTIMATION
86 17-Nov-14 HALL - 12 132540804001AARAF TABASSUM
HIDAYAT
Development and Validation of
Analytical Methods for
Metronidazole Benzoate and Related
Impurities in Bulk and
Pharmaceutical Formulation
Dr.Hasumati
Raj254
QUALITY
ASSURANCE930204 5
SIMULTENEOUS
ESTIMATION
87 17-Nov-14 HALL - 12 132540804003
BUCHIYA
FARHANABANU
VALI ISMAILBHAI
Development and Validation of
Analytical Methods for Estimation of
Cilnidipine and Valsartan in Synthetic
Mixture
Dr.Vineet Jain 254QUALITY
ASSURANCE930204 5
SIMULTENEOUS
ESTIMATION
88 17-Nov-14 HALL - 12 132540804004Lad Meeraben
Vijaybhai
Development and Validation of
Analytical Methods for Simultaneous
Estimation of Bromhexine
Hydrochloride, Guaifenesin and
Chlorpheniramine Maleate in Syrup
Dr.Vineet Jain 254QUALITY
ASSURANCE930204 5
SIMULTENEOUS
ESTIMATION
89 17-Nov-14 HALL - 12 132080804014BHATT TIRTH
ANILKUMAR
Development and Validation of
Analytical Method for Simultaneous
Estimationof Ibuprofen and
Dicyclomine in Pharmaceutical
Dosage Form
Mrs. Mona
Christian208
QUALITY
ASSURANCE930204 1
SIMULTENEOUS
ESTIMATION
90 17-Nov-14 HALL - 13 132390804501
PATEL
KINAKUMARI
DAHYABHAI
Development and validation of
analytical method for simultaneous
estimation of Ondansetron and
Pantoprazole in combined dosage
form
K.Jessi Kala
Veni239
QUALITY
ASSURANCE930204 5
SIMULTENEOUS
ESTIMATION
91 17-Nov-14 HALL - 13 132390804502BINALKUMARI
ASHOKBHAI PATEL
Analytical method development and
validation of Rabeprazole sodium and
Diclofenac potassium in combined
dosage form
K.Jessi Kala
Veni239
QUALITY
ASSURANCE930204 5
SIMULTENEOUS
ESTIMATION
92 17-Nov-14 HALL - 13 132390804503
KEYUREE
VISHNUBHAI
PATEL
Analytical method development and
validation of simultaneous estimation
of Sitagliptin and metformin in Tablet
dosage form
Madhuri
A.Hinge239
QUALITY
ASSURANCE930204 5
SIMULTENEOUS
ESTIMATION
93 17-Nov-14 HALL - 13 132390804002
BHOOMI
BHUPENDRABHAI
MISTRY
Analytical Method Developmentand
validation of Bromhexine
hydrochloride and terbutaline
sulphate in combined dosage form
P.Malairajan 239QUALITY
ASSURANCE930204 5
SIMULTENEOUS
ESTIMATION
94 17-Nov-14 HALL - 13 132390804007PATEL ANKITABEN
SHUKKARBHAI
Spectroscopic and chromatographic
method development and validation
for simultaneous estimation of
dexketoprofen trometamol and
dicyclomine HYDROCHLORIDe
Alisha p. patel 239QUALITY
ASSURANCE930204 5
SIMULTENEOUS
ESTIMATION
Method
development
and validation
95 17-Nov-14 HALL - 13 132540804006Patel Divyaben
Ashokbhai
Development and Validation of
Analytical Methods for Simultaneous
Estimation of Edaravone and
Argatroban in Synthetic Mixture
Dr.Hasumati
Raj254
QUALITY
ASSURANCE930204 5
SIMULTENEOUS
ESTIMATION
96 17-Nov-14 HALL - 13 132540804008
Patel
Vandanabahen
Mahendrabhai
Development and Validation of
Analytical Methods for Amlodipine
Besylate and Simvastatin in Synthetic
Mixture
Dr.Vineet Jain 254QUALITY
ASSURANCE930204 5
SIMULTENEOUS
ESTIMATION
97 17-Nov-14 HALL - 13 132540804013VIRANI PARAS
BABUBHAI
Development and Validation of
Analytical Methods for Simultaneous
Estimation of Irbesartan and
Atorvastatin in Synthetic Mixture
Dr.Vineet Jain 254QUALITY
ASSURANCE930204 5
SIMULTENEOUS
ESTIMATION
98 17-Nov-14 HALL - 13 132540804016
RANA
MONIKABAHEN
AJITSINH
Development and Validation of
Analytical Methods for Levosulpiride
and its Intermediate in bulk drug
Dr.Hasumati
Raj254
QUALITY
ASSURANCE930204 5
SIMULTENEOUS
ESTIMATION
99 17-Nov-14 HALL - 13 132540804018
TRIVEDI
GRISHMABEN
SUMANBHAI
Development and Validation of
Analytical Methods for Simultaneous
Estimation of Pravastatin and
Valsartan in Synthetic Mixture
Dr.Hasumati
Raj254
QUALITY
ASSURANCE930204 5
SIMULTENEOUS
ESTIMATION
100 17-Nov-14 HALL - 14 132080804015PANCHAL PARTH
MAHESHKUMAR
Development and Validation of
Stability Indicating HPLC Method for
Estimation of Cinacalcet
Hydrochloide in Tablets
Dr. Ragin Shah 208QUALITY
ASSURANCE930204 1 STABILITY STUDIES
101 17-Nov-14 HALL - 14 132150804002DESAI CHANDANI
HIRENBHAI
DEVELOPMENT AND VALIDATION OF
HPLC METHOD FOR ESTIMATION OF
THIOCOLCHICOSIDE FROM EXTRACT
OF SEED OF GLORIOSIA SUPERBA.
Mrs. HENAL
CHORAWALA215
QUALITY
ASSURANCE930204 5
OTHER (KINDLY
SPECIFY)
single
COMPONENT
estimation of
analyte from
seed extract
102 17-Nov-14 HALL - 14 132570804009
PATEL
HARESHKUMAR
LAXMANBHAI
Process Validation Study on
Theophylline Extended Release
Tablet
mr. ojas patel 257QUALITY
ASSURANCE930204 2 PROCESS VALIDATION
103 17-Nov-14 HALL - 14 132780804001JIVANI ISHITA
RAMESHBHAI
Analytical Method Development and
Validation For Simultaneous
Estimation of Naltrexone
Hydrochloride and Bupropion
Hydrochloride in Pharmaceutical
Dosage Form
Mrs minakshi
dhoru278
QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
104 17-Nov-14 HALL - 14 132780804002PATEL DHAVAL
ASHOKBHAI
Analytical Method Development and
Validation For Simultaneous
Estimation of Ambrisentan and
Tadalafil in Synthetic Mixture
Dr jitendra S
Patel278
QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
105 17-Nov-14 HALL - 14 132780804003PATEL REEPA
MAHENDRABHAI
Analytical Method Development and
Validation For Simultaneous
Estimation of Voglibose and
Mitiglinide Calcium Hydrate in
Pharmaceutical Dosage Form
Mr sandip
dholakia278
QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
106 17-Nov-14 HALL - 14 132780804004PATEL RICHU
BIPINBHAI
Analytical Method Development and
Validation For Simultaneous
Estimation of Paroxetine and
Amitriptyline in Synthetic Mixture
Dr jitendra S
Patel278
QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
107 17-Nov-14 HALL - 14 132780804005
RANJAN
MADANLAL
CHAUHAN
Analytical Method Development and
Validation For Simultaneous
Estimation of Risperidone and
Desipramine in Synthetic Mixture
Dr jitendra S
Patel278
QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
108 17-Nov-14 HALL - 14 132080804003PATEL NEHABEN
DALSUKHBHAI
Stability Indicating RP-HPLC Method
Development and Validation for
Estimation of Chloramphenicol and
Furbiprofen sodium in
Pharmaceutical Dosage Form
Mrs. Nisha
Parikh208
QUALITY
ASSURANCE930204 1 STABILITY STUDIES
109 17-Nov-14 HALL - 14 132080804010PATEL NIKITA
PASHABHAI
Development and Validation of
Stability Indicting RP-HPLC Method
for the Estimation of Torsemide and
Amiloride HCL in Tablet
Dr. Ragin Shah 208QUALITY
ASSURANCE930204 1 STABILITY STUDIES
110 18-Nov-14 HALL - 01 132640808002
DETROJA
VRUTIBEN
GOPALBHAI
DEVELOPMENT AND IN-VITRO
CHARACTERIZATION OF
ZALTOPROFEN EMULGEL FOR
TOPICAL DRUG DELIVERY
DR. RAMESH b.
parmar264 PHARMACEUTICS 930202 4
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
111 18-Nov-14 HALL - 01 132650808002BHATT KINJAL
ASHWIN
Development and Characterization of
Oxcarbazepine Nanosuspension for
nasal delivery targeted to brain
Miss. Ankita
Patel265 PHARMACEUTICS 930202 5
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
112 18-Nov-14 HALL - 01 132650808004
KOLI
RAHULKUMAR
SANTOSHBHAI
Formulation,Development and
characterization of Microsponge
enriched gel for topical drug delivery
Dr. Anil
Govindrao
Jadhav
265 PHARMACEUTICS 930202 5
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
113 18-Nov-14 HALL - 01 132690808003
ODEDRA
BHARATBHAI
MENANDBHAI
Formulation and development of
Valsartan tablet by Intestinal
Mucoadhesive Drug Delivery System
Mr. tushar
mahajan269 PHARMACEUTICS 930202 4
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
114 18-Nov-14 HALL - 01 132690808009
VASAVA
PUSHPVADANKUM
AR JIVANBHAI
Formulation and Evaluation of
Diclofenac Diethyl amine Microbeads
in Topical Gel for Sustained Drug
Delivery
mr. raval
kashyap269 PHARMACEUTICS 930202 4
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
115 18-Nov-14 HALL - 01 132780808001
CHAUHAN
KALPANABEN
NARESHBHAI
Formulation and Evaluation of Muco
Adhesive Buccal Film of A High First
Pass Metabolism Drug
Mr Rakshit N.
Sonpal278 PHARMACEUTICS 930202 2
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
116 18-Nov-14 HALL - 01 132780808002CHAVDA DIVYA
KRUSHNAKUMAR
Formulation and Evaluation of an
Iontophoretic Drug Delivery System
of a Hydrophilic Antihypertensive
Drug
Mr Rakshit N.
Sonpal278 PHARMACEUTICS 930202 2
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
117 18-Nov-14 HALL - 01 132780808004HARDIKKUMAR A
SHAH
Formulation, Evaluation and
Comparison of Transdermal Patch
and Proniosomal Gel of An Anti-
Parkinson’s Drug
Mr Rakshit N.
Sonpal278 PHARMACEUTICS 930202 2
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
118 18-Nov-14 HALL - 01 132780808005JOSHI VIRAG
VIJAYKUMAR
Development and Evaluation of
Muco – Adhesive Buccal Tablet of An
Anti-Allergic Drug
Mr Rakshit N.
Sonpal278 PHARMACEUTICS 930202 2
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
119 18-Nov-14 HALL - 01 132640808009PATEL PRITIBEN
RAJESHKUMAR
Formulation and In-vitro
characterization of Transdermal
Patch of Terbutaline Sulphate
DR. RAMESH b.
parmar264 PHARMACEUTICS 930202 4
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
120 18-Nov-14 HALL - 01 132640808004Vijeta
Bhattacharya
Design,Formulation and Evaluation of
Soluble Soft Gel Ocular Insert Of
Ketorolac Tromethamine using
Modified Locust Bean Gum
DR. RAMESH b.
parmar264 PHARMACEUTICS 930202 4
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
Ocular Insert
121 18-Nov-14 HALL - 02 132310808002
DHANEJA
BHAGIRATHKUMA
R MANILAL
a COMPARATIVE STUDY ON
DISSOLUTION ENHANCEMENT of
orlistat.
Dr. Sandip
Patel231 PHARMACEUTICS 930202 4
OTHER (KINDLY
SPECIFY)
comparative
study on
dissolution
enhancement
122 18-Nov-14 HALL - 02 132640808001
BUDDHADEV
ANKIT
JITENDRABHAI
Medicated Oral Jelly a novel
approach for the treatment of cough
: formulation and in vitro evaluation
DR. RAMESH b.
parmar264 PHARMACEUTICS 930202 4
OTHER (KINDLY
SPECIFY)
Jelly type
formulation
123 18-Nov-14 HALL - 02 132640808003
MADHANI
DIPAVALI
RANCHHODBHAI
ENHANCEMENT OF SOLUBILITY AND
DISSOLUTION RATE OF ETODOLAC BY
USING SOLID DISPERSION
TECHNIQUE.
DR. RAMESH b.
parmar264 PHARMACEUTICS 930202 4
CO PROCESSED, DC,
TABLET/CAPSULE
EXCIPIENTS AND
ATTRIBUTES
SOLID
DISPERSION
TECHNIQUE
124 18-Nov-14 HALL - 02 132640808007KARIA ITI
NILESHBHAI
Formulation and evaluation of fast
dissolving tablets of Olmesartan
medoxomil by using co-processed
excipients technique
DR. RAMESH b.
parmar264 PHARMACEUTICS 930202 4
CO PROCESSED, DC,
TABLET/CAPSULE
EXCIPIENTS AND
ATTRIBUTES
125 18-Nov-14 HALL - 02 132650808005PANDYA MIRAL
ASHWINKUMAR
Formulation and Evaluation of
semisolid matrix filled capsule of
Tamoxifen citrate
Dr. Sachin
Bhaskar
Narkhede
265 PHARMACEUTICS 930202 5
CO PROCESSED, DC,
TABLET/CAPSULE
EXCIPIENTS AND
ATTRIBUTES
126 18-Nov-14 HALL - 02 132690808004RAMANI PRITESH
MATHURBHAI
The Aim of present Study was to
Development and characterization of
time dependent IRBESARTAN Loaded
pulsatile release tablet for
Chronotherapy of Hypertension.
mr. raval
kashyap269 PHARMACEUTICS 930202 4
OTHER (KINDLY
SPECIFY)
time dependent
IRBESARTAN
Loaded pulsatile
release tablet
127 18-Nov-14 HALL - 02 132690808008
VALA
HASMUKHBHAI
SADABHAI
Design and Development of
Sustained Release Matrix
Formulation Of Bupropion
Hydrochloride
miss. komal
dhudashia269 PHARMACEUTICS 930202 4
OTHER (KINDLY
SPECIFY)
Sustained
Release Matrix
Formulation
128 18-Nov-14 HALL - 03 132650808006Patel Bhoomi
Gulabbhai
Enhancement of bioavailability of
furosemide by floating liquisolid
compacts
Dr. Sachin
Bhaskar
Narkhede
265 PHARMACEUTICS 930202 5
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
129 18-Nov-14 HALL - 03 132650808011PATIL PRIYANKA
RAMDASBHAI
Formulation and Development of
Sustained release tablets of
Ranolazine prepared using
“Polyelectrolyte Complex”
Dr. Anil
Govindrao
Jadhav
265 PHARMACEUTICS 930202 5
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
130 18-Nov-14 HALL - 03 132650808013Yadav Rajabhaiya
Chunkavan
Formulation and Evaluation of
Ganciclovir Microsphere for oral
extended release
Mr. Ajay Talele 265 PHARMACEUTICS 930202 5
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
131 18-Nov-14 HALL - 03 132650808015
PATEL
ZANKHNABEN
NARESHBHAI
Formulation evaluation and
optimization of Gastroretentive
Floating Bilayer tablet of Gliclazide
and Vildagliptin
Mr. Shailesh
Vijayendra
Luhar
265 PHARMACEUTICS 930202 5
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
132 18-Nov-14 HALL - 03 132650808017
TANDEL
CHANDNIBAHEN
THAKORBHAI
Formulation and Evaluation of
Microsphere-loaded Oral in-situ gel
of Aminophylline
Dr. Sachin
bhaskar
Narkhede
265 PHARMACEUTICS 930202 5
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
133 18-Nov-14 HALL - 03 132730808001
PARMAR
RAJESHKUMAR
KANUBHAI
DEVELOPMENT AND EVALUATION OF
EXTENDED RELEASE TABLET OF ANTI-
HYPERTENSIVE DRUG
mR. parimal m.
prajapati273 PHARMACEUTICS 930202 2
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
134 18-Nov-14 HALL - 03 132780808003CHAVDA HIRAL
DILIPSINH
Formulation and Evaluation of
Modified Pulsincap as Pulsatile Drug
Delivery System for treatment of
Rheumatoid Arthritis
Dr Madhabhai
M. Patel278 PHARMACEUTICS 930202 2
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
135 18-Nov-14 HALL - 03 132780808009
PATEL
NILESHKUMAR
BALDEVBHAI
Formulation and Evaluation of
Sustained Release Suppositories of an
Anti – Infective Drug
Mr Rakshit N.
Sonpal278 PHARMACEUTICS 930202 2
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
136 18-Nov-14 HALL - 03 132780808010PATEL SNEHA
RAMESHCHANDRA
Formulation and Evaluation of a
Novel Size Expanding Gastro
Retentive Drug Delivery System For
Treatment of Peptic Ulcer
Dr Madhabhai
M. Patel278 PHARMACEUTICS 930202 2
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
137 18-Nov-14 HALL - 03 132780808014GOHIL FALGUNI
CHHAGANLAL
Formulation and Evaluation of High
Density Gastro Retentive Drug
Delivery System of An Anti-
Hypertensive Drug
Mr Rakshit N.
Sonpal278 PHARMACEUTICS 930202 2
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
138 18-Nov-14 HALL - 04 132630808001
CHOTALIYA
ANILKUMAR
RAMNIKLAL
FORMULATION AND EVALUATION OF
CURCURMIN CHEWABLE TABLET
Mr. RONAK
KAMANI263 PHARMACEUTICS 930202 4
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
139 18-Nov-14 HALL - 04 132630808003MANSETA VIRAL
HASMUKHRAI
Formulation and evaluation of mouth
dissolving tablet of fexofenardine
hydrochloride
Mr. RONAK
KAMANI263 PHARMACEUTICS 930202 4
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
140 18-Nov-14 HALL - 04 132650808001 AJAY A NAIRFormulation and Evaluation of
Avanafil Orodispersible tablet
Dr. Anil
Govindrao
Jadhav
265 PHARMACEUTICS 930202 5
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
141 18-Nov-14 HALL - 04 132650808003 DIXIT NIKI SUNIL
Formulation , Evaluation and
Optimization of Orodispersible tablet
of Taste-masked Zafirlukast
Mr. Shailesh
Vijayendra
Luhar
265 PHARMACEUTICS 930202 5
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
142 18-Nov-14 HALL - 04 132690808002MATHUKIYA RAVI
DILSUKHRAY
Evaluation of Spray Dried Co-
Processed Excipients in Oro-
Dispersible Tablet
Mr. tushar
mahajan269 PHARMACEUTICS 930202 4
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
143 18-Nov-14 HALL - 04 132690808005RAVIYA JIGNESH
RAJANIBHAI
The Aim of Present Study was to
Formulation and Evolution of
Sublingual Tablet of VENLAFAXINE
HYDROCHLRIDE.
miss. komal
dhudashia269 PHARMACEUTICS 930202 4
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
144 18-Nov-14 HALL - 04 132780808011PATEL SNEHAL
RAJUBHAI
Formulation and Evaluation of Mouth
Dissolving Tablets of a Anti –
Migraine Drug by Different
Techniques
Dr Madhabhai
M. Patel278 PHARMACEUTICS 930202 2
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
145 18-Nov-14 HALL - 05 132630808005
SANGANI
BHAVINKUMAR
PARSHOTTAMBHAI
FORMULATION AND EVALUATION OF
controlled RELEASE carvedilol
phosphate capsule
Mr. RONAK
KAMANI263 PHARMACEUTICS 930202 4
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
146 18-Nov-14 HALL - 05 132640808005
AJMERA
SIDDHARTH
HARESHKUMAR
formulation and evaluation of
stomach specific in situ gel of
lafutidine
DR. RAMESH b.
parmar264 PHARMACEUTICS 930202 4
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
147 18-Nov-14 HALL - 05 132640808006
BHALODIA
MEETKUMAR
KANTILAL
Design Development and evaluation
of oral dispensable tablet of
antihypertensive drug
DR. RAMESH b.
parmar264 PHARMACEUTICS 930202 4
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
148 18-Nov-14 HALL - 05 132640808011SHINOJIYA NIDHI
KANTIBHAI
Design Development and evaluation
of ocular in situ gel As a vehicle for
anti glucoma drug
DR. RAMESH b.
parmar264 PHARMACEUTICS 930202 4
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
149 18-Nov-14 HALL - 05 132640808012THUMAR ARATI
JENTILAL
Formulation and Evaluation of
Floating Beads of Metoclopramide
Hydrochloride
DR. RAMESH b.
parmar264 PHARMACEUTICS 930202 4
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
150 18-Nov-14 HALL - 05 132650808008Patel Nehakumari
Manubhai
Development and characterization of
Oro-dispesible tablet of
Esomeprazole
Miss. Ankita
Patel265 PHARMACEUTICS 930202 5
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
151 18-Nov-14 HALL - 05 132650808009PATEL RONAKBEN
RAJNIKANTBHAI
Formulation and evaluation of
sublingual tablet of LoratadineMr. Ajay Talele 265 PHARMACEUTICS 930202 5
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
152 18-Nov-14 HALL - 05 132650808010PATEL TANVI
JAYSUKHLAL
Formulation and Evaluation of Raft
forming Chewable tablet of
Lafutidine
Mr. Ajay Talele 265 PHARMACEUTICS 930202 5
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
153 18-Nov-14 HALL - 05 132640808013VARMORA VIJAY
BABUBHAI
FORMULATION AND EVALUATION OF
MOUTH DISSOLVING FILM OF
ALMOTRIPTAN MALATE
DR. RAMESH b.
parmar264 PHARMACEUTICS 930202 4
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
154 18-Nov-14 HALL - 06 132310808001SINHAR MINABEN
JAYSUKHLAL
formulation and EVALUATION of
niosomal ocular insitu gel of
gatifloxacin
Dr. S.saisivam 231 PHARMACEUTICS 930202 4VESICULAR DRUG
DELIVERY SYSTEM
155 18-Nov-14 HALL - 06 132310808003
SADHU
PIYUSHKUMAR
KRUSHNARAM
design and characterization of
niosomes containing ethionamide.
Mr. Sujit
kumar
debnath
231 PHARMACEUTICS 930202 4VESICULAR DRUG
DELIVERY SYSTEM
156 18-Nov-14 HALL - 06 132640808010SHETH NIKET
RAJENDRAUMAR
formulation and in vitro evaluation of
extended release microsphere of
gabapentin enacarbil
DR. RAMESH b.
parmar264 PHARMACEUTICS 930202 4 MULTIPARTICULATE
157 18-Nov-14 HALL - 06 132690808006SIKOTARIYA VIVEK
MAHESH
Design Development and Evaluation
of Sustained Release Multiparticulate
System of Valsartan
Mr. tushar
mahajan269 PHARMACEUTICS 930202 4 MULTIPARTICULATE
158 18-Nov-14 HALL - 06 132780808007
PATEL
JAYMINKUMAR
GOVINDBHAI
Formulation and Evaluation of
Multiple Mini Tablets Containing Anti
– Diabetic Drug
Dr Madhabhai
M. Patel278 PHARMACEUTICS 930202 2 MULTIPARTICULATE
159 18-Nov-14 HALL - 06 132780808012SHAH JAYKUMAR
PRAKASHKUMAR
Preparation and Evaluation of
Multiple Unit Pellet System (MUPS)
of an Anti - Hypertensive Drug
Dr Madhabhai
M. Patel278 PHARMACEUTICS 930202 2 MULTIPARTICULATE
160 18-Nov-14 HALL - 07 132310808004
SOJITRA
PRIYANKABAHEN
CHANDUBHAI
formulation and CHARACTERIZATION
of eye drops containing nanoparticles
of moxifloxacin
dr. s. saisivam 231 PHARMACEUTICS 930202 4
NANO
SUSPENSION/EMULSI
ON, SEDDS, LIPID
BASED DDS
nanoparticles
161 18-Nov-14 HALL - 07 132310808005
VAZA
BHAGVATIBEN
KESHAVBHAI
Formulation and evaluation of mouth
dissolving films of ketotifen fumarate
sumit
chakraborty231 PHARMACEUTICS 930202 4
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
film
162 18-Nov-14 HALL - 07 132650808007Patel Meghaben
Manharbhai
Development and Evaluation of colon
targeted tablet of Celecoxib and
Curcumin
Dr. Sachin
bhaskar
Narkhede
265 PHARMACEUTICS 930202 5 MISCELANEOUS Colon targeted
163 18-Nov-14 HALL - 07 132650808012Varu Mital
Babubhai
Development and Evaluation of
Bilayer matrix tablet of Lornoxicam
and Thiocolchicoside
Dr. Anil
Govindrao
Jadhav
265 PHARMACEUTICS 930202 5 MISCELANEOUSBILAYER
MATRIX TABLET
164 18-Nov-14 HALL - 07 132650808014 PATEL BINAL
Formulation and Evaluation of Colon
targeted tablet of Olmesartan
medoxomil for chronotherapy
Mr. Shailesh
Vijayendra
Luhar
265 PHARMACEUTICS 930202 5 MISCELANEOUS Colon targeted
165 18-Nov-14 HALL - 07 132690808001HIRPARA JAYDEEP
JASUBHAI
Development and Characterization of
Self Micro emulsifying Drug delivery
System for Improvement of
Bioavailability of CEFDINIR.
Prof. Santosh
kirtane269 PHARMACEUTICS 930202 4
NANO
SUSPENSION/EMULSI
ON, SEDDS, LIPID
BASED DDS
166 18-Nov-14 HALL - 07 132780808006PATEL EKTABEN
JAYESHBHAI
Solubility Enhancement of a Poorly
Soluble Drug using Solid Dispersion
and ß Cyclo Dextrin Inclusion
Complex
Dr Madhabhai
M. Patel278 PHARMACEUTICS 930202 2
OTHER (KINDLY
SPECIFY)
SOLUBILITY
ENHANCEMENT
167 18-Nov-14 HALL - 07 132780808008PATEL KINJALBEN
ASHVINBHAI
Formulation and Evaluation of Patent
Non – Infringement Sustained
Release Tablet of an Anti – Anginal
Drug
Dr Madhabhai
M. Patel278 PHARMACEUTICS 930202 2
OTHER (KINDLY
SPECIFY)
patent non
infringement
formulation
168 18-Nov-14 HALL - 07 132780808013VADALIA PARTH
ASHWINBHAI
Formulation and Evaluation of Self
Micro Emulsifying Drug Delivery
System of a Hydrophobic Drug
Dr Madhabhai
M. Patel278 PHARMACEUTICS 930202 2
NANO
SUSPENSION/EMULSI
ON, SEDDS, LIPID
BASED DDS
169 18-Nov-14 HALL - 08 132630804003PANDARE TEJAS
SUBHASH
DEVELOPMENT AND VALIDATION OF
RP-HPLC METHOD FOR
SIMULTANEOUS ESTIMATION OF
ISONIAZID AND PYRIDOXINE IN THEIR
COMBINED PHARMACEUTICAL
DOSAGE FORM
dR. SHITAL
FALDU263
QUALITY
ASSURANCE930204 4
SIMULTENEOUS
ESTIMATION
170 18-Nov-14 HALL - 08 132630804005VALANKI LALJI
BHUPATBHAI
analytical method development and
validation for SIMULTANEOUS
ESTIMATION OF CLINIDIPINE AND
CHLORTHALIDONE IN ITS
PHARMACEUTICAL DOSAGE FORM by
HPLC
dR. SHITAL
FALDU263
QUALITY
ASSURANCE930204 4
SIMULTENEOUS
ESTIMATION
171 18-Nov-14 HALL - 08 132820804004
SHAIKH
TEHMINAKHATUN
ABDULSAMAD
Development and Validation of
Analytical methods for simultaneous
estimation of Cinitapride and
Pantoprazole in Pharmaceutical
Dosage form.
Miss. jigisha
patel282
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
172 18-Nov-14 HALL - 08 132690804003
RAJANI
PARTHKUMAR
RATANSHIBHAI
Analytical method Development and
validation for simultaneous
estimation of Aceclofenac and
Pregabalin in their combined
marketed formulation
mr. raval
kashyap269
QUALITY
ASSURANCE930204 4
SIMULTENEOUS
ESTIMATION
173 18-Nov-14 HALL - 08 132820804006ZANKAT JIGNABEN
RAGHUBHAI
Development and Validation of
Analytical methods for simultaneous
estimation of Azilsartan and
Amlodipine in synthetic mixture.
Mr. Mayank
bapna282
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
174 18-Nov-14 HALL - 08 132820804002PATEL MILINDBHAI
BHUPENDRABHAI
Development and Validation of
Analytical methods for simultaneous
estimation of Salicylic acid and
Betamethasone dipropoinate from
their combined topical formulation.
Mr. Mayank
bapna282
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
175 18-Nov-14 HALL - 08 132820804007BHATT DHRUPAD
ASHISHBHAI
Method development and validation
for simultaneous estimation of
Phenylephrine and Ketorolacin the
Pharmaceutical Dosage form.
Mrs. harsha d.
jani282
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
176 18-Nov-14 HALL - 08 132820804008
BHOI
KHUSHBUBEN
GIRISHKUMAR
Development and Validation of
Analytical methods for simultaneous
estimation of Cilnidpine and
Chlorthalidoen in their combined
dosage form.
Mr. Mayank
bapna282
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
177 18-Nov-14 HALL - 08 132310804008
RABADIYA
PRATIKKUMAR
RAMNIKLAL
analytical method development and
validation for simultaneous
estimation of mupirocin and
fluticasone in bulk and
pharmaceutical dosage form
mr. sibaji
sarkar231
QUALITY
ASSURANCE930204 4
SIMULTENEOUS
ESTIMATION
178 18-Nov-14 HALL - 08 132310804001BABARIYA BHAVIN
KANUBHAI
Development and validation of
spectrophotometric and rp-hplc
method for determination of
chloramphenicol and flurbiprofen
sodium in bulk and its combined
dosage form.
Mr.
Dillipkumar
dash
231QUALITY
ASSURANCE930204 4
SIMULTENEOUS
ESTIMATION
179 18-Nov-14 HALL - 08 132310804002
CHUDASAMA
PRADIPKUMAR
RATILAL
SIMULTANEOUS estimation of
atropine sulphate and
dexamethasone sodium phosphate in
eye drop by hplc.
Mr.
ashwinkumar
agola
231QUALITY
ASSURANCE930204 4
SIMULTENEOUS
ESTIMATION
180 18-Nov-14 HALL - 09 132640804001
ANJANA
GOVINDBHAI
PADHIYAR
development and validation of
analytical method for simultaneous
estimation of calcium drobesilate and
docusate sodium in their combined
dosage form
dr. parula b.
patel264
QUALITY
ASSURANCE930204 4
SIMULTENEOUS
ESTIMATION
181 18-Nov-14 HALL - 09 132640804004
CHAUHAN
NEETUBEN
RAMESHCHANDRA
developement and validation of
analytical methods for simultaneous
estimation of imipramine and
cilostazol in their parentral
formulation
dr. parula b.
patel264
QUALITY
ASSURANCE930204 4
SIMULTENEOUS
ESTIMATION
182 18-Nov-14 HALL - 09 132820804010CHAUHAN
CHHAYA KALIDAS
Development and Validation of
Analytical method for simultaneous
estimation of Methylcobolamine and
Duloxetine in Pharmaceutical dosage
form.
Miss. jigisha
patel282
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
183 18-Nov-14 HALL - 09 132820804011CHAUHAN STANAL
NIXON
Development and Validation of Bio-
analytical method for simultaneous
estimation of Amlodipine Besylate
and Indapamide in human plasma
Miss. jigisha
patel282
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
184 18-Nov-14 HALL - 09 132820804012JADAV PAYAL
BALUBHAI
Development and Validation of
Analytical method for simultaneous
estimation of Betamethasone,
Tolnaftate, Iodochlorohydroxyquin in
Pharmaceutical Dosage form.
Mr. Mayank
bapna282
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
185 18-Nov-14 HALL - 09 132820804013PATEL FAIZAL
ILYASBHAI
Analytical method development and
validation for simultaneous
estimation of Ilaprazole and
Domperidone
Mrs. harsha d.
jani282
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
186 18-Nov-14 HALL - 09 132820804014
PATEL
NARESHKUMAR
RAMCHANDRA
Development and Validation of
analytical method for simultaneous
estimation of Minoxidil and
Finasteride in bulk and
Pharmaceutical Dosage form.
Miss. jigisha
patel282
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
187 18-Nov-14 HALL - 09 132640804003BABIYA PARITA
KARSHANBHAI
development and validation of
analytical methods for simultaneous
estimation of metronidazole and
oxytetra cycline in their combined
dosage form
dr. parula b.
patel264
QUALITY
ASSURANCE930204 4
SIMULTENEOUS
ESTIMATION
188 18-Nov-14 HALL - 09 132640804008
MITAL GHADIYA
D/O
PARSOTAMBHAI
development and validation of
analytical method for simultaneous
estimation of cilnidipine and
chlorthalidone by hplc
dr. parula b.
patel264
QUALITY
ASSURANCE930204 4
SIMULTENEOUS
ESTIMATION
189 18-Nov-14 HALL - 09 132640804010
PARMAR
SNEHABEN
HARESHKUMAR
development and validation of
analytical method for simultaneous
estimation of atropine sulphate,
chloramphenicol and
dexomethasone sodium phosphate in
their combined ophthalmic
formulation
dr. parula b.
patel264
QUALITY
ASSURANCE930204 4
SIMULTENEOUS
ESTIMATION
190 18-Nov-14 HALL - 10 132310804003Patel Jyoti
Dineshbhai
ANALYTICAL METHOD
DEVELOPMENT AND VALIDATION of
tizanidine and diclofenac pottasium
in BULK AND COMBINED DOSAGE
FORM.
mr. sibaji
sarkar231
QUALITY
ASSURANCE930204 4
SIMULTENEOUS
ESTIMATION
191 18-Nov-14 HALL - 10 132310804005RAVAL MAYURI
ASHOKKUMAR
Analytical method development and
validation for simultaneous
estimation of aspirin and isosorbide
mononitrate in pharmaceutical solid
dosage form
ashwinkumar
agola231
QUALITY
ASSURANCE930204 4
SIMULTENEOUS
ESTIMATION
192 18-Nov-14 HALL - 10 132310804006
GAJERA
SIDHDHARTHKUM
AR VINODBHAI
simultaneous hplc estimation of
desoximetasone and clotrimazole in
cream formulation
mr. sibaji
sarkar231
QUALITY
ASSURANCE930204 4
SIMULTENEOUS
ESTIMATION
193 18-Nov-14 HALL - 10 132640804007
KUNDALIA
AMITABEN
ISHVARBHAI
dvelopment and validation of
analytical method for simultaneous
estimation of piracetam and
methylcobalamine in their combined
dosage form
dr. parula b.
patel264
QUALITY
ASSURANCE930204 4
SIMULTENEOUS
ESTIMATION
194 18-Nov-14 HALL - 10 132640804009
PARMAR
MRUGESHKUMAR
PARSOTAMBHAI
development and validation of
analytical method for simultaneous
estimation of diloxanite furoate and
ornidazole in their combined dosage
form
dr. parula b.
patel264
QUALITY
ASSURANCE930204 4
SIMULTENEOUS
ESTIMATION
195 18-Nov-14 HALL - 10 132820804015
PATEL
PRATIKKUMAR
ASHOKBHAI
Method development and validation
for simultaneous estimation of
Nifedipine and Lignocaine in the
Pharmaceutical Dosage form
Mrs. harsha d.
jani282
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
196 18-Nov-14 HALL - 10 132820804017
PATEL
SHIVANGIBEN
DAXESHKUMAR
Development and Validation of
Analytical methods for simultaneous
estimation of Moxifloxacin HCI and
Loteprednol Etabonate in its bulk and
pharmaceutical dosage form
Miss. jigisha
patel282
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
197 18-Nov-14 HALL - 10 132820804018
SHEKH
MAHMADTAUFIQ
MAHMADKASAM
Method development and validation
for simultaneous estimation of
Gliclazide, Metformin and Voglibose
in the pharmaceutical dosage form
Mrs. harsha d.
jani282
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
198 18-Nov-14 HALL - 10 132310804007
KHEMANI
BHAVESH
VINODKUMAR
analytical method development and
validation for simultaneous
estimation of clinidipine and
chlorthalidone in bulk and its solid
dosage form.
Mr.
Dillipkumar
dash
231QUALITY
ASSURANCE930204 4
SIMULTENEOUS
ESTIMATION
199 18-Nov-14 HALL - 10 132640804006
KARCHALIYA
CHETNA
VALLABHDAS
development and validation of
analytical methods for simultaneous
estimation of amytriptyline
hydrochloride and methylcobalamine
in their tablet dosage form
dr. parula b.
patel264
QUALITY
ASSURANCE930204 4
SIMULTENEOUS
ESTIMATION
200 18-Nov-14 HALL - 11 132270804014
Rathod
Jaldeepsinh
Vijaysinh
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHODS FOR
SIMULTANEOUS ESTIMATION OF
CILNIDIPINE AND VALSARTAN IN
SYNTHETIC MIXTURE.
MS.SWETA
PATEL227
QUALITY
ASSURANCE930204 1
SIMULTENEOUS
ESTIMATION
201 18-Nov-14 HALL - 11 132330804004
Dukandar
Abdulaziz
Daudbhai
A. Process Validation Of Ibuprofen
Film Coated Tablet BP. B.
Determination And Comparison Of
Nicotine Content In Various Brands
Of Smoking Tobacco Products.
Mrs. Falguni B.
Tandel233
QUALITY
ASSURANCE930204 3 PROCESS VALIDATION
202 18-Nov-14 HALL - 11 132330804008mistry jigisha
dineshbhai
Process Validation and Design Space
Study of Sitagliptin and Metformin
Hydrochloride Tablet.
Mr. Rikin Patel 233QUALITY
ASSURANCE930204 3 PROCESS VALIDATION
203 18-Nov-14 HALL - 11 132330804015
RATHAVA
RAKESHKUMAR
MOHANBHAI
Process Validation Of Loratadine
Tablet With Risk Assessment Study.
Ms. Dhara
Rathod233
QUALITY
ASSURANCE930204 3 PROCESS VALIDATION
204 18-Nov-14 HALL - 11 132330804017PATEL PURVI
JAYANTIBHAI
Process Validation Of Mefenamic
Acid Tablet With Risk Assessment
Study
Mr. Rikin Patel 233QUALITY
ASSURANCE930204 3 PROCESS VALIDATION
205 18-Nov-14 HALL - 11 132330804512SINGH ANJALI
VIJAY
Process Validation and Risk
Assessment Study of MEBEVERINE
HYDROCHLORIDE Tablet
Ms. Dhara
Rathod233
QUALITY
ASSURANCE930204 3 PROCESS VALIDATION
206 18-Nov-14 HALL - 11 132330804517PANDYA SEJALBEN
HARESHKUMAR
Process validation and design space
study of IBCAMOL capsule.
Ms. Dhara
Rathod233
QUALITY
ASSURANCE930204 3 PROCESS VALIDATION
207 18-Nov-14 HALL - 11 132820804005VYAS DISHANK
VIJAYKUMAR
Development and Validation of
colorimetric method for estimation
of Blonanserin in Pharmaceutical
Dosage form.
Miss. jigisha
patel282
QUALITY
ASSURANCE930204 3 PROCESS VALIDATION
208 18-Nov-14 HALL - 11 132820804003PATEL SWAPNIL
KIRTIBHAI
Development and Validation of HPLC
method for estimation of Blonanserin
in Pharmaceutical Dosage form.
Mr. Mayank
bapna282
QUALITY
ASSURANCE930204 3 PROCESS VALIDATION
209 18-Nov-14 HALL - 11 132820804009CHANDNANI
BHAVNA VASUDEV
Implementation of Quality by design
approach to analytical method
development and validation for
estimation of morniflumate in bulk
dosage form.
Mr. Mayank
bapna282
QUALITY
ASSURANCE930204 3 PROCESS VALIDATION
210 18-Nov-14 HALL - 12 132270804502
JADAV JIGNASHA
MAHENDRAKUMA
R
ANALYTICAL METHOD
DEVELOPMENT AND VALIDATION
FOR SIMULTANEOUS ESTIMATION
OF pRAZOSIN AND PROPRANOLOL in
synthetic Mixture
DR.JIGNESH
SHAH227
QUALITY
ASSURANCE930204 1
SIMULTENEOUS
ESTIMATION
211 18-Nov-14 HALL - 12 132270804503PATEL RADHIKA
SANJAYBHAI
ANALYTICAL METHOD
DEVELOPMENT AND VALIDATION
FOR SIMULTANEOUS ESTIMATION
OF TADALAFIL AND FLUOXETINE HCL
IN SYNTHETIC MIXTURE
DR.DILIP
MAHESHWARI227
QUALITY
ASSURANCE930204 1
SIMULTENEOUS
ESTIMATION
212 18-Nov-14 HALL - 12 132270804002Chodvadiya foram
jaysukhlal
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHODS FOR
SIMULTANEOUS ESTIMATION OF
ASPIRIN AND LANSOPRAZOLE IN
SYNTHETIC MIXTURE
MS.KRUPA
THULA227
QUALITY
ASSURANCE930204 1
SIMULTENEOUS
ESTIMATION
213 18-Nov-14 HALL - 12 132330804001BAROT SHIVANGI
DIPESHKUMAR
Simultaneous Estimation of
CETRIMIDE and GAMMA BENZENE
HYDROCHLORIDE by UV and HPLC
METHOD.
Mrs. Lalit Lata
Jha233
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
214 18-Nov-14 HALL - 12 132330804011PARMAR VIKRITA
MAHIPATSINH
Development and validation of
analytical method for simultaneous
estimation of Terbutaline sulphate
and Etofylline
Mr. Rakesh
Patel233
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
215 18-Nov-14 HALL - 12 132330804013Patel Malvika
naginbhai
Development and Validation of
Analytical Method for Simultaneous
Estimation of Ramipril and
Candesartan Cilexetil
Mr. Akhil
Nagar233
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
216 18-Nov-14 HALL - 12 132330804020
MIRZA
MAZHARHUSEN
GULAMMOHIYUD
DIN
Analytical method development and
validation of Diethyl Carbamazine
citrate ,Guaiphenesin and Cetrizine
Hydrochloride
Ms. Dhara
Rathod233
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
217 18-Nov-14 HALL - 12 132330804502
JADAV
PRAGNESHKUMAR
KAUSHIKBHAI
Method development and validation
for detection and quantification of
pesticides in BACOPA MONNIERI.
Ms. Komal
Patel233
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
218 18-Nov-14 HALL - 13 132270804003DAVE VISHWA
MUKESHBHAI
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHODS FOR
SIMULTANEOUS ESTIMATION OF
ENALAPRIL MALEATE AND
CHLORTHALIDONE IN SYNTHETIC
MIXTURE
MR.ARJUNSIN
H GOHIL227
QUALITY
ASSURANCE930204 1
SIMULTENEOUS
ESTIMATION
219 18-Nov-14 HALL - 13 132270804008Patel Drashti
Mahendrabhai
ANALYTICAL METHOD
DEVELOPMENT AND VALIDATION
FOR SIMULTANEOUS ESTIMATION OF
NEBIVOLOL AND CILNIDIPINE IN
PHARMACEUTICAL DOSAGE FORM
MS.SWETA
PATEL227
QUALITY
ASSURANCE930204 1
SIMULTENEOUS
ESTIMATION
220 18-Nov-14 HALL - 13 132270804505
AMRIN
AHMEDBHAI
GHANCHI
ANALYTICAL METHOD
DEVELOPMENT AND VALIDATION
FOR SIMULTANEOUS ESTIMATION
OF THIOCOLCHICOSIDE AND
HYDROCHLORTHIAZIDE
DR.DILIP
MAHESHWARI227
QUALITY
ASSURANCE930204 1
SIMULTENEOUS
ESTIMATION
221 18-Nov-14 HALL - 13 132330804009panchal artiben
ashokbhai
Method Development, Validation of
FT-IR And Comparison of FT-IR And
RP-HPLC For Estimation of 1,4-
Dihydropyridines In Bulk And
Pharmaceutical Formulation.
Mr.Ashish
Patel233
QUALITY
ASSURANCE930204 3
OTHER (KINDLY
SPECIFY)
METHOD
DEVELOPMENT
222 18-Nov-14 HALL - 13 132330804010Parmar Riddhi
Virendrabhai
Risk Assessment study of
Formulation development of
Ketorolac Tromethamine and
Phenylephrine Hydrochloride
Immediate release tablet;Analytical
method development and validation
for simultaneous estimation of drugs
in Immediate release tablet
Mrs. Falguni B.
Tandel233
QUALITY
ASSURANCE930204 3
OTHER (KINDLY
SPECIFY)
METHOD
DEVELOPMENT
AND QUALITY
RISK
MANAGEMENT
223 18-Nov-14 HALL - 13 132330804016
MAHESHWARI
JAYMALA
PITAMBARDAS
Development Of Dissolution Method
and Process Validation Of
Paracetamol And Caffeine Fixed Dose
Combination.
Dr. Sulekha
Bhadra233
QUALITY
ASSURANCE930204 3
OTHER (KINDLY
SPECIFY)
PROCESS
VALIDATION
AND
DISSOLUTION
STUDIES
224 18-Nov-14 HALL - 13 132330804505
PARMAR
KINJALBEN
AJITSINH
Process validation and analytical
method development and validation
of DESLORATIDINE.
Mrs. Falguni B.
Tandel233
QUALITY
ASSURANCE930204 3
OTHER (KINDLY
SPECIFY)
METHOD
DEVELOPMENT
AND PROCESS
VALIDATION
225 18-Nov-14 HALL - 13 132330804514VAIDYA NIDHI
RAJESHKUMAR
Manufacturing process validation of
a HERBO MINERAL PREPARATION
and Quantification of its Major
phytoconstituents.
Ms. Nikita
Patel233
QUALITY
ASSURANCE930204 3
OTHER (KINDLY
SPECIFY)
PROCESS
VALIDATION
AND HERBAL
226 18-Nov-14 HALL - 13 132630804001
CHABHADIYA
ANILKUMAR
DHIRUBHAI
analytical method DEVELOPMENT
AND VALIDATION OF a STABILITY
INDICATING METHODS FOR
SIMULTANEOUS ESTIMATION OF
PARACETAMOL and ETODOLAC IN
their combined pharmaceutical
dosage form
Mr. DARSHAN
MADIYA263
QUALITY
ASSURANCE930204 4 STABILITY STUDIES
227 18-Nov-14 HALL - 13 132640804005
JOBANPUTRA
KHYATI
ASHWINBHAI
developement and validation of
stability indicating hplc method for
estimation of metolazone in its tablet
formulation and its
photodegradation kinetic study using
uv visible spectrophotometer
dr. parula b.
patel264
QUALITY
ASSURANCE930204 4 STABILITY STUDIES
228 18-Nov-14 HALL - 14 132270804507 PARMAR ARTIBEN
ANALYTICAL METHOD
DEVELOPMENT AND VALIDATION
FOR SIMULTANEOUS ESTIMATION
OF MUPIROCIN AND MOMETASONE
FUROATE IN PHARMACEUTICAL
DOSAGE FORM
MS.SHAISHAVI
PARIKH227
QUALITY
ASSURANCE930204 1
SIMULTENEOUS
ESTIMATION
229 18-Nov-14 HALL - 14 132330804003 Dinesh Kumar
Bioanalytical Method Development
And Validation Of HCG(HUMAN
CHORIONIC GONADOTROPIN)
Mr. Anand
B.Pithadia233
QUALITY
ASSURANCE930204 3 BIOANALYTICAL
230 18-Nov-14 HALL - 14 132330804007MISTRY BINALBEN
RAJESHBHAI
Bioanalytical Method Development
And Validation For Simultaneous
Estimation Of Metformin
Hydrochloride And Rosuvastatin
Calcium By RP-HPLC.
Ms. Nikita
Patel233
QUALITY
ASSURANCE930204 3 BIOANALYTICAL
231 18-Nov-14 HALL - 14 132640804002 MANSI P KALARIA
estimation of atropine sulphate in
homeopathic preparations using
modern analytical techniques
dr. parula b.
patel264
QUALITY
ASSURANCE930204 4
OTHER (KINDLY
SPECIFY)
standardization
of homeopathic
preparations
232 18-Nov-14 HALL - 14 132270804005LAMB DIVYA
TIRATHRAM
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHODS FOR
SIMULTANEOUS ESTIMATION OF
IVABRADINE HYDROCHLORIDE AND
METOPROLOL SUCCINATE IN
SYNTHETIC MIXTURE.
DR.JIGNESH
SHAH227
QUALITY
ASSURANCE930204 1
SIMULTENEOUS
ESTIMATION
233 18-Nov-14 HALL - 14 132270804011PATEL RIDDHI
RAMESHKUMAR
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHODS FOR
SIMULTANEOUS ESTIMATION OF
TELMISARTAN AND CILOSTAZOLE IN
SYNTHETIC MIXTURE.
DR.DILIP
MAHESHWARI227
QUALITY
ASSURANCE930204 1
SIMULTENEOUS
ESTIMATION
234 18-Nov-14 HALL - 14 132270804013Priti Vishnubhai
Patel
ANALYTICAL METHOD
DEVELOPMENT AND VALIDATION
FOR SIMULTANEOUS ESTIMATION OF
TEMSIROLIMUS AND ITS RELATED
IMPURITIES IN PHARMACEUTICAL
DOSAGE FORM BY RP-HPLC METHOD
MR.JIGNESH
PANOT227
QUALITY
ASSURANCE930204 1
SIMULTENEOUS
ESTIMATION
235 18-Nov-14 HALL - 14 132270804508PATEL BHAVIN
SHAILESHBHAI
ANALYTICAL METHOD
DEVELOPMENT AND VALIDATION
FOR SIMULTANEOUS ESTIMATION
OF CARVEDILOL HCL AND
IVABRASTINE HCL IN SYNTHETIC
MIXTURE
MR.RAJESH
GAMI227
QUALITY
ASSURANCE930204 1
SIMULTENEOUS
ESTIMATION
236 18-Nov-14 HALL - 14 132270804509
SONEJI POOJA
DHARMENDRAKU
MAR
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHOD FOR
SIMULTANEOUS ESTIMATION OF
LEFLUNOMIDE AND METHOTRAXATE
IN SYNTHETIC MIXTURE
DR.JIGNESH
SHAH227
QUALITY
ASSURANCE930204 1
SIMULTENEOUS
ESTIMATION
237 18-Nov-14 HALL - 14 132310804004RADA DEEPABEN
SARMANBHAI
ANALYTICAL METHOD
DEVELOPMENT AND VALIDATION OF
ETHIONAMIDE IN BULK AND ITS
SOLID DOSAGE FORM
Mr.
Dillipkumar
dash
231QUALITY
ASSURANCE930204 4
OTHER (KINDLY
SPECIFY)
analytical
method
development
238 19-Nov-14 HALL - 01 132470808002
CHHAYABEN
DHIRAJBHAI
PARMAR
design and development of matrix
tablets for verapamil hydrochloridedr. ravi r. patel 247 PHARMACEUTICS 930202 2
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
239 19-Nov-14 HALL - 01 132450808001
GOSWAMI
RAVIBHARTHI
ISHVARBHARTHI
Formulation And Evaluation Of
Mirtazapine Sublingual TabletDr.M.R.Mehta 245 PHARMACEUTICS 930202 2 NULL
240 19-Nov-14 HALL - 01 132450808003PATEL DEVYANI
BIPINCHANDRA
Formulation and evaluation of
modified release Tablet of Donapezil
hydrochloride.
Dr.B.N.Patel 245 PHARMACEUTICS 930202 2 NULL
241 19-Nov-14 HALL - 01 132450808004PATEL DIMPALBEN
GANESHBHAI
Formulation and Optimization of raft
forming chewable tablets containing
Lafutidine.
Dr. D.M.Patel 245 PHARMACEUTICS 930202 2 NULL
Gastro-
rentative drug
delivery system
242 19-Nov-14 HALL - 01 132450808005PATEL RUCHIBEN
ISHVARLAL
Preparation and Evaluation of Fast
dissolving formulation of Flunarizine
dihydrochloride containing Ternary
solid dispersion
Dr. H. V.
Chavda245 PHARMACEUTICS 930202 2 NULL
Fast Dissolving
Drug Delivery
System
243 19-Nov-14 HALL - 01 132470808007KIKANI MEHUL
GORDHANBHAI
preparation and evaluation of
sustained release matrix tablets of
piroxicam using tamarindseed
polysaccharides
dr. ravi r. patel 247 PHARMACEUTICS 930202 2
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
244 19-Nov-14 HALL - 01 132470808018SHAH CHINTAN
ASHOKKUMAR
optimization of grnulation process
using design of experiment for
olmesartan and hydrochlorothiazide
tablets
dr. ravi r. patel 247 PHARMACEUTICS 930202 2
CO PROCESSED, DC,
TABLET/CAPSULE
EXCIPIENTS AND
ATTRIBUTES
245 19-Nov-14 HALL - 01 132470808022THAKKAR BANSARI
PRAVINBHAI
formulation and evaluation of
pulsatile drug delivery system of
lornoxocam
dr. ravi r. patel 247 PHARMACEUTICS 930202 2
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
246 19-Nov-14 HALL - 01 132680808006
JAYNISH
VIJAYKUMAR
TAILOR
Development of dual drug eluting
stent releasing paclitaxel and aspirin
in controlled manner
dr. dhiren p
shah268 PHARMACEUTICS 930202 5 NULL NULL
247 19-Nov-14 HALL - 01 132680808017
KHADSALIYA
PIYUSHKUMAR
PARSOTTAMBHAI
preparation and evaluation of mouth
dissolving tablet of lamotrigine
dr. dhiren p
shah268 PHARMACEUTICS 930202 5 NULL NULL
248 19-Nov-14 HALL - 02 132320808004patel rutul
ramanlal
Design and development of delayed
release tablet of IlaprazoleDr. J. K. Patel 232 PHARMACEUTICS 930202 2
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
249 19-Nov-14 HALL - 02 132470808003
PATEL
JIGNESHKUMAR
HARDASHBHAI
formulation and evaluation of
rasagiline fumarate suublingual
tablets
dr. ravi r. patel 247 PHARMACEUTICS 930202 2
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
250 19-Nov-14 HALL - 02 132470808004
PATEL
RONAKKUMAR
PRAHLADBHAI
formulation and evaluation of
buspirone hcl sublingual tablets
mr yogesh k.
patel247 PHARMACEUTICS 930202 2
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
251 19-Nov-14 HALL - 02 132470808005BAROT JAGDISH
RAMANBHAI
design and development of
transdermal patches of captoprildr. ravi r. patel 247 PHARMACEUTICS 930202 2
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
252 19-Nov-14 HALL - 02 132470808010
PATEL
BINKALKUMAR
BHIKHABHAI
preparation and characterization of
fluconazole vaginal films for the
treatment of vaginal candidiasis
mr. anil raval 247 PHARMACEUTICS 930202 2
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
253 19-Nov-14 HALL - 02 132680808001
Agraval
Jogeshkumar
Harivallabh
FORMULATION AND IN VITRO
CHARACTERIZATION OF
LORNOXICAM TRANSDERMAL
MATRIX PATCH.
MR. CHAINESH
N SHAH268 PHARMACEUTICS 930202 5
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
254 19-Nov-14 HALL - 02 132680808003
CHAUDHARI
SONALKUMARI
JAWAHARBHAI
MICROWAVE ASSISTED ISOLATION
OF TAMARIND SEED
POLYSACCHARIDE AND ITS
UTILIZATION IN MUCOADHESIVE
DRUG DELIVERY SYSTEM
DR. DHIREN P
SHAH268 PHARMACEUTICS 930202 5
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
255 19-Nov-14 HALL - 02 132680808016DESAI YUGMA
BHARATBHAI
formulation and in-vitro evaluation
of sustained release buccal bio-
adhesive tablets using neem gum as a
polymer
JITENDRA
SINGH YADAV268 PHARMACEUTICS 930202 5
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
256 19-Nov-14 HALL - 02 132680808018
PRAJAPATI
SUMITKUMAR
BHARATBHAI
DESIGN AND DEVELOPMENT OF
VAGINAL GEL CONTAINING
CURCUMIN AND NEEM OIL
Mrs. SONAL N
SOLANKI268 PHARMACEUTICS 930202 5
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
257 19-Nov-14 HALL - 02 132680808007Mehta Dhrutiben
Prakashchandra
DESIGN, DEVELOPMENT AND
CHARACTERIZATION OF
MICROEMULSION BASED HYDROGEL
OF CLOTRIMAZOLE FOR TOPICAL
DELIVERY SYSTEM
DR. DHIREN P
SHAH268 PHARMACEUTICS 930202 5
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
258 19-Nov-14 HALL - 03 132460808002
CHAUDHARI
PRAKASHBHAI
VAKTABHAI
FORMULATION AND EVALUATION OF
FAST DISPERSING TABLET OF
NEBIVOLOL HYDROCHLORIDE
zankhana
sheth246 PHARMACEUTICS 930202 3
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
259 19-Nov-14 HALL - 03 132470808006
GOSWAMI
CHIRAGBHARATHI
NIKULBHARTHI
formulation and evaluation of mouth
dissolving tablets of lisinoprildr. ravi r. patel 247 PHARMACEUTICS 930202 2
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
260 19-Nov-14 HALL - 03 132470808008PATEL ANAND
GOVINDBHAI
preparation and evaluation of oral
disintegration tablets of dipyridamole
mr. yogesh k.
patel247 PHARMACEUTICS 930202 2
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
261 19-Nov-14 HALL - 03 132470808009
PATEL
ANGATKUMAR
VISHNUBHAI
formulation and evaluation of
sublingual tablets of pitavastatinmr. anil raval 247 PHARMACEUTICS 930202 2
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
262 19-Nov-14 HALL - 03 132470808013
PATEL
TEJASKUMAR
BHARATBHAI
formulation and evaluation of mouth
dissolving tablets of almotriptan
maleate
dr. ravi r. patel 247 PHARMACEUTICS 930202 2
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
263 19-Nov-14 HALL - 03 132470808021SOLANKI DIPAK
PANKAJBHAI
formulation and evaluation of fast
dissolving tablets of valsartan
mr. yogesh k.
patel247 PHARMACEUTICS 930202 2
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
264 19-Nov-14 HALL - 03 132470808023TRIVEDI NIKUNJ
KIRTIBHAI
formulation and evaluation of mouth
dissolving tablets of dexomethasonemr. anil raval 247 PHARMACEUTICS 930202 2
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
265 19-Nov-14 HALL - 03 132460808004
JADAV
SUMITKUMAR
SADGUNBHAI
formulation and invitro
characterization of aripiprazole
mouth dispersible tablet
zankhana
sheth246 PHARMACEUTICS 930202 3
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
266 19-Nov-14 HALL - 03 132460808013SHAH BHAKTIBEN
MAHESHKUMAR
FORMULATION AND characterizaiton
of orodispersible tablet of aprepitant
zankhana
sheth246 PHARMACEUTICS 930202 3
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
267 19-Nov-14 HALL - 03 132460808009ANKITKUMAR
KANTIBHAI PATEL
formulation and evaluation of fast
dispersible tablet of nimodipine
zankhana
sheth246 PHARMACEUTICS 930202 3
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
268 19-Nov-14 HALL - 04 132450808006BIHARI BILALKHAN
SIKANDARKHAN
Formulation and Evaluation of Buccal
Patch of Paroxetine hydrochloride.Dr.D.M.Patel 245 PHARMACEUTICS 930202 2 NULL
Oromucosal
drug delivery
system
269 19-Nov-14 HALL - 04 132450808007
MAHESHWARI
PRIYANK
DASHRATBHAI
Formulation and Characterization of
Spray dried dispersion to Improve
Solubility of Cilnidipine
Dr. S. T.
Prajapati245 PHARMACEUTICS 930202 2 NULL
270 19-Nov-14 HALL - 04 132450808008
MODH
SHEFALIBEN
ISHWARLAL
FORMULATION AND OPTIMIZATION
OF SUBLINGUAL DOSAGE FORM OF
TELMISARTAN
Dr. S. T.
Prajapati245 PHARMACEUTICS 930202 2 NULL
271 19-Nov-14 HALL - 04 132450808010PATEL SHRUTIBEN
PRAVINBHAI
Formulation and development of
Mixed Matrix Tablet containing
Milnacipran Hydrochloride.
Dr.P.H.Prajapa
ti245 PHARMACEUTICS 930202 2 NULL
Sustained
release
formulation
272 19-Nov-14 HALL - 04 132460808003
DUBEY
MAHENDRAKUMA
R RAMRANG
design and DEVELOPMENT of oral
medicated jelly of an antiemitic drug
of palonosetron
zankhana
sheth246 PHARMACEUTICS 930202 3 MISCELANEOUS
273 19-Nov-14 HALL - 04 132470808011
PATEL
PRANAVKUMAR
AMRUTBHAI
comparison of enhanced solubility
and dissolution rate of irbesartan
through liquisolid and inclusion
complexation technique
miss disha
suthar247 PHARMACEUTICS 930202 2 MISCELANEOUS
274 19-Nov-14 HALL - 04 132470808016PRAJAPATI VISHAL
JOITARAM
formulation development,
characterization and solubility
enhancement of poorly water soluble
drug
mr. yogesh k.
patel247 PHARMACEUTICS 930202 2 MISCELANEOUS
275 19-Nov-14 HALL - 04 132680808002
CHAUDHARI
FRENIKUMARI
DINESHBHAI
Formulation and evaluation of
erythrosomes as mucosal vaccine
adjuvant
Mrs. SONAL N
SOLANKI268 PHARMACEUTICS 930202 5 MISCELANEOUS Erythrosomes
276 19-Nov-14 HALL - 04 132680808014patel tejas
jagdishbhai
DESIGN, DEVELOPMENT AND
CHARACTERIZATION OF DRY
POWDER INHALER OF
NANOPARTICULATE DOXORUBICIN
FOR PREVENTIVE THERAPY AGAINST
LUNG CANCER.
Mrs. SONAL N
SOLANKI268 PHARMACEUTICS 930202 5 MULTIPARTICULATE
277 19-Nov-14 HALL - 05 132320808001
patel
jitendrakumar
rameshchandra
Gastroretentive mucoadhesive
tablets of Cefixime trihydrate using
natural polymer
Mr. Hitesh a.
patel232 PHARMACEUTICS 930202 2
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
278 19-Nov-14 HALL - 05 132320808010PATEL SEJALBEN
MANILAL
A novel mucoadhesive film of
Tenofovir for vaginal drug delivery
Dr. Anita P.
Patel232 PHARMACEUTICS 930202 2
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
279 19-Nov-14 HALL - 05 132320808013
CHAUHAN
SANDEEPKUMAR
RAJABHAI
Formulation and evaluation of core-
compressed tablets of Tinidazole for
colon specific drug delivery
Mr. Bipin p.
patel232 PHARMACEUTICS 930202 2
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
280 19-Nov-14 HALL - 05 132460808006
PATEL
KISHANKUMAR
HARESHBHAI
formulation and evaluation of sustain
release tablet containing captopril
zankhana
sheth246 PHARMACEUTICS 930202 3
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
281 19-Nov-14 HALL - 05 132460808008SHAH JENISH
DEVESHBHAI
FORMULATION AND EVALUATION OF
BUCCAL TABLET OF LERCANDIPINE
zankhana
sheth246 PHARMACEUTICS 930202 3
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
282 19-Nov-14 HALL - 05 132470808012PATEL TARAK
PARMANAND
formulation, development and
characterization of solid dispersion of
cardio vascular drug
dr. ravi r. patel 247 PHARMACEUTICS 930202 2
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
283 19-Nov-14 HALL - 05 132470808017
RAOL
YASHPALSINH
TEJENDRASINH
effect of hydrophilic diluents on the
release profile of valsartan from
tablet formulations
miss disha
suthar247 PHARMACEUTICS 930202 2
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
284 19-Nov-14 HALL - 05 132470808019SHAH PARTH
AJAYKUMAR
formulation and evaluation of
sustained release mucoadhesive
microspheres of venlafaxine hcl
mr. yogesh k.
patel247 PHARMACEUTICS 930202 2
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
285 19-Nov-14 HALL - 05 132470808020SHARMA TUSHAR
KAILASHCHANDRA
formulation and evaluation of
mucoadhesive buccal tablets of
carvedilol
mr. yogesh k
patel247 PHARMACEUTICS 930202 2
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
286 19-Nov-14 HALL - 05 132470808024
ZALODIYA
MEHULKUMAR
JAYANTILAL
formulation and evaluation of buccal
tablets of metoprolol tartratedr. ravi r. patel 247 PHARMACEUTICS 930202 2
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
287 19-Nov-14 HALL - 05 132460808010KAJI
SADDAMHUSEN
FORMULATION AND INVITRO
CHARACTERIZATION OF
TRANSDERMAL PATCHES OF
ENALAPRIL MALEATE
zankhana
sheth246 PHARMACEUTICS 930202 3
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
288 19-Nov-14 HALL - 06 132320808002PATEL KOMALBEN
DINESHBHAI
Enhancement of solubility of poorly
water soluble drug by
nanopsuspension technique
Dr. Anita P.
Patel232 PHARMACEUTICS 930202 2
NANO
SUSPENSION/EMULSI
ON, SEDDS, LIPID
BASED DDS
289 19-Nov-14 HALL - 06 132320808006
VAGHELA
SOHANSINH
SAGRAMJI
Formulation development and
evaluation of nanosuspension of
poorly soluble drug
Dr. J. K. Patel 232 PHARMACEUTICS 930202 2
NANO
SUSPENSION/EMULSI
ON, SEDDS, LIPID
BASED DDS
290 19-Nov-14 HALL - 06 132320808012
PANCHAL
CHIRAGKUMAR
BHIKHABHAI
Design and development of
microemulsion based drug delivery
system for antimicrobial agent
Dr. J. K. Patel 232 PHARMACEUTICS 930202 2
NANO
SUSPENSION/EMULSI
ON, SEDDS, LIPID
BASED DDS
291 19-Nov-14 HALL - 06 132470808014
PRAJAPATI
DIPAKKUMAR
KANUBHAI
formulation and evaluation of solid
self emulsifying drug delivery system
of clorthalidone
mr. yogesh k.
patel247 PHARMACEUTICS 930202 2
NANO
SUSPENSION/EMULSI
ON, SEDDS, LIPID
BASED DDS
292 19-Nov-14 HALL - 06 132680808004
Chauhan
Drashtikumari
Hasmukhbhai
DESIGN AND DEVELOPMENT OF
RIFAMPICIN NANOSUSPENSION
JITENDRA
SINGH YADAV268 PHARMACEUTICS 930202 5
NANO
SUSPENSION/EMULSI
ON, SEDDS, LIPID
BASED DDS
293 19-Nov-14 HALL - 06 132680808008
patel
bhaveshkumar
ajitbhai
FORMULATION AND DEVELOPMENT
OF NANOSUSPENSION OF LIPID
LOWERING AGENT USING DOE
APPROACH
MR. CHAINESH
N SHAH268 PHARMACEUTICS 930202 5
NANO
SUSPENSION/EMULSI
ON, SEDDS, LIPID
BASED DDS
294 19-Nov-14 HALL - 06 132680808012PATEL SHACHIBEN
RAJENDRABHAI
PREPARATION AND
CHARACTERIZATION OF
NANOCRYSTALS FOR SOLUBILITY
AND DISSOLUTION RATE
ENHANCEMENT OF A MODEL DRUG
DR. DHIREN P
SHAH268 PHARMACEUTICS 930202 5
OTHER (KINDLY
SPECIFY)NANOCRYSTALS
295 19-Nov-14 HALL - 06 132680808015
Rathod
Hemendrasinh
Janaksinh
development and optimization of a
novel floating in-situ gel for stomach
specific sustained drug delivery
JITENDRA
SINGH YADAV268 PHARMACEUTICS 930202 5
OTHER (KINDLY
SPECIFY)
stomach
specific
296 19-Nov-14 HALL - 06 132680808005
DESAI
MAYURKUMAR
ASHOKBHAI
formulation and development of
aceclofenac loaded microsponges
topical drug delivery by quality by
design approach
dr. dhiren p
shah268 PHARMACEUTICS 930202 5
OTHER (KINDLY
SPECIFY)
Microsponge
drug delivery
system
297 19-Nov-14 HALL - 06 132460808001
ANKITA
JUGALKISHOR
PUNJABI
Formulation, evaluation and
optimization of injectables containing
combination of doxorubicin and
minoxidil for the treatment of cancer
zankhana
sheth246 PHARMACEUTICS 930202 3
NANO
SUSPENSION/EMULSI
ON, SEDDS, LIPID
BASED DDS
298 19-Nov-14 HALL - 07 132320808003
PATEL
ROHITKUMAR
MAHESHBHAI
Formulation and evaluation of fast
dissolving tablet of Amoxapine
Mr. Hitesh a.
patel232 PHARMACEUTICS 930202 2
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
299 19-Nov-14 HALL - 07 132320808005
SAGAR
DHEERAJKUMAR
KHANABHAI
Enhancement of solubility and
micromeritics property of Cinnarizine
by spherical crystallization technique
Dr. J. K. Patel 232 PHARMACEUTICS 930202 2
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
300 19-Nov-14 HALL - 07 132320808007
GOHIL
JAYDEEPSINH
VANUBHA
Formulation and evaluation of quick
dissolving sublingual film of anti
depressant drug
Dr. Anita P.
Patel232 PHARMACEUTICS 930202 2
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
301 19-Nov-14 HALL - 07 132320808009
PATEL
RAKESHKUMAR
DINESHBHAI
Formulation and evaluation of
sublingual tablet of LabetalolDr. J. K. Patel 232 PHARMACEUTICS 930202 2
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
302 19-Nov-14 HALL - 07 132460808005PATEL HETALBEN
JAYESHKUMAR
FORMULATION AND EVALUATION OF
BLONANSERIN SUSTAIN RELEASE
TABLET
zankhana
sheth246 PHARMACEUTICS 930202 3
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
303 19-Nov-14 HALL - 07 132460808007
PATEL
MALHARKUMAR
MAHENDRABHAI
DESIGN AND EVALUATION OF
VERAPAMIL HYDROCHLORIDE
CONTROLLED RELEASE MATRIX
TABLET
zankhana
sheth246 PHARMACEUTICS 930202 3
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
304 19-Nov-14 HALL - 07 132460808012
PANDYA
PALAKKUMARI
DIPAKKUMAR
FORMULATION AND EVALUATION OF
FLOATING TABLET CONTAINING
CINNARIZINE
zankhana
sheth246 PHARMACEUTICS 930202 3
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
305 19-Nov-14 HALL - 07 132680808009Patel Kinnaree
Shubhashbhai
Design, development and
characterization of nanostructured
lipid carriers for preventive therapy
of breast cancer
Mrs. SONAL N
SOLANKI268 PHARMACEUTICS 930202 5
VESICULAR DRUG
DELIVERY SYSTEM
306 19-Nov-14 HALL - 07 132680808011
PATEL
PRATIKSHABEN
ANANDBHAI
FORMULATION AND EVALUATION OF
FAST DISSOLVING STRIPS OF A
MODEL ANTI HYPERTENSIVE DRUG.
DR. DHIREN P
SHAH268 PHARMACEUTICS 930202 5
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
307 19-Nov-14 HALL - 07 132680808013patel sneha
bharatbhai
rizatriptan benzoate oro-dispersible
tablets: formulation, development
and evaluation using natural
superdisintegrant
JITENDRA
SINGH YADAV268 PHARMACEUTICS 930202 5
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
308 19-Nov-14 HALL - 07 132460808011
NAKARANI
BHARGAV
MAGANBHAI
FORMULATION AND
CHARACTERIZATION OF
VILDAGLIPTIN Sustain release
MATRIX TABLET
zankhana
sheth246 PHARMACEUTICS 930202 3
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
309 19-Nov-14 HALL - 08 132470804019 SAMBHUJYOTI DASProcess validation with product life
cycle
Mrs Arti
daithanker 247
QUALITY
ASSURANCE930204 2
OTHER (KINDLY
SPECIFY)
310 19-Nov-14 HALL - 08 132470804025VYAS URMI
ASHOKBHAI
development and validation of
spectroscopic and chromatographic
methods for piribedil in its dosage
form.
Mr kaushik
patel247
QUALITY
ASSURANCE930204 2
OTHER (KINDLY
SPECIFY)
311 19-Nov-14 HALL - 08 132450804001AAL LIMBESH
BABUBHAI
DEVELOPMENT AND VALIDATION OF
CHROMATOGRAPHIC METHOD FOR
SIMULTANEOUS DETERMINATION OF
RUTIN,VITAMIN-C AND MENADIONE
SODIUM BISULFITE IN TABLET
DOSAGE FORM
DR.
BADMANABAN
R.
245QUALITY
ASSURANCE930204 2 NULL
312 19-Nov-14 HALL - 08 132450804002
CHAUDHARI
VARSHABEN
VIJAYKUMAR
STABILITY INDICATING ASSAY
METHOD DEVELOPMENT AND
VALIDATION FOR ONDANSETRON
HYDROCHLORIDE AND
PANTOPRAZOLE SODIUM IN BULK
AND PHARMACEUTICAL DOSAGE
FORM
DR. C.N.PATEL 245QUALITY
ASSURANCE930204 2 NULL
STABILITY
STUDY
(STABILITY
INDICATING
ASSAY
METHOD)
313 19-Nov-14 HALL - 08 132450804003DOSHI NILANG
SHAILESHBHAI
STABILITY INDICATING ASSAY
METHOD DEVELOPMENT AND
VALIDATION FOR CILNIDIPINE AND
CHLORTHALIDONE IN BULK AND
TABLET DOSAGE FORM
DR. C.N.PATEL 245QUALITY
ASSURANCE930204 2 NULL
STABILITY
STUDY
(STABILITY
INDICATING
ASSAY
METHOD)
314 19-Nov-14 HALL - 08 132450804005
PARMAR
JIGNESHKUMAR
NAVINCHANDRA
DEVELOPMENT AND VALIDATION OF
STABILITY INDICATING ASSAY
METHOD FOR CILNIDIPINE AND
OLMESARTAN MEDOXOMIL
DR. D.M.PATEL 245QUALITY
ASSURANCE930204 2 NULL
STABILITY
STUDY
(STABILITY
INDICATING
ASSAY
METHOD)
315 19-Nov-14 HALL - 08 132450804006
PATEL
BHAVESHKUMAR
SURESHBHAI
DEVELOPMENT AND VALIDATION OF
STABILITY INDICATING
CHROMATOGRAPHIC ASSAY
METHOD FOR PARACETAMOL AND
METOCLOPRAMIDE
HYDROCHLORIDE IN TABLET DOSAGE
FORM
DR.BADMANA
BAN R.245
QUALITY
ASSURANCE930204 2 NULL
STABILITY
STUDY
(STABILITY
INDICATING
ASSAY
METHOD)
316 19-Nov-14 HALL - 08 132450804010
PRAJAPATI
SADHANABEN
BHARATBHAI
STABILITY INDICATING
CHROMATOGRAPHIC METHODS FOR
ESTIMATION OF MINOXIDIL AND
FINASTERIDE IN TOPICAL SOLUTION
DR. J.B.DAVE 245QUALITY
ASSURANCE930204 2 NULL
STABILITY
STUDY
(STABILITY
INDICATING
ASSAY
METHOD)
317 19-Nov-14 HALL - 08 132450804011
CHAUDHARI
HARDIKKUMAR
HALUBHAI
DEVELOPMENT AND VALIDATION OF
STABILITY INDICATING ASSAY
METHOD FOR THE ESTIMATION OF
AVANAFIL AND DAPOXETINE
HYDROCHLORIDE IN TABLET DOSAGE
FORM
DR. DHRUBO
JYOTI SEN245
QUALITY
ASSURANCE930204 2 NULL
STABILITY
STUDY
(STABILITY
INDICATING
ASSAY
METHOD)
318 19-Nov-14 HALL - 08 132450804013PATEL AMEEBEN
KAUSHIKKUMAR
DEGRADATION AND KINETIC STUDY
OF TADALAFIL
DR.DHRUBO
JYOTI SEN245
QUALITY
ASSURANCE930204 2 NULL
ISOMERIC
STUDY (ISOMER
SEPARATION)
319 19-Nov-14 HALL - 09 132320804002PATEL EKTA
KAMLESHBHAI
ANALYTICAL METHOD
DEVELOPMENT AND VALIDATION OF
SIMULTANEOUS ESTIMATION OF
DOSULEPINE HYDROCHLORIDE AND
METHYLCOBALAMINE IN
PHARMACEUTICAL DOSAGE FORM.
Dr.
Ujashkumar A.
Shah
232QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
320 19-Nov-14 HALL - 09 132320804003
PATEL
MONIKABEN
BHARATBHAI
ANALYTICAL METHOD
DEVELOPMENT AND VALIDATION OF
SIMULTANEOUS ESTIMATION OF
FAMOTIDINE AND DICYCLOMINE
HYDROCHLORIDE IN
PHARMACEUTICAL DOSAGE FORM
Dr. J. K. Patel 232QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
321 19-Nov-14 HALL - 09 132320804004PATEL MUKULBEN
VASANTBHAI
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHODS FOR
SIMULTANEOUS ESTIMATION OF
IBUPROFEN AND TIZANIDINE
HYDROCHLORIDE IN
PHARMACEUTICAL DOSAGE FORM
Dr.
Ujashkumar A.
Shah
232QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
322 19-Nov-14 HALL - 09 132320804001PATEL ASMITABEN
KHEMCHANDBHAI
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHODS FOR
SIMULTANEOUS ESTIMATION OF
IVERMECTIN AND ALBENDAZOLE IN
PHARMACEUTICAL DOSAGE FORM.
Dr. H. V. JoshI 232QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
323 19-Nov-14 HALL - 09 132450804004
PARMAR
ASHISHKUMAR
MANUBHAI
ANALYTICAL METHOD
DEVELOPMENT AND VALIDATION
FOR DISSOLUTION STUDY OF
PRASUGREL HYDROCHLORIDE
TABLETs
DR. H.U.PATEL 245QUALITY
ASSURANCE930204 2 BABE
324 19-Nov-14 HALL - 09 132450804008PATEL NIDHI
MANISHKUMAR
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHOD FOR
DISSOLUTION STUDY OF amlodipine
besylate and indapamide combined
dosage form
DR. C.N.PATEL 245QUALITY
ASSURANCE930204 2 BABE
325 19-Nov-14 HALL - 09 132450804012
KAPADIYA
GIRISHKUMAR
MANHARBHAI
ANALYTICAL METHOD
DEVELOPMENT AND VALIDATION
FOR DISSOLUTION STUDY OF
Dabigatran etexilate mesylate in
capsule dosage form
DR. H.U.PATEL 245QUALITY
ASSURANCE930204 2 BABE
STABILITY
STUDY
(STABILITY
INDICATING
ASSAY
METHOD)
326 19-Nov-14 HALL - 09 132470804005
KOLADARA
NILESHKUMAR
VASUDEVBHAI
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHODs FOR
SIMULTANEOUS ESTIMATION OF
verdenafil AND dapoxetine IN
COMBINED DOSAGE FORM.
Mr kaushik
patel247
QUALITY
ASSURANCE930204 2 BABE
327 19-Nov-14 HALL - 10 132320804010MODI CHIRAG
KANAIYALAL
STABILITY INDICATING RP-HPLC
METHOD DEVELOPMENT FOR
ESTIMATION OF SITAGLIPTIN AND
METFORMIN HYDROCHLORIDE IN
PHARMACEUTICAL DOSAGE
Dr.
Ujashkumar A.
Shah
232QUALITY
ASSURANCE930204 2 STABILITY STUDIES
328 19-Nov-14 HALL - 10 132320804014
PATEL
PRATIKKUMAR
DAYALBHAI
STABILITY INDICATING RP-HPLC
METHOD DEVELOPMENT FOR
ESTIMATION OF GABAPENTIN AND
NORTRYPTILINE IN
PHARMACEUTICAL DOSAGE FORM
Dr.
Ujashkumar A.
Shah
232QUALITY
ASSURANCE930204 2 STABILITY STUDIES
329 19-Nov-14 HALL - 10 132470804010
PATEL
GAURANGKUMAR
DASHRATHLAL
development and validation of
stability indicating hplc method for
dronedarone hydrochloride and its
dosage form.
Mrs Arti
daithanker 247
QUALITY
ASSURANCE930204 2 STABILITY STUDIES
330 19-Nov-14 HALL - 10 132470804015
PATEL
NITINKUMAR
CHANDRAKANT
development and validation of
stability indicating rp-hplc method for
simultaneous estimation of
diclofenac and pentoprazole in
combined dosage form.
Mr kaushik
patel247
QUALITY
ASSURANCE930204 2 STABILITY STUDIES
331 19-Nov-14 HALL - 10 132470804016PATEL RONAKBEN
PARESHKUMAR
development and validation of
stability indicating hplc method for
simultaneous estimation of
duloxetine and methylcobalamin in
its dosage form.
mrs arti
daithanker247
QUALITY
ASSURANCE930204 2 STABILITY STUDIES
332 19-Nov-14 HALL - 10 132460804002Patel Jankiben
Raojibhai
Development and validation of
stability indicating method for
simultaneous estimation of
Ceftriaxone and Sulbactum in bulk
and combined pharmaceutical
dosage form
dR. aNKITA
bHAVSAR246
QUALITY
ASSURANCE930204 3 STABILITY STUDIES
333 19-Nov-14 HALL - 10 132460804003PATEL SEJUBEN
DILIPBHAI
ANALYTICAL APPROACH FOR
DEVELOPMENT AND VALIDATION OF
STABILITY INDICATING METHOD FOR
SIMULTANEOUS ESTIMATION OF
ARTEROLANE MALEATE AND
PIPERAQUINE PHOSPHATE IN BULK
AND PHARMACEUTICAL DOSAGE
FORM
Dr. Ankita
Bhavsar246
QUALITY
ASSURANCE930204 3 STABILITY STUDIES
334 19-Nov-14 HALL - 11 132320804005PATEL NIKITA
AMRUTLAL
PROCESS VALIDATION OF
METRONIDAZOLE TABLETDr. J. K. Patel 232
QUALITY
ASSURANCE930204 2 PROCESS VALIDATION
335 19-Nov-14 HALL - 11 132320804007
SATHAVARA
POOJA
NAROTTAMBHAI
PROCESS VALIDATION OF
LEVOFLOXACIN TABLET.
Dr.
Ujashkumar A.
Shah
232QUALITY
ASSURANCE930204 2 PROCESS VALIDATION
336 19-Nov-14 HALL - 11 132470804018
RAJAGURU
BHOOMIBEN
KAPILKUMAR
RELATED SUBSTANCE METHOD
DEVELOPMENT AND VALIDATION OF
nimodipine BY HPLC
mrs arti
daithnker247
QUALITY
ASSURANCE930204 2 IMPURITY PROFILING
337 19-Nov-14 HALL - 11 132470804024
VYAS
JAIMINKUMAR
HARESHBHAI
Method Development and Validation
of RP-HPLC for Related Substances of
Proton Pump Inhibitor and
Antiemetic Agent in Combined
Capsule Dosage Form.
Mr ronak patel 247QUALITY
ASSURANCE930204 2 IMPURITY PROFILING
338 19-Nov-14 HALL - 11 132450804019
PRAJAPATI
MITTALBEN
JAGADISHBHAI
STABILITY INDICATING ASSAY
METHOD DEVELOPMENT AND
VALIDATION FOR BRIMONIDINE
TARTRATE AND TIMOLOL MALEATE
IN OPTHALMIC DOSAGE FORM
DR. C.N.PATEL 245QUALITY
ASSURANCE930204 2 NULL
STABILITY
STUDY
(STABILITY
INDICATING
ASSAY
METHOD)
339 19-Nov-14 HALL - 11 132450804020
SHAH
KHUSHALIBEN
ATULKUMAR
ESTIMATION OF MOMETASONE
FUROATE IN NASAL/INHALATION
PREPARATION AND IN
COMBINATION WITH MICONAZOLE
NITRATE IN CREAM FORMULATION
DR. J.B.DAVE 245QUALITY
ASSURANCE930204 2 NULL
340 19-Nov-14 HALL - 11 132470804003CHAVADA RAKESH
ISHAVARBHAI
related substance method
development and validation of
gliclizide by hplc
Mrs Arti
daithanker 247
QUALITY
ASSURANCE930204 2 IMPURITY PROFILING
341 19-Nov-14 HALL - 11 132470804008
PATEL
DHAVALKUMAR
MANILAL
method development and validation
of nifidepine in human plasma by
lcms-ms method
Mr ronak patel 247QUALITY
ASSURANCE930204 2 BIOANALYTICAL
342 19-Nov-14 HALL - 12 132320804006PATEL POOJA
JIVANBHAI
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHODS FOR
SIMULTANEOUS ESTIMATION OF
MIFEPRISTONE AND MISOPROSTOL
IN PHARMACEUTICAL DOSAGE
FORM.
Dr.
Ujashkumar A.
Shah
232QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
343 19-Nov-14 HALL - 12 132320804009
GUNJALIYA
VARSHABEN
PUNAJI
DEVELOPMENT AND VALIDATION OF
RP-HPLC AND
SPECTROPHOTOMETRIC METHODS
FOR THE SIMULTANEOUS
DETERMINATION OF ERYTHROMYCIN
STEARATE AND BROMHEXINE
HYDROCHLORIDE IN
PHARMACEUTICAL DOSAGE FORM.
Dr. H. V. JoshI 232QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
344 19-Nov-14 HALL - 12 132470804020SINDHAV MIRAL
NIKHIL
development and validation of
analytical method for simultaneous
estimation of solifenacin succinate
and alfuzosin hydrochloride in
combined dosage form.
mrs arti
daithanker247
QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
345 19-Nov-14 HALL - 12 132470804021SINDHAV NIKHIL
KHODIDAS
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHOD FOR
SIMULTANEOUS ESTIMATION OF
olopatadine hydrochloride AND
phenylephrine HYDROCHLORIDE IN
COMBINED DOSAGE FORM.
Mrs Arti
daithanker 247
QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
346 19-Nov-14 HALL - 12 132470804022SISODIYA JAYA
ISHWARSINGH
Analytical method developmenT and
validation for simultaneous
estimation of Desoximetasone and
Clotrimazole in their pharmaceutical
dosage form
Mrs Arti
daithanker 247
QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
347 19-Nov-14 HALL - 12 132470804023SOLANKI DHAVAL
PARSOTTAMBHAI
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHOD FOR
SIMULTANEOUS ESTIMATION OF
glimepiride AND metformin
HYDROCHLORIDE IN COMBINED
DOSAGE FORM.
Mr kaushik
patel247
QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
348 19-Nov-14 HALL - 12 132460804001
BHOJAVIA
BHUMIKABEN
KANTILAL
Analytical method development and
validation for simultaneous
estimation of Phenylephrine
hydrochloride and Bromhexine
hydrochloride in bulk and combined
pharmaceutical dosage form
Dr. Ankita
Bhavsar246
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
349 19-Nov-14 HALL - 13 132320804011
PATEL
BHUMIBAHEN
JASHVANTBHIA
SIMULTANEOUS ESTIMATION OF
DICYCLOMINE HYDROCHLORIDE
AND LOPERAMIDE HYDROCHLORIDE
IN PHARMACEUTICAL DOSAGE FORM
BY RP-HPLC
Dr. H. V. JoshI 232QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
350 19-Nov-14 HALL - 13 132320804012
PATEL
DARSHANABEN
HARGOVANBHAI
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHODS FOR
SIMULTANEOUS ESTIMATION OF
DICLOFENAC POTASSIUM AND
TIZANIDINE HYDROCHLORIDE IN
PHARMACEUTICAL DOSAGE FORM
Dr. J. K. Patel 232QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
351 19-Nov-14 HALL - 13 132320804013
PATEL
JAGRUTIBEN
VISHNUBHAI
ANALYTICAL METHOD
DEVELOPMENT AND VALIDATION OF
SIMULTANEOUS ESTIMATION OF
ATORVASTIN AND
METHYLCOBALAMINE IN THEIR
PHARMACEUTICAL DOSAGE FORM
BY RP-HPLC
Dr.
Ujashkumar A.
Shah
232QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
352 19-Nov-14 HALL - 13 132320804015PATEL VARSHABEN
RAMABHAI
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHODS FOR
SIMULTANEOUS ESTIMATION OF
ONDANSETRON AND
ESOMEPRAZOLE IN
PHARMACEUTICAL DOSAGE FORM.
Dr. J. K. Patel 232QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
353 19-Nov-14 HALL - 13 132470804001PATEL EKTA
RAMESHBHAI
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHODS FOR
SIMULTANEOUS ESTIMATION OF
clonidine AND chlorthalidone IN
COMBINED dosage form.
Mr kaushik
patel247
QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
354 19-Nov-14 HALL - 13 132470804002
SHAH
BINITKUMAR
VINAYBHAI
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHOD FOR
SIMULTANEOUS ESTIMATION OF
mupirocin AND fluticasone
propionate IN COMBINED DOSAGE
FORM.
Mr kaushik
patel247
QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
355 19-Nov-14 HALL - 13 132470804004
JOSHI
KULDIPKUMAR
SHIVRAM
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHOD FOR
SIMULTANEOUS ESTIMATION OF
mupirocin AND beclomethasone IN
cream
Mr ronak patel 247QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
356 19-Nov-14 HALL - 13 132470804006
MEHTA PRIYESH
MAHENDRAKUMA
R
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHODs FOR
SIMULTANEOUS ESTIMATION OF
atorvastatin AND methylcobalamine
IN COMBINED DOSAGE FORM.
Mr kaushik
patel247
QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
357 19-Nov-14 HALL - 13 132470804007MEVADA MAULIK
BABUBHAI
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHODS FOR
SIMULTANEOUS ESTIMATION OF
rosiglitazone AND glimepiride IN
COMBINED dosage form.
Mr ronak patel 247QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
358 19-Nov-14 HALL - 14 132450804014
PATEL
KEYURKUMAR
DINESHBHAI
STABILITY INDICATING
CHROMATOGRAPHIC METHODS FOR
SIMULTANEOUS ESTIMATION OF
TELMISARTAN, AMLODIPINE AND
HYDROCHLOROTHIAZIDE IN TABLET
DOSAGE FORM
DR.J.B.DAVE 245QUALITY
ASSURANCE930204 2 NULL
STABILITY
STUDY
(STABILITY
INDICATING
ASSAY
METHOD)
359 19-Nov-14 HALL - 14 132450804015
PATEL
KHUSHBUBEN
MAHENDRAKUMA
R
SIMULTANEOUS ESTIMATION OF
HYDROQUINONE, TRETINOIN WITH
CORTICOSTEROIDS IN CREAM
FORMULATION
DR. J.B.DAVE 245QUALITY
ASSURANCE930204 2 NULL
360 19-Nov-14 HALL - 14 132450804016
PATEL
KHUSHBUBEN
SHANKARBHAI
DEGRADATION AND KINETIC STUDY
OF TRAMADOL HYDROCHLORIDEDR.D.J.SEN 245
QUALITY
ASSURANCE930204 2 NULL
ISOMERIC
STUDY (ISOMER
SEPARATION)
361 19-Nov-14 HALL - 14 132450804018
PATEL
VISHVESHKUMAR
RAMESHBHAI
STABILITY INDICATING ASSAY
METHOD FOR THE ESTIMATION OF
CEFPODOXIME PROXETIL AND
AZITHROMYCIN IN TABLET DOSAGE
FORM
DR. C. S. RAMI 245QUALITY
ASSURANCE930204 2 NULL
STABILITY
STUDY
(STABILITY
INDICATING
ASSAY
METHOD)
362 19-Nov-14 HALL - 14 132470804009PATEL DOLLY
KANUBHAI
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHODS FOR
SIMULTANEOUS ESTIMATION OF
clinidipine AND chlorthalidone IN
combined dosage form.
Mr ronak patel 247QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
363 19-Nov-14 HALL - 14 132470804011PATEL HIREN
SHANTILAL
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHODS FOR
SIMULTANEOUS ESTIMATION OF
imipramine AND cilostazole IN
COMBINED dosage form.
Mr kaushik
patel247
QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
364 19-Nov-14 HALL - 14 132470804012PATEL KRUPABEN
MANGALDAS
analytical method development and
validation for simultaneous
estimation of minoxidil and
finasteride in its dosage form.
Mrs Arti
daithanker 247
QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
365 19-Nov-14 HALL - 14 132470804013PATEL KRUPESH
VINODBHAI
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHODS FOR
SIMULTANEOUS ESTIMATION OF
buproprion AND naltrexone IN
COMBINED dosage form.
Mr kaushik
patel247
QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
366 19-Nov-14 HALL - 14 132470804014
PATEL
NISARGKUMAR
BHUPENDRABHAI
Analytical method development and
validation for simultaneous
estimation of alprazolam and
imipramine hydrochloride in its
pharmaceutical dosage form.
Mr ronak patel 247QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
367 20-Nov-14 HALL - 01 132270810006NARSINH TAHA
AKIL
FORMULATION,DEVELOPMENT AND
EVALUATION OF MUCOADHESIVE
BUCCAL TABLETS OF SERTRALINE
HYDROCHLORIDE
MR.PRATIK
UPADHYAY227
PHARMACEUTICA
L TECHNOLOGY930202 1
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
368 20-Nov-14 HALL - 01 132270810009Patel Shalvi
dharmeshbhai
FORMULATION AND EVALUATION OF
PEEL OFF FACE MASK OF
CLINDAMYCIN FOR THE TREATMENT
OF ACNE VULGARIS
Dr.SHREERAJ
SHAH227
PHARMACEUTICA
L TECHNOLOGY930202 1
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
369 20-Nov-14 HALL - 01 132270810012SHAH NISARGI
RAJESH
FORMULATION,OPTIMIZATION AND
EVALUATION OF SUSTAIN RELEASE
MATRIX TABLET CONTAINING
FLURBIPROFEN
mr.chintan oza 227PHARMACEUTICA
L TECHNOLOGY930202 1
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
370 20-Nov-14 HALL - 01 132270810013
SONGARA
HARSHIL
HARGOVINDBHAI
FORMULATION,DEVELOPMENT AND
EVALUATION OF MOUTH
DISSOLVING TABLET OF
DIMENHYDRINATE
mr.chintan oza 227PHARMACEUTICA
L TECHNOLOGY930202 1
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
371 20-Nov-14 HALL - 01 132330808002
GOHIL
VIKRAMBHAI
KESHAVBHAI
Development and evaluation of
mucoadhesive buccal tablet of
Oxybutyline Hcl
Mr. Surjya
Narayan
Mandal
233 PHARMACEUTICS 930202 3
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
mucoadhesive
buccal trablet
372 20-Nov-14 HALL - 01 132330808012
VISHVESH
VINODKUMAR
PATEL
Thermoreversible hydrogel
containing Gemcitabine conjugated
with polymer: Development &
evaluation
Mrs. Lalit Lata
Jha233 PHARMACEUTICS 930202 3
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
Thermoreversib
le
373 20-Nov-14 HALL - 01 132330808013 gajera avinkumar rFormulation & evaluation of topical
spray for wound healing
Dr. Sulekha
Bhadra233 PHARMACEUTICS 930202 3
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
374 20-Nov-14 HALL - 01 132330808017 priya pushpan
Formulation & characterization of
hydrogel scaffolds of Neomycin
sulphate for topical wound healing
Dr. Rajesh
K.S./ Mrs. bijal
prajapati
233 PHARMACEUTICS 930202 3
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
375 20-Nov-14 HALL - 01 132330808506
PATEL
AASHISHKUMAR
RAJENDRAKUMAR
Formulation & evaluation of nasal
drug delivery system containing
Famodipine.
Mr.
SurjyaNarayan
Mandal
233 PHARMACEUTICS 930202 3
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
Mucoadhesive
nasal
formulation
376 20-Nov-14 HALL - 01 132330808508 patel faiyaz dFormulation & evaluation of topical
hydrogel for an antifungal agent.
Dr. Rajesh
K.S./ mr. surjya
narayan
mandal
233 PHARMACEUTICS 930202 3
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
Hydrogel
377 20-Nov-14 HALL - 02 132240808016
LATHIYA
SARTHAKBHAI
SHAMBHUBHAI
FORMULATION AND EVALUATION OF
RUPATADINE FUMARATE SUSTAINED
RELEASE MATRIX TABLETs
Mrs. Sejal M.
Solanki224 PHARMACEUTICS 930202 1
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
378 20-Nov-14 HALL - 02 132240808022RAJPUT PRINCE
JAYPRAKASH
DEVELOPMENT AND EVALUATION OF
BILAYER TABLET FORMULATION OF
GLIMEPIRIDE AS IMMEDIATE
RELEASE AND METFORMIN
HYDROCHLORIDE AS EXTENDED
RELEASE
Dr. Ankit
Ajmera224 PHARMACEUTICS 930202 1
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
379 20-Nov-14 HALL - 02 132240808023SINGH ADITYA
RAMANAND
preparation and evaluation of
linezolid bilayer tablets
Dr. Ankit
Ajmera224 PHARMACEUTICS 930202 1
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
380 20-Nov-14 HALL - 02 132270810007 NIXIPT A PATEL
Formulation and Development of Bi-
layer Gastro-retentive dosage form
of combination therapy of
Moxifloxacin & Ranitidine for
eradication of H.pylori infection
Dr.SHREERAJ
SHAH227
PHARMACEUTICA
L TECHNOLOGY930202 1
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
381 20-Nov-14 HALL - 02 132270810010
PRAJAPATI
AMITKUMAR
RAMESHBHAI
FORMULATION AND EVALUATION OF
NANOPARTICLE LOADED
OPHTHALMIC IN-SITU GEL OF
OFLOXACIN AND DEXAMETHASONE
MR.JAYMIN
PATEL227
PHARMACEUTICA
L TECHNOLOGY930202 1
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
382 20-Nov-14 HALL - 02 132330808008MISTRY RUCHITA
NAVINBHAI
Formulation, optimization and
evaluation of novel floating ring
capsule of famotidine.
Mrs. Lalit Lata
Jha233 PHARMACEUTICS 930202 3
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
Ring capsule
383 20-Nov-14 HALL - 02 132330808009
RATHVA
DEVENDRAKUMAR
PRATAPSINH
Formulation, optimization and
evaluation of colon targeted delivery
system for Isradipine
Ms. Shweta
Gupta233 PHARMACEUTICS 930202 3
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
Colon targeted
384 20-Nov-14 HALL - 02 132240808002Changela Chandani
Vasantbhai
Formulation and Evaluation of Bilayer
Tablet of Atomoxetin Hydrochloride Kinjal Solanki 224 PHARMACEUTICS 930202 1
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
385 20-Nov-14 HALL - 02 132240808020PATEL PALAK
NARESHBHAI
Formulation and Evaluation of
Sandwich Osmotic Tablet of
Metformin Hydrochloride and
Glibenclamide
Kinjal Solanki 224 PHARMACEUTICS 930202 1
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
386 20-Nov-14 HALL - 02 132270810003Ishita shankar
Sengupta
FORMULATION,OPTIMIZATION AND
CHARACTERIZATION OF NOVEL
FLOATING IN-SITU GELLING SYSTEM
FOR SUSTAINED DELIVERY OF
LAFUTIDINE FOR THE TREATMENT OF
PEPTIC ULCER
Dr.SHREERAJ
SHAH227
PHARMACEUTICA
L TECHNOLOGY930202 1
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
387 20-Nov-14 HALL - 03 132060808002
Damor
Sumitkumar
Dalpatsing
Formulation and Evaluation of Novel
Stable Amoxicilline Trihydrate
Chewable Tablet
MR. NIKUNJ
PAREKH206 PHARMACEUTICS 930202 1
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
388 20-Nov-14 HALL - 03 132060808011RAGHVENDRAKU
MAR YADAV
Development and evalution of
Amlotriptan Sublingual tablet
MR. NIKUNJ
PAREKH206 PHARMACEUTICS 930202 1
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
389 20-Nov-14 HALL - 03 132240808001
BHADRESH
NAROTTAMBHAI
PATEL
Formulation and Evaluation of
sustained Release Tablets of
Levosulpiride
keyur patel 224 PHARMACEUTICS 930202 1
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
390 20-Nov-14 HALL - 03 132240808004Pandya Vaidehi
AmrishBhai
FORMULATION AND EVALUATION OF
FLOATING TABLETs OF LABETALOL
HYDROCHLORIDE
Pranit B. Patel 224 PHARMACEUTICS 930202 1
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
391 20-Nov-14 HALL - 03 132240808006Patel Dipakkumar
khemabhai
Formulation and evaluation of
sustain release metoprolol and
immediate release olmesartan
Dr. Ankit
Ajmera224 PHARMACEUTICS 930202 1
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
392 20-Nov-14 HALL - 03 132240808009RATHOD RAKESH
BABULAL
FORMULATION AND EVALUATION OF
FINASTERIDE SUSTAINED RELEASE
TABLETs
Kinjal Pragnesh
Solanki224 PHARMACEUTICS 930202 1
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
393 20-Nov-14 HALL - 03 132240808010
THAKKAR
MOHANA
HASMUKHBHAI
FORMULATION AND EVALUATION OF
GASTRORETENTIVE BILAYER TABLETs
OF CIPROFLOXACIN HYDROCHLORIDE
Dr. Ankit
Ajmera224 PHARMACEUTICS 930202 1
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
394 20-Nov-14 HALL - 03 132240808013BHAVSAR JAYMIN
DIPAKKUMAR
formulation and evaluation of colon
targeting tablets of deflazacortPranit B. Patel 224 PHARMACEUTICS 930202 1
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
395 20-Nov-14 HALL - 03 132270810008PATEL DIPALBEN
MUKESHKUMAR
FORMULATION AND EVALUATION OF
MOUTH DISSOLVING FILM OF
BETAHISTINE dihydrochloride
MR.PRATIK
UPADHYAY227
PHARMACEUTICA
L TECHNOLOGY930202 1
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
396 20-Nov-14 HALL - 03 132330808003HARDIK SAVABHAI
MAKWANA
Formulation, Optimization and
Evaluation of taste masking ODT of
Verapamil HCl
Mr. Parag
Patel233 PHARMACEUTICS 930202 3
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
397 20-Nov-14 HALL - 04 132060808003
DHRUV
DASHRATHBHAI
PATEL
Formulation and Optimization of
Bilayered Matrix Tablet of Matformin
Hydrochloride and Repaglinide
MR. NISHITH
PATEL206 PHARMACEUTICS 930202 1
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
398 20-Nov-14 HALL - 04 132240808003PANDYA DEEP
RAJANIKANT
Formulation and Evaluation of
floating Microspheres of Carbidopa
and Levodopa
Pranit B. Patel 224 PHARMACEUTICS 930202 1 MULTIPARTICULATE
399 20-Nov-14 HALL - 04 132240808011AMIN MILIND
JAYESHKUMAR
Formulation and Evaluation of
Sustained Release Pellets of
Lornoxicam
keyur patel 224 PHARMACEUTICS 930202 1 MULTIPARTICULATE
400 20-Nov-14 HALL - 04 132240808012
BAJAG
JAYANTIBHAI
VASHRAMBHAI
FORMULATION AND EVALUATION OF
IMMEDIATE RELEASE PELLETS OF
CANDESARTAN CILEXETIL
Pranit B. Patel 224 PHARMACEUTICS 930202 1 MULTIPARTICULATE
401 20-Nov-14 HALL - 04 132330808004Kureshi Mohsin
Mahamadhanif
Polymeric dosage Form of
Capecitabine- Development and
Evaluation
Dr. Rajesh K.S. 233 PHARMACEUTICS 930202 3 MISCELANEOUSPolymeric
dosage form
402 20-Nov-14 HALL - 04 132330808011
SONDARVA
KIRITKUMAR
NATHABHAI
Development of cefixime lozenge for
the treatment of throat infection
Dr. Sulekha
Bhadra233 PHARMACEUTICS 930202 3 MISCELANEOUS LOZENGES
403 20-Nov-14 HALL - 04 132330808504
CHAUHAN
ANIRUDDH
ANUPSINH
Formulation and Evaluation of
Alfuzosin HCl and Dutasteride
combination bilayer tablet
Dr. Rajesh
K.S./ Mr.
gajanan shinde
233 PHARMACEUTICS 930202 3 MISCELANEOUSModified
release tablet
404 20-Nov-14 HALL - 04 132330808505DIXIT TARUN
SANJAY
Formulation optimization &
evaluation of fast disintigrating
modified release tablet of
deflazacort.
Mrs. Lalit Lata
Jha233 PHARMACEUTICS 930202 3 MISCELANEOUS
Modified
release tablet
405 20-Nov-14 HALL - 04 132240808017
MADHAK
SEJALBEN
ARVINDBHAI
Preparation and Evaluation of
sustained release Microspheres of
Quetiapine fumarate
keyur patel 224 PHARMACEUTICS 930202 1 MULTIPARTICULATE
406 20-Nov-14 HALL - 04 132270810001BHAVSAR PARTH
HITENDRABHAI
FORMULATION AND EVALUATION OF
FEXOFENADINE HCL TABLET BY DRY
GRANULATION USING SeDeM
EXPERT SYSTEM
mr.chintan oza 227PHARMACEUTICA
L TECHNOLOGY930202 1 MISCELANEOUS
407 20-Nov-14 HALL - 05 132270810011
RUPARELIYA
DIVYESH
DHIRAJLAL
DEVELOPMENT OF NANOPARTICLE
BASED FORMULATION FOR
TREATMENT OF BREAST CANCER
MR.JAYMIN
PATEL227
PHARMACEUTICA
L TECHNOLOGY930202 1
NANO
SUSPENSION/EMULSI
ON, SEDDS, LIPID
BASED DDS
408 20-Nov-14 HALL - 05 132270810503Pandya Bhaumik
Dineshchandra
FORMULATION DEVELOPMENT AND
EVALUATION OF SELF-
MICROEMULSIFYING DRUG DELIVERY
SYSTEM OF COMBINATION THERAPY
OF PARACETAMOL AND VITAMIN E
ACETATE
Dr.SHREERAJ
SHAH227
PHARMACEUTICA
L TECHNOLOGY930202 1
NANO
SUSPENSION/EMULSI
ON, SEDDS, LIPID
BASED DDS
409 20-Nov-14 HALL - 05 132330808001 Gaurav VaishnavTo formulate and evaluate scaffold
containing silver nano particles
Mr. Rakesh
Patel233 PHARMACEUTICS 930202 3
NANO
SUSPENSION/EMULSI
ON, SEDDS, LIPID
BASED DDS
NANOPARTICLE
S
410 20-Nov-14 HALL - 05 132330808006
MANANI
HIRALBEN
MANSUKHBHAI
Enhancement of Oral Bioavaibility by
Pre-Liposomal Formulation.
Mrs. Bijal
Prajapati233 PHARMACEUTICS 930202 3
NANO
SUSPENSION/EMULSI
ON, SEDDS, LIPID
BASED DDS
411 20-Nov-14 HALL - 05 132330808014 kulkarni bhavna d
Formulation and evaluation of
nanocapsules of budesonide for
crohn's disease
Mr. gajanan
shinde233 PHARMACEUTICS 930202 3
NANO
SUSPENSION/EMULSI
ON, SEDDS, LIPID
BASED DDS
412 20-Nov-14 HALL - 05 132330808016 patel priyanka d
Mucoadhesive nanoemulsion:
Development and evaluation for
intranasal application of Nimodipine.
Mr.
SurjyaNarayan
Mandal
233 PHARMACEUTICS 930202 3
NANO
SUSPENSION/EMULSI
ON, SEDDS, LIPID
BASED DDS
mucoadhesive
nasal
formulation
413 20-Nov-14 HALL - 05 132330808018
SONCHHATRA
ANKITA
PRADUMANBHAI
Nanostructured lipid carriers - based
gel for topical delivery of Mupirocin:
Formulation and evaluation
Mr. Gajanan
Shinde233 PHARMACEUTICS 930202 3
NANO
SUSPENSION/EMULSI
ON, SEDDS, LIPID
BASED DDS
NLC
414 20-Nov-14 HALL - 05 132330808503 AHIR HARDIK VDevelopment of celecoxib emulsion
to improve its bioavailability
Dr. Sulekha
Bhadra233 PHARMACEUTICS 930202 3
NANO
SUSPENSION/EMULSI
ON, SEDDS, LIPID
BASED DDS
415 20-Nov-14 HALL - 06 132330808005
MAHETA
SHAILESHKUMAR
DAYASHANKAR
Design and Development of
Budesonide Proniosomes for Oral
delivery
Mrs. Lalit Lata
Jha233 PHARMACEUTICS 930202 3
VESICULAR DRUG
DELIVERY SYSTEM
416 20-Nov-14 HALL - 06 132330808007
MARVANIYA
KHUSHBOO
VALLABHDAS
Formulation and evaluation of novel
stealth liposomes for effective
treatment of cancerous cells.
Mr. Gajanan
Shinde233 PHARMACEUTICS 930202 3
VESICULAR DRUG
DELIVERY SYSTEM
417 20-Nov-14 HALL - 06 132330808015kumbhani purva
dhirajlal
Transferosomal gel of Fluticasone
Propionate for the treatment of
Psoriasis
Mr. Gajanan
Shinde233 PHARMACEUTICS 930202 3
VESICULAR DRUG
DELIVERY SYSTEMtopical
418 20-Nov-14 HALL - 06 132330808507PATEL CHIRAG
ARVINDBHAI
Nanocochleates of 5-Fluorouracil for
treatment of Colorectal cancer
Ms. Shweta
Gupta233 PHARMACEUTICS 930202 3
VESICULAR DRUG
DELIVERY SYSTEMLipid DDS
419 20-Nov-14 HALL - 06 132330808509patel kinjalkumar
kishorbhai
Solubility enhancement of
Candesartan Cilexetil
Dr. Sulekha
Bhadra233 PHARMACEUTICS 930202 3
OTHER (KINDLY
SPECIFY)
SOLUBILIZATIO
N
420 20-Nov-14 HALL - 06 132410808001AMIN PRASHANT
MANISHKUMAR
Formulation and evaluation of
floating drug delivery system of
antihypertensive drugs
mr. jaimin
patel241 PHARMACEUTICS 930202 3
DELAYED/EXTENDED
RELEASE , FLOATING,
INSITU.
NULL
421 20-Nov-14 HALL - 06 132410808002
PANARA
SABINABANU
MOHAMMEDAIYU
B
Formulation and evaluation of
immediate release tablets of
montelukast and levocetirizine
mr. jignesh
patel241 PHARMACEUTICS 930202 3
IR,ODT,DT,SUBLINGUA
L,FAST
DISPERSIBLE/DISSOLVI
NG
NULL
422 20-Nov-14 HALL - 06 132410808003PATEL NIRAV
RAJENDRAKUMAR
Preparation and evaluation of mouth
dissolving tablet containing
cyclodextrine complex of
fexofenadine hydrochloride
mr.jignesh
patel241 PHARMACEUTICS 930202 3
IR,ODT,DT,SUBLINGUA
L,FAST
DISPERSIBLE/DISSOLVI
NG
NULL
423 20-Nov-14 HALL - 06 132410808004
PATEL
NIRAVKUMAR
BHUPENDRABHAI
Formulation and evaluation of self
micro emulsifying drug delivery
system containing curcuma longa
(turmeric)
mr.jignesh
patel241 PHARMACEUTICS 930202 3
NANO
SUSPENSION/EMULSI
ON,SEDDS,LIPID
BASED DDS
NULL
424 20-Nov-14 HALL - 06 132410808008
RATHOD
RAJESHBHAI
MULJIBHAI
Formulation and development of
Biperiden hydrochloride
percutaneous absorption delivery
system for treatment of Parkinson’s
disease
mr. jaimin
patel241 PHARMACEUTICS 930202 3 BUCO/MUCOADHESIV
E,TDDS,TOPICAL,HYDR
OGELS NASAL
NULL
425 20-Nov-14 HALL - 06 132410808009VYAS ANAND
VINODKUMAR
Formulation and evaluation of
intranasal micro emulsion containing
bacopa monnieri (brahmi) for the
treatment of cns disorders
mr. jignesh
patel241 PHARMACEUTICS 930202 3
NANO
SUSPENSION/EMULSI
ON,SEDDS,LIPID
BASED DDS
NULL
426 20-Nov-14 HALL - 07 132060808008SHUKLA KRUPA
DIPAKKUMAR
Formulation and Optimization of
Floating Multiparticulate System of
Acyclovir
MR. NISHITH
PATEL206 PHARMACEUTICS 930202 1 MULTIPARTICULATE
427 20-Nov-14 HALL - 07 132270810014VORA DHRUV
PRASHANTKUMAR
FORMULATION,DEVELOPMENT AND
OPTIMIZATION OF SUSTAINED
RELEASE PELLETS FILLED IN CAPSULE
OF MODEL DRUG
MR.PRATIK
UPADHYAY227
PHARMACEUTICA
L TECHNOLOGY930202 1
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
428 20-Nov-14 HALL - 07 132270810015
DHORAJIA
CHINTAN
RAMBHAI
FORMULATION AND EVALUATION OF
SUSTAINED RELEASE BI-LAYER
TABLET OF LOSARTAN POTASSIUM
MR.JAYMIN
PATEL227
PHARMACEUTICA
L TECHNOLOGY930202 1
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
429 20-Nov-14 HALL - 07 132270810501
GADHAVI CHARAN
KULDEEP
SUBHASHCHANDR
A
DEVELOPMENT OF TASTE MASKED
FAST DISSOLVING TABLET OF
GEMIFLOXACIN BY USING NOVEL CO-
PROCESSED SUPER DISINTEGRANT
MR.JAYMIN
PATEL227
PHARMACEUTICA
L TECHNOLOGY930202 1
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
430 20-Nov-14 HALL - 07 132270810502
Khalani
Akilahemad
Abbasbhai
FORMULATION AND EVALUATION OF
GASTRO RETENTIVE FLOATING DRUG
DELIVERY SYSTEM CONTAINING
SIMVASTATIN
mr.chintan oza 227PHARMACEUTICA
L TECHNOLOGY930202 1
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
431 20-Nov-14 HALL - 07 132270810504PATEL JAIMIN
GHANSHYAMBHAI
FORMULATION,CHARACTERIZATION
AND EVALUATION OF EXEMESTANE
LOADED NANOPARTICLES FOR THE
TREATMENT OF BREAST CANCER
MR.PRATIK
UPADHYAY227
PHARMACEUTICA
L TECHNOLOGY930202 1
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
432 20-Nov-14 HALL - 07 132270810505Patel Pratik
Prakash
FORMULATION AND EVALUATION OF
GASTRO RETENTIVE MUCOADHESIVE
DRUG DELIVERY SYSTEM
CONTAINING LORNOXICAM
mr.chintan oza 227PHARMACEUTICA
L TECHNOLOGY930202 1
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
433 20-Nov-14 HALL - 07 132270810506PATEL PRITIBEN
KANUBHAI
FORMULATION AND EVALUATION OF
FAST DISSOLVING SUBLINGUAL FILM
OF ISRADIPINE
MR.JAYMIN
PATEL227
PHARMACEUTICA
L TECHNOLOGY930202 1
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
434 20-Nov-14 HALL - 07 132270810507SODHA HARDIP
DINESHBHAI
A FACTORIAL STUDY ON
ENHANCEMENT OF SOLUBILITY AND
DISSOLUTION RATE OF
GLIBENCLAMIDE(GLYBURIDE)
EMPLOYING VARIOUS ß-CD-
SURFACTANTS AND ß-CD-SOLID
DISPERSION
MR.PRATIK
UPADHYAY227
PHARMACEUTICA
L TECHNOLOGY930202 1
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
435 20-Nov-14 HALL - 07 132270810508VATS TANVI
SANJAY
FORMULATION, OPTIMIZATION AND
EVALUATION OF SUSTAINED
RELEASE KETOROLAC
TROMETHAMINE PELLETS
Dr.SHREERAJ
SHAH227
PHARMACEUTICA
L TECHNOLOGY930202 1
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
436 20-Nov-14 HALL - 08 132330804002
CHAUHAN
BELABEN
KESARISINH
Analytical Method Development and
Validation of Drug Loading Capacity
and Release Profile of Transfersome
Dr. Sulekha
Bhadra233
QUALITY
ASSURANCE930204 3 DISSOLUTION STUDIES
437 20-Nov-14 HALL - 08 132330804504
Megha
Rajeshkumar
Jayswal
Development and validation of HPLC
method for estimation of related
substances of RALTEGRAVIR
POTASSIUM
Mr. Rikin Patel 233QUALITY
ASSURANCE930204 3 IMPURITY PROFILING
438 20-Nov-14 HALL - 08 132330804518SHARMA GUNJAN
PRADEEPKUMAR
Development and Validation of Bio-
analytical method for simultaneous
estimation of ATORVASTATIN
CALCIUM AND EZETIMIBE in
developed nanosuspension.
Mr.
Surjyanarayan
Mandal
233QUALITY
ASSURANCE930204 3
OTHER (KINDLY
SPECIFY)
BIOANALYTICAL
AND
FORMULATION
DEVELOPMENT
439 20-Nov-14 HALL - 08 132330813003CHOTALIA MUDRA
HARSHADKUMAR
Identification and Quantification of
Polymorphic Impurity by FT-RAMAN
Spectroscopy in Phenytoin tablet
Ms. Nikita
Patel233
QUALITY
ASSURANCE
TECHNIQUE
930204 3OTHER (KINDLY
SPECIFY)
IMPURITY
PROFILING
440 20-Nov-14 HALL - 08 132410804001AMIPARA MANISH
HIMMATLAL
Development and validation of
chromatographic method for
estimation of Terbinafine
Hydrochloride, Clobetasol
propionate, Ornidazole and Ofloxacin
In their combined semi-solid
pharmaceutical dosage form.
Dr. Nehal J.
Shah241
QUALITY
ASSURANCE930204 3
SIMULTANEOUS
ESTIMATION
NULL
441 20-Nov-14 HALL - 08 132410804002
ANAND
DIVYESHKUMAR
SUBHASHBHAI
Development and validation of
analytical methods for estimation of
Apixaban in its tablet dosage form.
Dr. Nehal J.
Shah241
QUALITY
ASSURANCE930204 3
Development &
Validation of
Analytical method for
a Single Drug
NULL
442 20-Nov-14 HALL - 08 132410804003Gosai Bijalben
Rajeshpuri
Development and validation of
analytical methods for estimation of
Meclizine Hydrochloride and Caffeine
in their combined tablet dosage form
Dr. Nehal J.
Shah241
QUALITY
ASSURANCE930204 3
SIMULTANEOUS
ESTIMATION
NULL
443 20-Nov-14 HALL - 08 132410804004PATEL JITENDRA
MOTIBHAI
Development and validation of
analytical methods for estimation of
Mebeverine Hydrochloride and
Chlordiazepoxide in their combined
pharmaceutical dosage form.
Dr. Nehal J.
Shah241
QUALITY
ASSURANCE930204 3
SIMULTANEOUS
ESTIMATION
NULL
444 20-Nov-14 HALL - 08 132410804005PATEL NIKITABEN
ASHOKBHAI
Development and validation of
analytical methods for estimation of
Chlorthalidone and Atenolol in their
combined tablet dosage form
Dr. Nehal J.
Shah241
QUALITY
ASSURANCE930204 3
SIMULTANEOUS
ESTIMATION
NULL
445 20-Nov-14 HALL - 08 132410804006PATEL RITISHABEN
GIRISHBHAI
Development and validation of
analytical methods for estimation of
Gentamicin sulphate and Clobetasol
propionate in their combined
semisolid dosage form.
Dr. Nehal J.
Shah241
QUALITY
ASSURANCE930204 3
SIMULTANEOUS
ESTIMATION
NULL
446 20-Nov-14 HALL - 09 132250804004DHOLAKIA DHARA
RAMESHCHANDRA
Analytical method development and
validation for Regorafenib.
dr.deepa r.
patel225
QUALITY
ASSURANCE930204 2
OTHER (KINDLY
SPECIFY)
method
development
and validation
447 20-Nov-14 HALL - 09 132250804017TRIVEDI MANAN
RAVINDRABHAI
Determination of related substances
of Telmisartan and Amlodipine
besylate in tablet dosage form by
using RP-HPLC.
dr.
piyushkumar
m. patel
225QUALITY
ASSURANCE930204 2
OTHER (KINDLY
SPECIFY)
448 20-Nov-14 HALL - 09 132330804006
Maisuriya
Bhavishaben
Yatindrakumar
Risk Assessment Study Of
Gemcitabine hydrochloride Loaded
Colon Targeted Nanoparticle.
Mr.
Surjyanarayan
Mandal
233QUALITY
ASSURANCE930204 3
QUALITY RISK
MANAGEMENT
449 20-Nov-14 HALL - 09 132330804014PATEL VICHIKABEN
RAMESHBHAI
Bioanalytical Method Development
And Validation For Estimation Of
Vitamin E From Dried Blood Spot.
Mrs. Archana
Navale233
QUALITY
ASSURANCE930204 3 BIOANALYTICAL
450 20-Nov-14 HALL - 09 132330804018SHAH MEGHABEN
DILIPKUMAR
Risk assessment study of
Capecitabine tabletDr. Rajesh K.S. 233
QUALITY
ASSURANCE930204 3
QUALITY RISK
MANAGEMENT
451 20-Nov-14 HALL - 09 132330804019
CHAUDHARI
HEMAXI
ASHOKBHAI
Risk assessment study for
formulation development of nano
particle loaded topical gel of
Deflazacort
Mrs. Falguni B.
Tandel233
QUALITY
ASSURANCE930204 3
QUALITY RISK
MANAGEMENT
452 20-Nov-14 HALL - 09 132330804511shekhat radhika
ashokbhai
Risk Assessment study for
formulation development of
BRINZOLAMIDE and BRIMONIDINE
TARTRATE insitu hydrogel
Mrs. Bijal
Prajapati233
QUALITY
ASSURANCE930204 3
QUALITY RISK
MANAGEMENT
453 20-Nov-14 HALL - 09 132330804516JOSHI YASHODHAR
KIRITBHAI
Bioanalytical Method development
and Validation of ISOSORBIDE-5-
MONONITRATE in human plasma by
LC-MS/MS.
Dr. Sulekha
Bhadra233
QUALITY
ASSURANCE930204 3 BIOANALYTICAL
454 20-Nov-14 HALL - 09 132330813007
KALAVADIYA
AAKASH
SATISHBHAI
to DEVELOP azithromycin syrup using
qbd approach
Dr. Sulekha
Bhadra233
QUALITY
ASSURANCE
TECHNIQUE
930204 3QUALITY RISK
MANAGEMENTQbD
455 20-Nov-14 HALL - 10 132330804513Thakkar Khyatiben
Dilipkumar
Development and Validation of
Analytical Method for Estimation of
Bergenin in Polyherbal Formulation
Mrs. Lalit Lata
Jha233
QUALITY
ASSURANCE930204 3 HERBAL
456 20-Nov-14 HALL - 10 132410804007Patel Shrutiben
Pravinkumar
Development and validation of
analytical methods for estimation of
Minoxidil and Aminexil in their
combined topical solution.
Dr. Nehal J.
Shah241
QUALITY
ASSURANCE930204 3
SIMULTANEOUS
ESTIMATION
NULL
457 20-Nov-14 HALL - 10 132410804008
PATHAN
SHAHRUKHKHAN
AIYUBKHAN
Development and validation of
chromatographic method for
estimation of Paracetamol , Caffiene,
Nimesulide, Cetrizine Hydrochloride
and Phenylephrine Hydrochloride in
their combined tablet dosage form.
Dr. Nehal J.
Shah241
QUALITY
ASSURANCE930204 3
SIMULTANEOUS
ESTIMATION
NULL
458 20-Nov-14 HALL - 10 132410804010
PATEL
HIRENKUMAR
NARESHBHAI
Development and validation of
analytical methods for estimation of
Betamethasone dipropionate and
Ketaconazole in their combined
semisolid dosage form
Dr. Nehal J.
Shah241
QUALITY
ASSURANCE930204 3
SIMULTANEOUS
ESTIMATION
NULL
459 20-Nov-14 HALL - 10 132600804001PATEL HEMINA
PRAHLADBHAI
Development and Validation of
Stability Indicating HPLC method for
Estimation of Palonosetron
Hydrochloride in Tablet Dosage Form
Mrs. hetal
kunal patel260
QUALITY
ASSURANCE930204 1 STABILITY STUDIES
460 20-Nov-14 HALL - 10 132600804002PATEL MILI
ASHWINBHAI
Development and Validation of
Stability Indicating HPLC method for
Simultaneous Estimation of
Epalrestat and Methylcobalamin in
Tablet Dosage Form
Mr. sagar s.
patel260
QUALITY
ASSURANCE930204 1 STABILITY STUDIES
461 20-Nov-14 HALL - 10 132600804006PURVISHA D
PARMAR
Analytical Method Development and
Validation for Simultaneous
Estimation of Ketorolac
Tromethamine and Phenylephrine
Hydrochloride in their Synthetic
Mixture
Mrs. hetal
kunal patel260
QUALITY
ASSURANCE930204 1
SIMULTENEOUS
ESTIMATION
462 20-Nov-14 HALL - 10 132600804009MAKANI JINALBEN
NERENDRAKUMAR
Bioequivalence study of
Lercanidipine Hydrochloride 10mg
test formulation with marketed
reference formulation by LC-MS/MS
Dr. bhavesh s.
nayak260
QUALITY
ASSURANCE930204 1 BABE
463 20-Nov-14 HALL - 11 132250804003DALSANIYA DIXITA
JAYANTILAL
Development and validation of
stability indicating assay method for
Tapentadol hydrochloride and
Paracetamol.
dr.
piyushkumar
m. patel
225QUALITY
ASSURANCE930204 2 STABILITY STUDIES
464 20-Nov-14 HALL - 11 132250804008
PATEL
GITESHKUMAR
CHANDULAL
Development and validation of
stability indicating assay method for
estimation of Cinitrapride and
Pantoprazole sodium in bulk and
pharmaceutical dosage form.
dr.
piyushkumar
m. patel
225QUALITY
ASSURANCE930204 2 STABILITY STUDIES
465 20-Nov-14 HALL - 11 132250804010PATEL JHANAVI
AMRUTBHAI
Analytical method development and
validation of Withaferin A and
Piperine in marketed formulation.
ms. advaita b.
patel225
QUALITY
ASSURANCE930204 2 HERBAL
466 20-Nov-14 HALL - 11 132250804014
PURSNANI
VISHALKUMAR
LAXMANBHAI
Analytical method development and
validation of Berberina hydrochloride
and Plumbagine in marketed
polyherbal formulation.
dr.deepa r.
patel225
QUALITY
ASSURANCE930204 2 HERBAL
467 20-Nov-14 HALL - 11 132250804018
PATEL
VIMALKUMAR
JAYANTILAL
Stability indicating chromatographic
method for Cilnidipine and
Chlorthalidone in pharmaceutical
dosage form.
mr. ravi j. shah 225QUALITY
ASSURANCE930204 2 STABILITY STUDIES
468 20-Nov-14 HALL - 11 132330813005 APOORVA JAIN
Bioavailability Study and Estimation
of Fentanyl Citrate in human plasma
by LCMS/MS
Ms. Dhara
Rathod233
QUALITY
ASSURANCE
TECHNIQUE
930204 3OTHER (KINDLY
SPECIFY)
469 20-Nov-14 HALL - 11 132330813006GANDA VISHAL
ATULBHAI
Bioanalytical Method development
and validation of DUTASTERIDE to
analyze bioavailability in plasma by
LC-MS/MS
Mr. Rikin Patel 233
QUALITY
ASSURANCE
TECHNIQUE
930204 3OTHER (KINDLY
SPECIFY)BIOANALYTICAL
470 20-Nov-14 HALL - 11 132330813009
TRIVEDI
FALGUNIBEN
PRAVINCHANDRA
Risk Assessment and Process
Validation on New Product Transfer
of Paracetamol 500mg Tablet.
Mrs. Lalit Lata
Jha233
QUALITY
ASSURANCE
TECHNIQUE
930204 3OTHER (KINDLY
SPECIFY)
QUALITY RISK
MANAGEMENT
AND PROCESS
VALIDATION
471 20-Nov-14 HALL - 11 132330813501
BUDDH MONIKA
KRUSHNAKANTBH
AI
Method development and Validation
of FT-IR and comparision of FT-IR
and RP-HPLC for estimation of
Triptans in bulk and pharmaceutical
formulation.
Mr. Gajanan
Shinde233
QUALITY
ASSURANCE
TECHNIQUE
930204 3OTHER (KINDLY
SPECIFY)
METHOD
DEVELOPMENT
472 20-Nov-14 HALL - 12 132250804001MEHTA BHARGAV
SURESHKUMAR
Analytical method development and
validation for simultaneous
estimation of Cilostazole and
Telmisartan in bulk drug.
dr. maulik r.
amin225
QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
473 20-Nov-14 HALL - 12 132250804002PATEL KINJAL
RAMESHBHAI
Analytical method development and
validation for simultaneous
estimation of Naftopidil and
Dutasteride in bulk drug.
dr.
piyushkumar
m. patel
225QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
474 20-Nov-14 HALL - 12 132250804005MAHERIYA ASHOK
POPATBHAI
Analytical method development and
validation of Lafutidine and
Rabeprazole in their combined
dosage form.
dr.deepa r.
patel225
QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
475 20-Nov-14 HALL - 12 132250804006MISTRY BHAVIK
DASHRATHBHAI
A) Analytical method development
and validation of Gabapentin capsule.
B) Process validation of Gabapentin
capsule.
dr.deepa r.
patel225
QUALITY
ASSURANCE930204 2 PROCESS VALIDATION
476 20-Nov-14 HALL - 12 132250804007PATEL DIMPALBEN
KANAIYALAL
Analytical method development and
validation for simultaneous
estimation of Moxonidine and
Amlodipine besylate in
pharmaceutical dosage form.
dr.
piyushkumar
m. patel
225QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
477 20-Nov-14 HALL - 12 132250804016
SADHU
SUNILKUMAR
GHANSHYAMBHAI
A) Analytical method development
and validation of Tramadol
hydrochloride and Acetaminophen
tablet. B) Process validation of
Tramadol hydrochloride and
Acetaminophen tablet.
dr.deepa r.
patel225
QUALITY
ASSURANCE930204 2 PROCESS VALIDATION
478 20-Nov-14 HALL - 12 132330804506PATEL JIGNA
RAJNIKANT
Analytical method development and
validation for estimation of CALCIUM
DOBESILATE and DOCUSATE SODIUM
in pharmaceutical dosage form with
QBD approach.
Mr. Rikin Patel 233QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
479 20-Nov-14 HALL - 12 132330804507
PATEL
PRATIKKUMAR
BECHARBHAI
Analytical method development and
validation of AMBROXOL AND
TERBUTALINE in pharmaceutical
dosage form.
Ms. Dhara
Rathod233
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
480 20-Nov-14 HALL - 12 132330804508
RAYLY
TAJWARBANU
IQBAL MUSA
Development and validation of
analytical method for simultaneous
estimation of BENZOCAINE, SODIUM
METHYLPARABEN and SODIUM
PROPYLPARABEN in gel Dosage form.
Mr. Javid
Mansuri233
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
481 20-Nov-14 HALL - 12 132330804509SHAH SWINALBEN
SHAILESHKUMAR
Development and validation of
Analytical method for simultaneous
estimation of ETORICOXIB,MENTHOL
and METHYL SALICYLATE in Synthetic
Mixture
Mrs. Falguni B.
Tandel233
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
482 20-Nov-14 HALL - 13 132330804005KATE PAYAL
KISHORBHAI
Stability indicating RP-HPLC method
development and validation of
Etizolam and Propranolol
Hydrochloride in pharmaceutical
dosage form.
Mr. Parag
Patel233
QUALITY
ASSURANCE930204 3 STABILITY STUDIES
483 20-Nov-14 HALL - 13 132330804012Patel Aesha
Maheshkumar
Stability Indicating Analytical Method
Development And Validation Of
Cilnidipine And Chlorthalidone in
Tablet Dosage Form
Mr. Rikin Patel 233QUALITY
ASSURANCE930204 3 STABILITY STUDIES
484 20-Nov-14 HALL - 13 132330804501
CHAVDA
RASHMIBEN
KIRANSINH
Stability indicating analytical method
development and validation of
METOPROLOL SUCCINATE and
RAMIPRIL in tablet dosage form
Mr. Rikin Patel 233QUALITY
ASSURANCE930204 3 STABILITY STUDIES
485 20-Nov-14 HALL - 13 132330804503Kumpavat
Ruturajsinh Lalsinh
stability indicating analytical method
development and validation for
NIMORAZOLE and OFLOXACIN in
Pharmaceutical dosage form.
Dr. Rajesh
K.S./ Mr. Parag
patel
233QUALITY
ASSURANCE930204 3 STABILITY STUDIES
486 20-Nov-14 HALL - 13 132330804515GAJRE RITIKA
UMESHCHANDRA
Stability indicating RP-HPLC method
development and validation of
GLIMEPIRIDE and EZETIMIBE
Ms. Nikita
Patel233
QUALITY
ASSURANCE930204 3 STABILITY STUDIES
487 20-Nov-14 HALL - 13 132600804003patel swati
jayantibhai
Development and Validation of
Stability Indicating HPLC method for
Simultaneous Estimation of
Atorvastatin calcium and Ramipril in
Tablet Dosage Form
Mr. sagar s.
patel260
QUALITY
ASSURANCE930204 1 STABILITY STUDIES
488 20-Nov-14 HALL - 13 132600804004patel urvashi
vinodbhai
Development and Validation of
Stability Indicating RP-HPLC method
for Simultaneous Estimation of
Carvedilol and Ivabradine in Tablet
Dosage Form
Dr. bhavesh s.
nayak260
QUALITY
ASSURANCE930204 1 STABILITY STUDIES
489 20-Nov-14 HALL - 13 132600804005
PATEL URVI
CHANDRAKANTBH
AI
Development and Validation of
Stability Indicating HPLC method for
Simultaneous Estimation of
Pregabalin and Methylcobalamine in
Tablet Dosage Form
Dr. bhavesh s.
nayak260
QUALITY
ASSURANCE930204 1 STABILITY STUDIES
490 20-Nov-14 HALL - 13 132600804010PATEL BHUMI
RAJDEVBHAI
Development and Validation of
Stability Indicating HPLC method for
Simultaneous Estimation of
Duloxetine Hydrochloride and
Methylcobalamin in Tablet Dosage
Form
Mrs. hetal
kunal patel260
QUALITY
ASSURANCE930204 1 STABILITY STUDIES
491 20-Nov-14 HALL - 13 132600804011VYAS HELI
RAJESHKUMAR
Development and Validation of
Stability Indicating HPLC method for
Simultaneous Estimation of Nebivolol
Hydrochloride and Valsartan in
Tablet Dosage Form
Mr. sagar s.
patel260
QUALITY
ASSURANCE930204 1 STABILITY STUDIES
492 20-Nov-14 HALL - 14 132250804009PATEL HARIKESH
PRANAVKUMAR
Analytical method development and
validation for simultaneous
estimation of Minoxidil and
Finasteride in pharmaceutical dosage
form.
dr.
piyushkumar
m. patel
225QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
493 20-Nov-14 HALL - 14 132250804011PATEL MAHESH
AMBARAMBHAI
Analytical method development and
validation for Timolol maleate and
Dorzolamide hydrochloride in sterile
eye drop formulation.
dr.deepa r.
patel225
QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
494 20-Nov-14 HALL - 14 132250804012PATEL PRIYANKA
KANUBHAI
Analytical method development and
validation for simultaneous
estimation of Mupirocin and
Fluticasone in pharmaceutical dosage
form.
dr.
piyushkumar
m. patel
225QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
495 20-Nov-14 HALL - 14 132250804013PATEL RIPAL
VINODBHAI
Analytical method development and
validation of Resveratrol and Piperine
in marketed formulation.
dr.deepa r.
patel225
QUALITY
ASSURANCE930204 2 BABE
496 20-Nov-14 HALL - 14 132250804015
RAJPUROHIT
ARVINDKUMAR
NARSINHBHAI
Analytical method development and
validation for simultaneous
estimation of Cefpodoxime proxetil
and Dicycloxacillin sodium in
pharmaceutical dosage form.
dr.
piyushkumar
m. patel
225QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
method
development
and validation
497 20-Nov-14 HALL - 14 132330804510SHAH TUSHAR
ASHWINBHAI
Analytical method development and
validation for simultaneous
estimation of CARISOPRODOL and
IBUPROFEN in tablet dosage form.
Mr. Viral Patel 233QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
498 20-Nov-14 HALL - 14 132330813001
BHAVSAR
PUJAKUMARI
MANHARLAL
Development and validation of
analytical method for simultaneous
estimation of AMITRIPTYLINE
Hydrochloride and KETAMINE
Hydrochloride by DOE approach.
Ms. Shweta
Gupta233
QUALITY
ASSURANCE
TECHNIQUE
930204 3SIMULTENEOUS
ESTIMATION
499 20-Nov-14 HALL - 14 132330813002
BHAYJI
JENULABEDIN
RASHID
Analytical method development and
validation for simultaneous
estimation of Bromocriptine
Mesylate and Metformin
Hydrochloride with DOE approach.
Mrs. Falguni B.
Tandel233
QUALITY
ASSURANCE
TECHNIQUE
930204 3SIMULTENEOUS
ESTIMATION
500 20-Nov-14 HALL - 14 132330813004
HIRPARA
MAYURBHAI
BHIMJIBHAI
Formulation of Diclofenac Sodium
and Benzocaine topical dosage form
and Method Development and
Validation of analytical method for
simultaneous estimation.
Dr. Rajesh K.S. 233
QUALITY
ASSURANCE
TECHNIQUE
930204 3SIMULTENEOUS
ESTIMATION
501 20-Nov-14 HALL - 14 132330813008PATEL RUCHI
PRAVINBHAI
Development and validation of
analytical method for simultaneous
estimation of Minoxidil and Aminexil
in pharmaceutical dosage form
Mr. Parag
Patel233
QUALITY
ASSURANCE
TECHNIQUE
930204 3SIMULTENEOUS
ESTIMATION
502 28-Nov-14 HALL - 01 132020808008SHINGADIYA
ANAND LALJIBHAI
FORMULATION AND IN-VITRO
CHARACTERIZATION OF BUCCAL
BILAYER TABLETs CONTAINING
CILNIDIPINE.
dR.V.A.PATEL 202 PHARMACEUTICS 930202 3
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
503 28-Nov-14 HALL - 01 132020808009
SINGH
PREETIKUMARI PK
SINGH
FORMULATION DEVELOPMENT AND
IN-VITRO EVALUATION OF BUCCAL
TABLETS CONTAINING BETA
BLOCKER
MR.S.P.PAWA
R202 PHARMACEUTICS 930202 3
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
504 28-Nov-14 HALL - 01 132020808010SOLANKI NEHABA
NATWARSINH
formulation and in-vitro evaluation
of orotrans mucoadhesive drug
delivery system of olanzapine
dr. n. p. chotai 202 PHARMACEUTICS 930202 3
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
505 28-Nov-14 HALL - 01 132020808011DHOBI ZINKAL
PAPPUBHAI
formulation and in-vitro evaluation
of mucoadhesive buccal drug delivery
system of raloxifene hcl
dR.
N.P.CHOTAI202 PHARMACEUTICS 930202 3
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
506 28-Nov-14 HALL - 01 132050808003
GOHIL
JAYDEVSINH
VIKRAMSINH
DEVELOPMENT AND
CHARACTERIZATION OF TOPICAL
ORGANOGEL CONTAINING
DIACEREIN AND ACECLOFENAC FOR
THE TREATMENT OF ARTHRITIS
dr. mukesh c.
gohel205 PHARMACEUTICS 930202 3
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
507 28-Nov-14 HALL - 01 132050808005
MALEK
IRFANODDIN
NASIRUDDIN
design and development of
transdermal patch containing
lornoxicam and thiocolchicoside for
treatment of gout
dr. vaishali t.
thakkar205 PHARMACEUTICS 930202 3
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
508 28-Nov-14 HALL - 01 132050808011
Mughdha
Sharadchandra
Kabrawala
FORMULATION AND EVALUATION OF
TOPICAL SPRAY FOR THE
TREATMENT OF PSORIASIS
dr. vaishali t.
thakkar205 PHARMACEUTICS 930202 3
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
509 28-Nov-14 HALL - 01 132050808013Patel Rinkuben
Nareshkumar
Development and assessment of
hydrogel containing antimicrobial
and auxillary agents for treatment of
acid burns
dr. vaishali t.
thakkar205 PHARMACEUTICS 930202 3
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
510 28-Nov-14 HALL - 01 132050808508
VAGHANI
DHAVALKUMAR
HARJIBHAI
exploring polymeric micelles as
targeted pulmonary delivery of
rifampicin,ethambutol and ofloxacine
for treatment of tuberculosis
ms. asha s.
patel205 PHARMACEUTICS 930202 3
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
511 28-Nov-14 HALL - 01 132050808509Bhoi Sejalben
Govindbhai
IN-DEPTH INVESTIGATIONS IN THE
DOSAGE FORM DEVELOPMENT OF
SOLANESOL FOR THE TREATMENT OF
DIABETIC FOOT ULCER
dr. mukesh c.
gohel205 PHARMACEUTICS 930202 3
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
512 28-Nov-14 HALL - 01 132020808007
RUTIKA
SHASHIKANT
PATEL
formulation and evaluation of
microsponge for topical delivery of
piroxicam
mr. saikat
pande202 PHARMACEUTICS 930202 3
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
topical
microsponge
513 28-Nov-14 HALL - 02 132050808001
AAKASHKUMAR
PARIMALBHAI
PATEL
DEMONSTRATION OF RISK
ASSESSMENT FOR THE
DEVELOPMENT OF COMPRESSION
COATED TABLET CONTAINING
ASPIRIN AND CLOPIDOGREL
ms. asha S.
patel205 PHARMACEUTICS 930202 3
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
cOMPRESSION
COATED
514 28-Nov-14 HALL - 02 132050808002
BABARIYA
POONAMBEN
RAMESHBHAI
identification of key formulation
variables for modulating release of
lornoxicam from hydrophobic matrix
in hydro-alcoholic dissolution media
dr. mukesh c.
gohel205 PHARMACEUTICS 930202 3
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
sustained
release
515 28-Nov-14 HALL - 02 132050808007PATEL PRACHI
GIRISHCHANDRA
fabrication and evaluation of locally
acting contraceptive in-situ gel
containing neem extract and copper
gluconate employing the current
concept of regulators for females
dr. mukesh c.
gohel205 PHARMACEUTICS 930202 3
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
516 28-Nov-14 HALL - 02 132050808010 Chandni Rangani
science based development and
evaluation of functional solid oral
dosage form of rudraksha employing
innovatively prepared leaf extract
dr. mukesh c.
gohel205 PHARMACEUTICS 930202 3 MISCELANEOUS
Oral dosage
form
517 28-Nov-14 HALL - 02 132050808502JOSHI MAULIN
JANAKKUMAR
development and characterization of
medicated chocolate containing
cefpodoxime proxetil:as a paediatric
dosage form
dr. vaishali t.
thakkar205 PHARMACEUTICS 930202 3 MISCELANEOUS
medicated
chocolate
formulation
518 28-Nov-14 HALL - 02 132050808504PANSURIYA NIRALI
RAMESHCHANDRA
PATIENT CENTRIC DEVELOPMENT OF
EXTENDED RELEASE FORMULATION
FOR INTRAVAGINAL APPLICATION OF
SELECTIVE CHEMOTHERAPEUTIC
AGENT
dr. vaishali t.
thakkar205 PHARMACEUTICS 930202 3
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
vaginal drug
delivery system
519 28-Nov-14 HALL - 02 132050808511Dhodi Sneha
Chunilal
DEVELOPMENT AND
CHARACTERIZATION OF IN-SITU GEL
FORMING IMPLANT CONTAINING
DICLOFENAC SODIUM AND
THIOCOLCHICOSIDE FOR THE
TREATMENT OF GOUT
dr. mukesh c.
gohel205 PHARMACEUTICS 930202 3
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
IMPLANT
520 28-Nov-14 HALL - 02 132050808512Kotwal Roshni
Kamleshbhai
ENHANCEMENT OF SOLUBILITY OF
SUSTAIN RELEASE CARVEDILOL
CONTAINING DISINTEGRATION
CONTROLLED MATRIX TABLET BY
SOLID DISPERSION
dr. vaishali t.
thakkar205 PHARMACEUTICS 930202 3
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
521 28-Nov-14 HALL - 02 132050808513RAVIN ANILBHAI
PANDYA
INVESTIGATION OF AN ACTIVE FILM
COATED TABLET CONTAINING
TIZANIDINE AND IBUPROFEN FOR
THE TREATMENT OF POST-
OPERATIVE PAIN MANAGEMENT
AFTER PERIODONTAL SURGERY
MR. LALJI H.
BALDANIYA205 PHARMACEUTICS 930202 3
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
aCTIVE
COATING
522 28-Nov-14 HALL - 02 132130808007
SHRIVASTAV
NIRAVKUMAR
ATULBHAI
Formulation and evaluation of
stomach specific in-situ gel of
Cefadroxil monohydrate
Mrs.Meenaksh
i Patel213 PHARMACEUTICS 930202 3
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
523 28-Nov-14 HALL - 02 132130808010
Gamit
PiyushKumar
VirjiBhai
Formulation , Optimization and
Evaluation of Press Coated Pulsatile
Release Tablets Containing
OLMESARTAN MEDOXOmIL.
Dr.Tejash H.
Serasiya213 PHARMACEUTICS 930202 3
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
524 28-Nov-14 HALL - 02 132230810002
GAJJAR
JUGALKUMAR
GIRISHCHANDRA
FORMULATION DEVELOPMENT AND
EVALUATION OF NIFEDIPINE
EXTENDED RELEASE TABLET USING
QbD APPROACH
Dr. (Mrs.)
Mrunali R.
Patel
223PHARMACEUTICA
L TECHNOLOGY930202 3
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
525 28-Nov-14 HALL - 02 132130808004maroliya dhara
pravinchandra
Formulation,evaluation and
optimization of gastroretentive
multiparticulate drug delivery system
of Pioglitazone Hydrochloride.
Mrs. Raj
Khiani213 PHARMACEUTICS 930202 3
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
526 28-Nov-14 HALL - 03 132020808001
BHANDERI
SURBHIBEN
HARJIBHAI
preparation and characterization of s-
smedds containing poorly water
soluble drug
dr. AJAY B.
SOLANKI202 PHARMACEUTICS 930202 3
NANO
SUSPENSION/EMULSI
ON, SEDDS, LIPID
BASED DDS
527 28-Nov-14 HALL - 03 132020808005
PATEL
HITESHKUMAR
LALLUBHAI
DEVELOPMENT AND
CHARACTERIZATION OF
NANOPARTICULATE DRUG DELIVERY
SYSTEM CONTAINING POORLY
WATER SOLUBLE DRUG.
Dr. AJAy b.
solanki202 PHARMACEUTICS 930202 3
NANO
SUSPENSION/EMULSI
ON, SEDDS, LIPID
BASED DDS
528 28-Nov-14 HALL - 03 132050808004JAVIYA ARATIBEN
KANAIYALAL
OPTIMIZATION OF PREPARATIVE
CONDITIONS FOR DEVELOPMENT OF
BIODEGRADABLE MICROSPHERES OF
DOXOFYLLINE FOR LUNG TARGETING
dr. mukesh c.
gohel205 PHARMACEUTICS 930202 3 MULTIPARTICULATE
529 28-Nov-14 HALL - 03 132050808006PATEL HETALBEN
BABUBHAI
practical application of the quality by
design for the development of
zaltoprofen tablets with improved
dissolution functionALITY.
dr. mukesh c.
gohel205 PHARMACEUTICS 930202 3
NANO
SUSPENSION/EMULSI
ON, SEDDS, LIPID
BASED DDS
530 28-Nov-14 HALL - 03 132050808009Ankitaben
Ashvinbhai Purohit
demonstration of science based
development of self micro
emulsifying drug delivery system
containing bacopa monnieri extract
for improved in-vitro functionality
dr. mukesh c.
gohel205 PHARMACEUTICS 930202 3
NANO
SUSPENSION/EMULSI
ON, SEDDS, LIPID
BASED DDS
531 28-Nov-14 HALL - 03 132050808012Patel Pratikkumar
Kantibhai
FORMULATION AND ASSESSMENT OF
SPRINKLE PELLETS CONTAINING
ARTEMETHER AND LUMEFANTRINE
FOR PAEDIATRIC PATIENT
MR. LALJI H.
BALDANIYA205 PHARMACEUTICS 930202 3 MULTIPARTICULATE
PELLET
FORMULATION
532 28-Nov-14 HALL - 03 132050808501
CHOVATIYA
HARDIK
POPATBHAI
PREPARATION, CHARACTERIZATION
AND IN-VITRO EVALUATION OF
MEFENAMIC ACID - PHOSPHOLIPID
COMPLEX FOR ENHANCEMENT OF
SOLUBILITY AND DISSOLUTION
dr. vaishali t.
thakkar205 PHARMACEUTICS 930202 3
NANO
SUSPENSION/EMULSI
ON, SEDDS, LIPID
BASED DDS
SOLUBILITY
ENHANCEMENT
533 28-Nov-14 HALL - 03 132140808002DHRUMILKUMAR
MAYURBHAI SHAH
FORMULATION AND
CHARACTERIZATION OF ALBUMIN
BASED NANOPARTICLES FOR ANTI-
TUMOR ACTIVITY
dr. dipti patel 214 PHARMACEUTICS 930202 3
NANO
SUSPENSION/EMULSI
ON, SEDDS, LIPID
BASED DDS
534 28-Nov-14 HALL - 04 132020808003Gandhi Nevilkumar
Subhashchandra
Formulation and Evaluation of
microspheres for nasal delivery of
chlorpheniramine maleate
mr.saikat
pande202 PHARMACEUTICS 930202 3
OTHER (KINDLY
SPECIFY)
nasal
microspheres
535 28-Nov-14 HALL - 04 132020808004PATEL HARI
RAJNIKANT
preparation and in-vitro
characterization of spherical
agglomerates of estrogen receptor
modulator
dr. jolly r.
parikh202 PHARMACEUTICS 930202 3
OTHER (KINDLY
SPECIFY)
spherical
agglomerates
536 28-Nov-14 HALL - 04 132020808006Patel Suchi
Ramubhai
Preparation and in-vitro
characterization of crystallo-co-
agglomerates of anti hypertensive
drug
dr.jolly r.
parikh.202 PHARMACEUTICS 930202 3
OTHER (KINDLY
SPECIFY)
crystallo-co-
agglomerates
537 28-Nov-14 HALL - 04 132140808005SUNILKUMAR
RATILAL PRANAMI
HYALURONAN-MODIFIED
PROLIPOSOMAL DRY POWDER
INHALER FOR PEPTIDE DELIVERY IN
THE TRETMENT OF CYSTIC FIBROSIS
dr. deepa patel 214 PHARMACEUTICS 930202 3OTHER (KINDLY
SPECIFY)
Modified dry
powder inhalers
for peptide
delivery
538 28-Nov-14 HALL - 04 132140808006GOSWAMI POOJA
GIRISH
FORMULATION DEVELOPMENT AND
CHARACTERIZATION OF EXTENDED
RELEASE TABLET CONTAINING
COMBINATION OF ANTI DIABETIC
AGENTS
mr nishit a
gohel214 PHARMACEUTICS 930202 3
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
539 28-Nov-14 HALL - 04 132140808503
PATEL
BHUMIKABEN
RAJANIKANTBHAI
FORMULATION AND
CHARACTERIZATION OF COLON
TARGETED DRUG DELIVERY FOR
INFLAMMATORY BOWEL DISEASE
Mr Nishit a
gohel214 PHARMACEUTICS 930202 3
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
540 28-Nov-14 HALL - 04 132020808013
SONI HEMALI
CHANDRESHKUMA
R
formulation development and in-
vitro characterization of raft forming
chewable tablets of ranitidine
hydrochloride
dr.v.a.patel 202 PHARMACEUTICS 930202 3
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
raft forming
541 28-Nov-14 HALL - 04 132140808008PATEL NIRALIBEN
MAHESHBHAI
METHOTREXATE ENCAPSULATED
ALBUMIN-HYALURONATE
NANOPARTICLES AS SELECTIVE
NANOVECTORS FOR RHEUMATOID
ARTHRITIS
dr. deepa patel 214 PHARMACEUTICS 930202 3OTHER (KINDLY
SPECIFY)
tARGETED
NANOPARTICLE
S FOR
RHEUMATOID
ARTHRITIS
542 28-Nov-14 HALL - 04 132140808010
SOLANKI
SHREYABEN
RAMESHBHAI
FABRICATION AND EVALUATION OF
INJECTABLE IN SITU FORMING
BIODEGRADABLE SCAFFOLD FOR
ANTICANCER DRUG DELIVERY
dr. deepa patel 214 PHARMACEUTICS 930202 3
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
INJECTABLE IN
SITU FORMING
BIODEGRADABL
E SCAFFOLD
543 28-Nov-14 HALL - 04 132140808011 YESHABEN PATEL
FABRICATION AND
CHARACTERIZATION OF SCAFFOLD
OF BIODEGRADABLE POLYMER AND
INORGANIC SUBSTRATE NANO-
HYDROXYAPATITE FOR
OSTEOMYELITIS
dr. deepa patel 214 PHARMACEUTICS 930202 3OTHER (KINDLY
SPECIFY)
BIODEGRADABL
E SCAFFOLD
544 28-Nov-14 HALL - 05 132050808008RAMI DHARINI
KIRTIKUMAR
EXPLORATION OF FOAM
GRANULATION TECHNIQUE FOR THE
PREPARATION OF FAST
DISINTEGRATING TABLET
CONTAINING FLUPIRTINE MALEATE
FOR PAIN MANAGEMENT
MR. LALJI H.
BALDANIYA205 PHARMACEUTICS 930202 3
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
545 28-Nov-14 HALL - 05 132050808014Sevak Yagni
Bharatbhai
FORMULATION, OPTIMIZATION AND
EVALUATION OF SUBLINGUAL FILM
OF CANDESARTAN CILEXETIL
dr. vaishali t.
thakkar205 PHARMACEUTICS 930202 3
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
546 28-Nov-14 HALL - 05 132050808503
KETANKUMAR
MANSUKHBHAI
JAVIYA
Development and evaluation of poly
herbal formulation containing lipid
lowering agents
dr. vaishali t.
thakkar205 PHARMACEUTICS 930202 3
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
Poly herbal oral
dosage form
547 28-Nov-14 HALL - 05 132050808505PATEL AMI
PIYUSHBHAI
dEVELOPMENT aND eVALUATION oF
aN aNTI-STRESS POLY HERBAL
FORMULATION
ms. asha s.
patel205 PHARMACEUTICS 930202 3
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
Poly herbal oral
dosage form
548 28-Nov-14 HALL - 05 132130808005PATEL DHRUTIBEN
NARENDRAKUMAR
Formulation and Evaluation of
Cilostazol tablet by Liquisolid
technique
Dr Ashok
Mahajan213 PHARMACEUTICS 930202 3
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
549 28-Nov-14 HALL - 05 132140808504PATEL REENI
PRAVINBHAI
FORMULATION AND EVALUATION OF
ORODISPERSIBLE FILM USING ANTI-
HISTAMINE AGENT
MRS.RUPAL
JANI214 PHARMACEUTICS 930202 3
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
550 28-Nov-14 HALL - 05 132140808003GANDHI AANAL
YOGENDRAKUMAR
COMPARATIVE ESTIMATION OF
NATURAL SUPERDISINTIGRANTS
WITH STANDARD
SUPERDISINTIGRANT IN
ORODISPERSIBLE TABLET
MRS.RUPAL
JANI214 PHARMACEUTICS 930202 3
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
551 28-Nov-14 HALL - 05 132140808506
BAMANIYA
MITESHKUMAR
HIMMATSINH
DISSOLUTION RATE ENHANCEMENT
OF ANTIHYPERTENSIVE DRUG USING
LIQUISOLID TABLET
MRS.RUPAL
JANI214 PHARMACEUTICS 930202 3
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
liqui-solid tablet
552 28-Nov-14 HALL - 05 132050808506PATEL NISHIT
DINESHKUMAR
DEVELOPMENT AND EVALUATION OF
AN ANTI-HYPERTENSIVE POLY
HERBAL FORMULATION
MR. LALJI H.
BALDANIYA205 PHARMACEUTICS 930202 3
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
Poly herbal oral
dosage form
553 28-Nov-14 HALL - 05 132130808006PATEL SHREYA
NAGINBHAI
Formulation and Evaluation of
Bicalutamide tablet by liquisolid
technique
Dr Ashok
Mahajan213 PHARMACEUTICS 930202 3
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
554 28-Nov-14 HALL - 05 132130808003malani ketan
ashokbhai
Formulation, optimization and
evaluation of liquisolid tablets
containing tadalafil.
Dr.Tejash H.
Serasiya213 PHARMACEUTICS 930202 3
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
555 28-Nov-14 HALL - 06 132020808014
PATEL
DIGANTKUMAR
HARIBHAI
formulation and evaluation of
floating microspheres of a selected
drug
mr. saikat
pande202 PHARMACEUTICS 930202 3 MULTIPARTICULATE
556 28-Nov-14 HALL - 06 132050808507SHAH CHIRAG
INDRAVADAN
eXPlORATION OF cyclodextrin
derivative for use in extrusion
spheronization for acheiving dual
objective of faster erosion and
improved drug dissolution
dr. mukesh c.
gohel205 PHARMACEUTICS 930202 3 MULTIPARTICULATE
PELLET
FORMULATION
557 28-Nov-14 HALL - 06 132050808510
Chauhan
Happykumar
Kantilal
FABRICATION AND EVALUATION OF A
NEWER COMBINATION CONTAINING
CILOSTAZOL AND TELMISARTAN
WITH IMPROVED FUNCTIONALITY
FOR THE TREATMENT OF
CARDIOVASCULAR COMPLICATION
ASSOCIATED WITH DIABETES
dr. vaishali t.
thakkar205 PHARMACEUTICS 930202 3 MULTIPARTICULATE
PELLET
FORMULATION
558 28-Nov-14 HALL - 06 132140808009RAO RISHITI
RAMANATH
CO-PROCESSED DIRECTLY
COMPRESSIBLE EXCIPIENT FOR
EXTENDED RELEASE TABLET
DR. DIPTI
PATEL214 PHARMACEUTICS 930202 3
CO PROCESSED, DC,
TABLET/CAPSULE
EXCIPIENTS AND
ATTRIBUTES
559 28-Nov-14 HALL - 06 132230810001PATEL APEXA
DHANSUKHBHAI
FORMULATION AND EVALUATION OF
BENZOYL PEROXIDE LOADED
MICROSPONGE FOR TOPICAL
DELIVERY SYSTEM
Dr. (Mrs.)
Harsha V. Patel223
PHARMACEUTICA
L TECHNOLOGY930202 3 MULTIPARTICULATE
560 28-Nov-14 HALL - 06 132230810003VIHOL DIVYA
DILIPSINH
DISSOLUTION BEHAVIOUR OF
FLUCONAZOLE BY CRYSTALLIZATION
TECHNIQUE
Dr. Chirag D.
Nagda223
PHARMACEUTICA
L TECHNOLOGY930202 3
CO PROCESSED, DC,
TABLET/CAPSULE
EXCIPIENTS AND
ATTRIBUTES
561 28-Nov-14 HALL - 06 132130808009VYAS UDIT
DHARMESH
Formulation, evaluation and
optimization of novel vesicular
topical gel of Betamethasone
dipropionate for Psoriasis
Mrs.Prachi
Pandey213 PHARMACEUTICS 930202 3
VESICULAR DRUG
DELIVERY SYSTEM
562 28-Nov-14 HALL - 07 132020808012PATEL DIXITA
ISHWARBHAI
FORMULATION AND EVALUATION OF
SUBLINGUAL TABLET OF AN
ANTIHYPERTENSIVE DRUG.
MR.S.P.PAWA
R202 PHARMACEUTICS 930202 3
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
563 28-Nov-14 HALL - 07 132130808002
DIVYABEN
BHARATBHAI
MISTRY
Formulation and evaluation of
Ropinirole Hydrochloride Nasal spray.
Mr Milind M
Thosar213 PHARMACEUTICS 930202 3
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
NAsal spray
564 28-Nov-14 HALL - 07 132130808008 Shuchi Khode
Formulation and evaluation of
LECITHIN BASED SYSTEM for dermal
delivery of Halobetasol propionate
Dr Manisha
Lalan213 PHARMACEUTICS 930202 3
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
565 28-Nov-14 HALL - 07 132140808001Chaudhary Kinjal
Laxmanbhai
FABRICATION AND
CHARACTERIZATION OF NIOSOMAL
GEL FOR OSTEOPOROSIS
Dr. dipti Patel 214 PHARMACEUTICS 930202 3
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
566 28-Nov-14 HALL - 07 132140808004
Sanghvi
Adityakumar
Nileshkumar
FORMULATION AND EVALUATION OF
MUCOADHESIVE BUCCAL FILM
CONTAINING ANTI-DIABETIC AGENT
Mr Nishit a
gohel214 PHARMACEUTICS 930202 3
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
567 28-Nov-14 HALL - 07 132140808007PANDYA RADHA
DUSHYANT
COMPARATIVE STUDY OF
MUCOADHESIVE AGENTS IN THE
FORMULATION OF MUCOADHESIVE
NASAL DROPS FOR THE TREATMENT
OF PARKINSON'S DISEASE
dr dipti patel 214 PHARMACEUTICS 930202 3
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
568 28-Nov-14 HALL - 07 132140808501
CHAWADA
PRIYANKABEN
LAXMANSINH
IMPROVE PERMEATION OF ANTI-
HYPERTENSIVE DRUG FROM
TRANSDERMAL PATCH USING
ESSENTIAL OILS
MRS.RUPAL
JANI214 PHARMACEUTICS 930202 3
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
569 28-Nov-14 HALL - 07 132140808502PANDYA VISHAL
HARENDRABHAI
DESIGN, DEVELOPMENT AND
CHARACTERIZATION OF
MICROEMULSION BASED TOPICAL
GEL FOR RHEUMATOID ARTHRITIS
DR. DIPTI
PATEL214 PHARMACEUTICS 930202 3
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
570 28-Nov-14 HALL - 07 132140808505
PATIL
VIMALSHARAN
HARESHBHAI
MODIFIED HYDROGEL FILM BASED
WOUND DRESSING OF NATURAL
BIOPOLYMERS FOR WOUND CARE
APPLICATION
dr. deepa patel 214 PHARMACEUTICS 930202 3
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
MODIFIED
HYDROGEL
FILM BASED
WOUND
DRESSING
571 28-Nov-14 HALL - 07 132020808002GAJJAR PALAK
DINESHBHAI
FORMULATION DEVELOPMENT AND
EVALUATION OF FAST
DISINTEGRATING TABLET
CONTAINING ANTIHYPERTENSIVE
DRUG
MR. s. p.
pawar202 PHARMACEUTICS 930202 3
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
572 28-Nov-14 HALL - 08 132020804006PATEL ROMEL
MUKESHBHAI
analytical method development and
validation for estimation of
poly(hexamethylene
biguanide)hydrochloride in marketed
formulation
dr
anandkumari
captain
202QUALITY
ASSURANCE930204 3
OTHER (KINDLY
SPECIFY)
estimation of
single drug from
formulation
573 28-Nov-14 HALL - 08 132020804007RAVAL KISHAN
HARESHBHAI
development and validation of
analytical methods for quantitative
estimation of abiraterone acetate in
pharmaceutical dosage form
mr.dinesh v.
thakkar202
QUALITY
ASSURANCE930204 3
OTHER (KINDLY
SPECIFY)
estimation of
single drug from
formulation
574 28-Nov-14 HALL - 08 132020804011PATEL KEDAR
HIRENBHAI
DEVELOPMENT and validation of
analytical method for the estimation
of memantine hcl
Dr.v.v.karkhani
s 202
QUALITY
ASSURANCE930204 3
OTHER (KINDLY
SPECIFY)
Estimation of
single drug from
formulation
575 28-Nov-14 HALL - 08 132020804012
PATEL
SHRADHABEN
KETANKUMAR
development and validation of
analytical method for estimation of
leflunomide
dr.v.v.karkhani
s202
QUALITY
ASSURANCE930204 3
OTHER (KINDLY
SPECIFY)
estimation of
single drug from
formulation
576 28-Nov-14 HALL - 08 132130804007PATEL SHWETA
FAKIRBHAI
Development and validation of
spectrophotometric method for the
estimation of some poorly water
soluble drugs using hydrotopic
agents.
Dr. Shailesh
Koradia213
QUALITY
ASSURANCE930204 3
OTHER (KINDLY
SPECIFY)
Hydrotopic
solubalization
577 28-Nov-14 HALL - 08 132130804013Vaswani Mamta
Mohan
Development and validation of
analytical methods for estimation of
SIMULTANEOUS ESTIMATION OF
DRUGS USED FOR TREATMENT OF
ERECTILE DYSFUNCTIONING IN BULK
AND IN THEIR COMBINED DOSAGE
FORM.
Dr. Vandana B.
Patel213
QUALITY
ASSURANCE930204 3
OTHER (KINDLY
SPECIFY)
Analytical
method
development
578 28-Nov-14 HALL - 08 132020804005NAREGALKAR
NEHA SHIRISH
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHOD FOR
QUANTITATIVE ESTIMATION OF
AsENAPINE MALEATE IN
PHARMACEUTICAL FORMULATION.
dR. RASHMIN
B. PATEL202
QUALITY
ASSURANCE930204 3
OTHER (KINDLY
SPECIFY)
ASSAY METHOD
DEVELOPMENT
AND
VALIDATION
579 28-Nov-14 HALL - 08 132020804009VEKARIA KHYATI
BHARATBHAI
development and validation of
analytical method for quantitative
estimation of lurasidone
hydrochloride in pharmaceutical
formulation
Dr. rashmin b.
patel202
QUALITY
ASSURANCE930204 3
OTHER (KINDLY
SPECIFY)
assay mehod
development
and validation
580 28-Nov-14 HALL - 08 132050804506Sindha Neelamben
Umedsinh
CLEANING VALIDATION FOR
ESTIMATION OF PHARMACEUTICAL
RESIDUES USING RISK BASED
ANALYSIS
dr.purvi a.
shah205
QUALITY
ASSURANCE930204 3
OTHER (KINDLY
SPECIFY)
CLEANING
VALIDATION
581 28-Nov-14 HALL - 08 132130804009SHAH RIMA
GOPALBHAI
Development and validation of
analytical methodS for estimation of
FebuXostat in its pharmaceutical
dosage form.
Mr. Hemant
Patel213
QUALITY
ASSURANCE930204 3
OTHER (KINDLY
SPECIFY)
Analytical
method
development
582 28-Nov-14 HALL - 08 132130804003parima udaybhai
desai
Development and validation of
analytical methods for estimation of
Sertaconazole nitrate in its
pharmaceutical dosage form.
Dr. Vandana B.
Patel213
QUALITY
ASSURANCE930204 3
OTHER (KINDLY
SPECIFY)
Analytical
method
development
583 28-Nov-14 HALL - 09 132020804002gor niyatiben
pankajkumar
development and validation of
analytical method for quantitative
estimation of bupropion
hydrochloride in pharmaceutical
dosage form.
dr. vipul m.
vaghela202
QUALITY
ASSURANCE930204 3 STABILITY STUDIES
584 28-Nov-14 HALL - 09 132050804001
BHATT
UNNATIBEN
DIPAKKUMAR
development and validation of
stability indicating hplc method for
pranlukast dry syrup
dr. kalpana g.
patel205
QUALITY
ASSURANCE930204 3 STABILITY STUDIES
585 28-Nov-14 HALL - 09 132050804006PATEL NAIYABEN
DINESHBHAI
STABILITY INDICATING ANALYTICAL
METHOD FOR ESTIMATION OF
ANAGLIPTIN USING ANALYTICAL
QUALITY BY DESIGN APPROACH
MR. HITESH g.
RAVAL205
QUALITY
ASSURANCE930204 3 STABILITY STUDIES
AQBD
APPROACH
586 28-Nov-14 HALL - 09 132050804013
Rajyaguru
Upasanaben
Milankumar
development and validation of
stability indicating hplc method for
estimation of alvimopan in soft
gelatin capsule
dr.kalpana g.
patel205
QUALITY
ASSURANCE930204 3 STABILITY STUDIES
587 28-Nov-14 HALL - 09 132140804002PATEL KRISHNA
MAHESHBHAI
stability indicating rp-hplc method
development and validation of
amiloride hydrochloride and
furosemide in pharmaceutical dosage
form
ms jignasha m
derasari214
QUALITY
ASSURANCE930204 3 STABILITY STUDIES
588 28-Nov-14 HALL - 09 132140804004
PRIYANKA
ARVINDBHAI
DHOBI
development and validation of
spectrophotometric and stability
indicating hplc methods for
simultaneous estimation of
nifedipine and candesartan cilexetil in
synthetic mixture.
Ms Jignasa G
Modi214
QUALITY
ASSURANCE930204 3 STABILITY STUDIES
589 28-Nov-14 HALL - 09 132140804010JOSHI MAULIK
JAGDISHKUMAR
DEVELOMENT AND VALIDATION OF
STABILITY INDICATING ASSAY
METHOD FOR SIMULTANEOUS
ESTIMATION OF FUROSEMIDE AND
TRIAMTERENE IN TABLET DOSAGE
FORM
Dr.priyanka
patil214
QUALITY
ASSURANCE930204 3 STABILITY STUDIES
590 28-Nov-14 HALL - 09 132140804501
CHAUHAN
ARVINDKUMAR
MOHANBHAI
stability indicating rp-hplc method
development and validation of
aliskiren and enalapril in bulk and
synthetic mixture.
Ms Jignasa G
Modi214
QUALITY
ASSURANCE930204 3 STABILITY STUDIES
591 28-Nov-14 HALL - 09 132140804505GURJAR HARESH
NARANBHAI
stability INDICATING HPLC METHOD
DEVELOPMENT AND VALIDATION OF
HYDROXYCITRIC ACID IN WEIGHT
MANAGEMENT CAPSULE
dr t y pasha 214QUALITY
ASSURANCE930204 3 STABILITY STUDIES
592 28-Nov-14 HALL - 09 132130804011Suthar Manasi
Vinubhai
Development and validation of
analytical methods for simultanous
estimation of Camylofin
dihydrochloride and Diclofenac
potassium in their combined
pharmaceutical dosage form.
Ms.
Farhatjahan
Shaikh
213QUALITY
ASSURANCE930204 3 STABILITY STUDIES
593 28-Nov-14 HALL - 09 132130804012
UNNATIBEN
DEVENDRABHAI
PATEL
Development and validation of
stability indicating RP-HPLC method
for simultaneous estimation of
Ondansetron HYDROCHLORIDE and
Pantoprazole SODIUM in their
combined pharmaceutical dosage
form.
Ms.
Farhatjahan
Shaikh
213QUALITY
ASSURANCE930204 3 STABILITY STUDIES
594 28-Nov-14 HALL - 09 132130804016PATEL DHAVAL
THAKORBHAI
Development and Validation of
stability indicating RP-HPLC method
for simultaneous estimation of
Levocetrizine dihyrochloride and
Phenylephrine hydrochloride in their
combined tablet dosage form.
Dr. Vandana B.
Patel213
QUALITY
ASSURANCE930204 3 STABILITY STUDIES
595 28-Nov-14 HALL - 10 132020804001CHANGELA NEEL
GIRISH
DEVELOPMENT and validation of
ANALYTICal methods for
simultaneous estimation of
Tolterodine tartrate and tamsulosin
hydrochloride
Dr.
Anandkumari
Captain
202QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
596 28-Nov-14 HALL - 10 132020804004Mona Pravinbhai
Mashru
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHODS FOR
SIMULTENEOUS ESTIMATION OF
BENDROFLUMETHIAZIDE AND
TIMOLOL MALEATE
MR.Dinesh v.
thakkar202
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
597 28-Nov-14 HALL - 10 132020804008ROKAD MOHIT
RAVIKUMAR
development and validation of
analytical method for quantitative
estimation of valsartan and its
impurities.
dr. vipul m.
vaghela202
QUALITY
ASSURANCE930204 3 IMPURITY PROFILING
598 28-Nov-14 HALL - 10 132020804010
KORADIYA
BINITABEN
RAMESHBHAI
DEVELOPMENT AND VALIDATION OF
NEW ANALYTICAL METHODS FOR
THE ESTIMATION OF PHENTERMINE
HYDROCHLORIDE AND TOPIRAMATE
IN THEIR SYNTHETIC MIXTURE.
DR. R. S.
MEHTA202
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
599 28-Nov-14 HALL - 10 132050804012Patel Hinalben
Jitendrabhai
development and validation of
chromatographic method for
simultaneous determination of
preservatives in marketed
formulation
dr. kalpana g.
patel205
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
herbal
formulation
600 28-Nov-14 HALL - 10 132050804503Gamit Nirajkumar
Ukediyabhai
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHODS FOR
SIMULTANEOUS ESTIMATION OF
AMBROXOL HYDROCHLORIDE,
LORATADINE AND GUAIFENESIN IN
COMBINED DOSAGE FORM USING
EXPERIMENTAL DESIGN
Mr. HITESH G.
RAVAL205
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
601 28-Nov-14 HALL - 10 132050804507Vyas Grishma
Girishkumar
analytical method development and
validation for simultaneous
estimation of lansoprazole and
aspirin in pharmaceutical dosage
form
Mr.hitesh
g.raval205
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
602 28-Nov-14 HALL - 10 132050804504Godhani Prutha
Pravinbhai
Simultaneous estimation of
telmisartan and cilostazol in newer
pharmaceutical formulation and its in
vivo pharmacokinetic study
dr. kalpana g.
patel205
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
formulation
development
603 28-Nov-14 HALL - 10 132020804003GOTHALIYA GOPI
RAJNISH
analytical method development and
validation for simultaneous
estimation of ketorolac
tromethamine and phenylephrine
hydrochloride in injectable dosage
form
dr. r.s.mehta 202QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
604 28-Nov-14 HALL - 10 132050804002
CHAUDHARI
DIPIKAKUMARI
PRAVINBHAI
development and validation of
analytical methods for simultaneous
estimation of erdosteine, terbutaline
sulphate and guaiphenesin in
combined dosage form
dr.purvi a.
shah205
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATIONdoe approach
605 28-Nov-14 HALL - 10 132050804009SHAH PRIYANKA
SHAILESHBHAI
Development and validation of
analytical method for simultaneous
estimation of ambroxol
hydrochloride and doxofylline in
pharmaceutical dosage form.
Dr. kalpana G.
patel205
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
STABILITY
INDICATING
METHOD
606 28-Nov-14 HALL - 10 132050804014Shah Pratik
Mukeshkumar
development and validation of
analytical methods for simultaneous
determination of nadifloxacin,
mometasone furoate and miconazole
nitrate in semisolid dosage form
dr. kalpana g.
patel205
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
using doe
approach
607 28-Nov-14 HALL - 11 132130804001DOSHI JANKI
NARESHBHAI
Formulation, development and
validation of analytical methods for
estimation of Curcumin in chewable
tablets.
Mr. Hemant
Patel213
QUALITY
ASSURANCE930204 3 HERBAL
608 28-Nov-14 HALL - 11 132130804002PARIKH RADHA
BIMALBHAI
Development of formulation and
analytical method, IT'S validation
AND PROCESS VALIDATION of herbal
TABLET CONTAINING Bacopa
monniereA extract.
Ms.
Farhatjahan
Shaikh
213QUALITY
ASSURANCE930204 3 HERBAL
609 28-Nov-14 HALL - 11 132140804008AKOLA TULSI
RAMNIKBHAI
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHODS FOR
SIMULTANEOUS ESTIMATION OF
KETOROLAC TROMETHAMINE AND
PHENYLEPHRINE HYROCHLORIDE IN
PHARMACEUTICAL DOSAGE FORM
Mrs.pinkal
patel214
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
610 28-Nov-14 HALL - 11 132140804009DADHANIA RUCHI
DINESHKUMAR
Stability indicating analytical method
development and validation FOR
SIMULTANEOUS ESTIMATION of
Paracetamol and Zaltoprofen in solid
dosage form
Mr. Virag
Gophane214
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
stability
indicating
analytical
method
611 28-Nov-14 HALL - 11 132140804503
PATEL
PRIYANKABEN
GOPALBHAI
Development and validation of
spectrophotometry and stability
indicating HPLC method for
simultaneous estimation of
cilnidipine and chlorthalidone in their
pharmaceutical dosage form
Mr. Stavan
Master214
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
612 28-Nov-14 HALL - 11 132140804504Savalia Khushbu
Parasottambhai
Analytical method development and
validation for simultaneous
estimation of Pravastatin sodium
and Fenofibrate in pharmaceutical
dosage form
Mr. Virag
Gophane214
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
613 28-Nov-14 HALL - 11 132140804502PATEL HETALBEN
VIJAYKUMAR
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHODS FOR
SIMULTANEOUS ESTIMATION OF
valsartan and cilnidipine in tablet
dosage form
Mrs.pinkal
patel214
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
614 28-Nov-14 HALL - 11 132050804501PATEL PAYALBEN
RAJANIKANT
isolation of ursolic acid from nerium
oleander leaves and quantification of
ursolic acid in herbal formulation
dr.purvi a.
shah205
QUALITY
ASSURANCE930204 3 HERBAL
isolation and
method
development
and validation
615 28-Nov-14 HALL - 11 132050804505Patel Digna
Dipakkumar
development and validation of
discriminating dissolution method for
aceclofenac and tizanidine by qbd
approach
dr.purvi a.
shah205
QUALITY
ASSURANCE930204 3 DISSOLUTION STUDIES QbD approach
616 28-Nov-14 HALL - 11 132140804007SHAIKH TANVI
SHAMMIUDAIN
Development and validation of
analytical methods for estimation of
ASPIRIN and LANSOPRAZOLE in bulk
Dosage form
dr t y pasha 214QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
617 28-Nov-14 HALL - 11 132130804008
ROSHNI
DEVENDRABHAI
AMIN
Formulation of PUNICA GRANATUM
TABLETS AND METHOD
DEVELOPMENT OF ITS
PHYTOCONSTITUENT.
Dr. Vandana B.
Patel213
QUALITY
ASSURANCE930204 3 HERBAL
618 28-Nov-14 HALL - 12 132130804004Patel Dhruviben
Kantibhai
Development and validation of
analytical methods for simultaneous
estimation of Diclofenac potassium
and Tizanidine in their combined
tablet dosage form.
Dr. Shailesh
Koradia213
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
619 28-Nov-14 HALL - 12 132130804010
SURBHIBAHEN
BHARATBHAI
PATEL
Development and validation of
analytical methods for simultaneous
estimation of Phrenylephrine
hydrochloride and Ketorolac
tromethamine in their bulk and
combined pharmaceutical dosage
form.
Mr. Hemant
Patel213
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
620 28-Nov-14 HALL - 12 132130804015
VINITA
PRAVINBHAI
PATEL
Development and Validation of
ANALYTICAL METHODS FOR THE
ESTIMATION OF Benidipine
HYDROCHLORIDE IN BULK AND ITS
PHARMACEUTICAL DOSAGE FORM .
Dr. Shailesh
Koradia213
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
621 28-Nov-14 HALL - 12 132230807001AHIR ADITI
NARANBHAI
DEVELOPMENT OF ANALYTICAL
METHODS FOR ESTIMATION OF
ALOGLIPTIN AND METFORMIN
HYDROCHLORIDE IN ITS COMBINED
DOSAGE FORM
Dr. DIMAL A.
SHAH223
PHARMACEUTICA
L ANALYSIS930207 3
SIMULTENEOUS
ESTIMATION
622 28-Nov-14 HALL - 12 132230807002
KORADIA
DISHABEN
SURYAKANT
DEVELOPMENT OF ANALYTICAL
METHODS FOR ESTIMATION OF
ESLICARBAZEPINE ACETATE IN
PHARMACEUTICAL DOSAGE FORM
Dr. DIMAL A.
SHAH223
PHARMACEUTICA
L ANALYSIS930207 3
SIMULTENEOUS
ESTIMATION
623 28-Nov-14 HALL - 12 132230807003MACWAN SWETA
STANISLAUS
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHODS FOR
ESTIMATION OF MESNA IN
PHARMACEUTICAL DOSAGE FORM
Dr. DIMAL A.
SHAH223
PHARMACEUTICA
L ANALYSIS930207 3
SIMULTENEOUS
ESTIMATION
624 28-Nov-14 HALL - 12 132230807004Patel Dhruvkumar
Bharatbhai
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHODS FOR
SIMULTANEOUS ESTIMATION OF
CHLORZOXAZONE, PARACETAMOL,
FAMOTIDINE AND DICLOFENAC
POTASSIUM IN THEIR COMBINED
PHARMACEUTICAL DOSAGE FORM
Dr.
USMANGANI
CHHALOTIYA
223PHARMACEUTICA
L ANALYSIS930207 3
SIMULTENEOUS
ESTIMATION
625 28-Nov-14 HALL - 12 132230807005PATEL NIKITABEN
MUKESHBHAI
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHODS FOR
ESTIMATION OF SAROGLITAZAR IN
PHARMACEUTICAL DOSAGE FORM
Dr. FALGUN A.
MEHTA223
PHARMACEUTICA
L ANALYSIS930207 3
SIMULTENEOUS
ESTIMATION
626 28-Nov-14 HALL - 12 132050804007PATEL RUPALBEN
AMBALAL
RISK BASED APPROACH FOR
EVALUATION OF BLOW-FILL-SEAL
TECHNOLOGY
Dr. kalpana G.
patel205
QUALITY
ASSURANCE930204 3
QUALITY RISK
MANAGEMENT
eQUIPMENT
QUALIFICATION
627 28-Nov-14 HALL - 12 132130804005PATEL NIDHIBEN
KANUBHAI
Development and validation of
stability indicating RP-HPLC method
for simultaneous estimation of
Beclomethasone dipropionate and
Formeterol fumarate in their
combined pharmaceutical dosage
form.
Dr. Shailesh
Koradia213
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
628 28-Nov-14 HALL - 12 132130804006patel payalben
parbhubhai
Development and validation of
analytical method for simultaneous
estimation of Fluticasone propionate
and Azelastine hydrochloride in
THEIR combined pharmaceutical
dosage form.
Dr. Vandana B.
Patel213
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
629 28-Nov-14 HALL - 13 132130804017Soni Neelkumar
Gaurangkumar
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHOD FOR
SIMULTANEOUS ESTIMATION OF
PARACETAMOL, DICLOFENAC
POTASSIUM AND CHLORZOXAZONE
IN THEIR COMBINED DOSAGE FORM.
Dr. Vandana B.
Patel213
QUALITY
ASSURANCE930204 3 PROCESS VALIDATION
630 28-Nov-14 HALL - 13 132140804003PATEL MITI
ASHOKKUMAR
Analytical method developement and
validation for simultaneous
estimation Of simvastatin and
fenofibrate in synthetic mixture
dr t y pasha 214QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
631 28-Nov-14 HALL - 13 132140804005
sabliya
ganapatkumar
kuvarjibhai
analytical method development and
validation for simultaneous
estimation of azilsartan medoxomil
and amlodipine besylate
hydrochloride in bulk and
pharmaceutical dosage form
ms jignasha m
derasari214
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
632 28-Nov-14 HALL - 13 132140804006SHAH SHRADDHA
PRADIPKUMAR
Development and validation of
Analytical Method for simultaneous
estimation of Atorvastatin calcium
and Irbesartan in pharmaceutical
dosage form
Mr. Stavan
Master214
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
633 28-Nov-14 HALL - 13 132230807006
PATEL
NISHMABEN
MUKESHCHANDRA
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHODS FOR
SIMULTANEOUS ESTIMATION OF
ALPRAZOLAM AND MEBEVERINE IN
THEIR COMBINED PHARMACEUTICAL
DOSAGE FORM
Dr.
USMANGANI
CHHALOTIYA
223PHARMACEUTICA
L ANALYSIS930207 3
SIMULTENEOUS
ESTIMATION
634 28-Nov-14 HALL - 13 132230807007
S ELAKKIYA L
SHUNMUGANATH
AN
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHODS FOR
ESTIMATION OF TICAGRELOR IN
PHARMACEUTICAL DOSAGE FORM
Dr. DIMAL A.
SHAH223
PHARMACEUTICA
L ANALYSIS930207 3
SIMULTENEOUS
ESTIMATION
635 28-Nov-14 HALL - 13 132230807008
SINDHAV
JAYKUMAR
RAMESHBHAI
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHODS FOR
SIMULTANEOUS ESTIMATION OF
CHLORHEXIDINE GLUCONATE AND
SILVER SULPHADIAZINE IN THEIR
COMBINED PHARMACEUTICAL
DOSAGE FORM
Dr.
USMANGANI
CHHALOTIYA
223PHARMACEUTICA
L ANALYSIS930207 3
SIMULTENEOUS
ESTIMATION
636 28-Nov-14 HALL - 13 132230807009PATEL ARPITA
LALITCHANDRA
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHOD FOR THE
ESTIMATION OF FLURBIPROFEN,
LIDOCAINE, AMITRIPTYLINE AND
BACLOFEN IN COMBINATION.
Dr. FALGUN A.
MEHTA223
PHARMACEUTICA
L ANALYSIS930207 3
SIMULTENEOUS
ESTIMATION
637 28-Nov-14 HALL - 13 132230807010PATEL DIVYABEN
RAMUBHAI
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHODS FOR
ESTIMATION OF ACECLOFENAC AND
TOLPERISONE HYDROCHLORIDE IN
COMBINATION
Dr. FALGUN A.
MEHTA223
PHARMACEUTICA
L ANALYSIS930207 3
SIMULTENEOUS
ESTIMATION
638 28-Nov-14 HALL - 13 132050804015Yugashri Bhojraj
Phadnis
prospective process validation of
levofloxacin infusion based on quality
risk management principles
hitesh g. raval 205QUALITY
ASSURANCE930204 3 PROCESS VALIDATION
Quality Risk
management
639 28-Nov-14 HALL - 13 132130804014VELANI ARPITA
DINESHBHAI
Validation of manufacturing process
for combined tablet dosage form
containing Tadalafil and Dapoxetine
hydrochloride.
Dr. Shailesh
Koradia213
QUALITY
ASSURANCE930204 3 PROCESS VALIDATION
640 28-Nov-14 HALL - 14 132050804003
HINGOO
KAVITABEN
TUSHARBHAI
Bioanalytical method development
and validation for estimation of
zaltoprofen and its pharmacokinetic
application in rat plasma
dr. purvi a.
shah205
QUALITY
ASSURANCE930204 3 BIOANALYTICAL
641 28-Nov-14 HALL - 14 132050804004Memon Nargis
Hanifbhai
solubility enhancement of diclofenac
sodium and chlorzoxazone in
combined dosage form and its
pharmacokinetic application by RP-
HPLC method
dr. purvi a.
shah205
QUALITY
ASSURANCE930204 3 BIOANALYTICAL
solubility
enhancement
642 28-Nov-14 HALL - 14 132050804005PARMAR AARTI
DINESHBHAI
simultaneous estimation of
lornoxicam and thiocolchicoside and
its pharmacokinetic application in rat
plasma by chromatographic method.
dr.purvi a.
shah205
QUALITY
ASSURANCE930204 3 BIOANALYTICAL
643 28-Nov-14 HALL - 14 132050804010
TIVARI
RAVIKUMAR
SUDHAKARBHAI
bioanalytical method development
and validation for estimation of
clonazepam in k3edta human plasma
using uplc/esi-ms/ms
dr. kalpana g.
patel205
QUALITY
ASSURANCE930204 3 BIOANALYTICAL
644 28-Nov-14 HALL - 14 132050804011Vahora Hanna
Aaftabbhai
development and validation of
bioanalytical method for
simultaneous estimation of
aceclofenac and diacerein and its
pharmacokinetic application
mr. hitesh g.
raval205
QUALITY
ASSURANCE930204 3 BIOANALYTICAL
645 28-Nov-14 HALL - 14 132140804001Ajudiya Keyur
Sureshbhai
PROCESS VALIDATION OF DIAZEPAM
IN PHARMACEUTICAL DOSAGE FORM
dr priyanka
patil214
QUALITY
ASSURANCE930204 3 BABE
646 28-Nov-14 HALL - 14 132230807011PATEL PRAGNESH
JAYENDRABHAI
DEVELOPMENT OF ANALYTICAL
METHODS FOR ESTIMATION OF
ONDANSETRON AND RANITIDINE IN
COMBINED DOSAGE FORM
Dr. DIMAL A.
SHAH223
PHARMACEUTICA
L ANALYSIS930207 3
SIMULTENEOUS
ESTIMATION
647 28-Nov-14 HALL - 14 132230807012
KURVAH
OMNARAYANSINH
LAKHANSINH
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHODS FOR
ESTIMATION OF ALOSETRON
HYDROCHLORIDE IN
PHARMACEUTICAL DOSAGE FORM
Dr. FALGUN A.
MEHTA223
PHARMACEUTICA
L ANALYSIS930207 3
SIMULTENEOUS
ESTIMATION
648 28-Nov-14 HALL - 14 132230807013
SOLANKI
KALPESHKUMAR
RAVJIBHAI
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHODS FOR
SIMULTANEOUS ESTIMATION OF
MOXONIDINE AND
HYDROCHLOROTHIAZIDE IN THEIR
COMBINED PHARMACEUTICAL
DOSAGE FORM
Dr.
USMANGANI
CHHALOTIYA
223PHARMACEUTICA
L ANALYSIS930207 3
SIMULTENEOUS
ESTIMATION
649 28-Nov-14 HALL - 14 132050804008
PATEL
SWETABAHEN
SURESHKUMAR
bIOANALYTICAL METHOD
DEVELOPMENT AND VALIDATION
FOR ESTIMATION OF
METRONIDAZOLE IN HUMAN
PLASMA BY UPLC-MS/MS METHOD.
Mr. HITESH G.
RAVAL205
QUALITY
ASSURANCE930204 3 BIOANALYTICAL
650 28-Nov-14 HALL - 14 132050804502Zankhana
Jagdishbhai Solanki
Development and validation of uplc-
ms/ms method for estimation of
olmesartan medoxomil in human
plasma and its pharmacokinetic
application
dr.purvi a.
shah205
QUALITY
ASSURANCE930204 3 BIOANALYTICAL
651 29-Nov-14 HALL - 01 132240808005PATEL BRINDABEN
DIVYESHKUMAR
FORMULATION AND EVALUATION OF
MOUTH DISSOLVING FILM OF
TOPIRAMATE
Mrs. Sejal M.
Solanki224 PHARMACEUTICS 930202 1
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
652 29-Nov-14 HALL - 01 132240808007PATEL PARUL
SHANTILAL
FORMULATION AND EVALUATION OF
FAST DISINTEGRATING
EFFERVESCENT TABLETs OF GLIPIZIDE
Dr. Ankit
Ajmera224 PHARMACEUTICS 930202 1
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
653 29-Nov-14 HALL - 01 132240808018
PARMAR
DILIPKUMAR
NARAYANBHAI
FORMULATION AND EVALUATION OF
CLONAZEPAM SUBLINGUAL TABLET
Mrs. Sejal M.
Solanki224 PHARMACEUTICS 930202 1
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
654 29-Nov-14 HALL - 01 132240808019
PATEL
JIGARKUMAR
RAMESHBHAI
Formulation and evaluation of fast
dissolving film of olanzapinekeyur patel 224 PHARMACEUTICS 930202 1
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
655 29-Nov-14 HALL - 01 132520808001
DAMOR
SHRADDHA
RAMABHAI
Design and Development of Dual
Release Oral Reconstitutable
Suspension of Cefpodoxime Proxetil
Dr. Mukesh S.
Patel252 PHARMACEUTICS 930202 2 NULL
656 29-Nov-14 HALL - 01 132520808002
JETHARA
SAHILHUSEN
IQBALHUSEN
Design and Development of
Tolperisone HCl and Diclofenac
Sodium Sustained Release Tablet
Dr. Mukesh R.
Patel252 PHARMACEUTICS 930202 2 NULL
657 29-Nov-14 HALL - 01 132520808004
PARMAR
NITINKUMAR
SUKHLAL
Strategies to Design Sustained
Release Formulation of Pioglitazone
and Optimization by Artificial Neural
Network
Dr. Alpesh. D
Patel252 PHARMACEUTICS 930202 2 NULL
658 29-Nov-14 HALL - 01 132520808005PATEL PRACHIBEN
JAGDISHBHAI
Design and Development of Micro-
emulsion Based Gel of Isotretinoin
Dr. Mukesh S.
Patel252 PHARMACEUTICS 930202 2 NULL
659 29-Nov-14 HALL - 01 132520808006
PATEL
PRASHANTKUMAR
VINODCHANDRA
Formulation and In Vitro Evaluation
of Baclofen Floating Tablet Using
Natural Polymer
Dr. Kanu. R.
Patel252 PHARMACEUTICS 930202 2 NULL
660 29-Nov-14 HALL - 02 132520808007
RAMJIYANI
KHUSHBUBEN
MANILAL
Design and Development of
Lurasidone Hydrochloride Fast
Dissolving Tablet
Dr. Mukesh R.
Patel252 PHARMACEUTICS 930202 2 NULL
661 29-Nov-14 HALL - 02 132520808008
RATHOD
DIMPALKUMARI
BHAGVANSINH
Formulation and Evaluation of Fast
Dissolving Orodispersible Film of
Levocetrizine Dihydrochloride
Dr. Maulik J
Patel252 PHARMACEUTICS 930202 2 NULL
662 29-Nov-14 HALL - 02 132520808009Shah Samirkumar
Jagmohandas
Design and Development of
Quetiapine Fumarate Extended
Release Pellets
Dr. Mukesh S.
Patel252 PHARMACEUTICS 930202 2 NULL
663 29-Nov-14 HALL - 02 132520808010THAKAR KUSHAL
RAMESHCHANDRA
Design and Development of
Mucoadhesive Buccal Tablet of
Glibenclamide Using Central
Composite Design
Dr. Alpesh. D.
Patel252 PHARMACEUTICS 930202 2 NULL
664 29-Nov-14 HALL - 02 132520808011
UPADHYAY
SHIVANIBAHEN
MUKESHKUMAR
Design and Development of
Tizanidine Hydrochloride Sustained
Release Pellets
Dr. Kanu R.
Patel252 PHARMACEUTICS 930202 2 NULL
665 29-Nov-14 HALL - 02 132660808001ANKIT JAYNTIBHAI
DEVANI
FORMULATION AND EVALUATION OF
PULSATILE DRUG DELIVERY SYSTEM
OF TERBUTALINE
CHINTAN
JOBANPUTRA266 PHARMACEUTICS 930202 4
OTHER (KINDLY
SPECIFY)PULSATILE
666 29-Nov-14 HALL - 02 132660808002BAVASIYA KRUNAL
SURESHBHAI
DESIGN DEVELOPMENT &
EVALUATION OF OCCULAR INSERT OF
AN ANTIFUNGAL AGENT
CHINTAN
JOBANPUTRA266 PHARMACEUTICS 930202 4
OTHER (KINDLY
SPECIFY)OCULAR INSERT
667 29-Nov-14 HALL - 02 132660808008NAKRANI SANJAY
POPATBHAI
formulation and evaluation of
periodontal films for controlled
delivery of metronidazole and
minocycline
CHINTAN
JOBANPUTRA266 PHARMACEUTICS 930202 4
OTHER (KINDLY
SPECIFY)periodontal film
668 29-Nov-14 HALL - 02 132660808016DESAI VISHAL
HARIBHAI
FORMULATION AND EVALUATION OF
monolayer osmotic drug delivery
system of cardiovascular drug
DR. H. M.
TANK266 PHARMACEUTICS 930202 4
OTHER (KINDLY
SPECIFY)osmotic
669 29-Nov-14 HALL - 02 132660808017
JIVANI
KUNJAYKUMAR
MANHARBHAI
design development and evaluation
of occular controlled drug delivery
system of an antimicrobial agent
DR. H. M.
TANK266 PHARMACEUTICS 930202 4
OTHER (KINDLY
SPECIFY)
occular
controlled drug
delivery
670 29-Nov-14 HALL - 03 132440808007PATEL JAIMIN
NARENDRABHAI
FORMULATION OF
HYDROCHLOROTHIAZIDE AS
NANOSUSPENSION FOR ORAL
ADMINISTRATION
Rakesh s.
parmar244 PHARMACEUTICS 930202 3
NANO
SUSPENSION/EMULSI
ON, SEDDS, LIPID
BASED DDS
671 29-Nov-14 HALL - 03 132520808014PATEL NIKITABEN
KANTILAL
Development, Formulation and
Evaluation of Nebivolol Fast
Dissolving Film
Dr. Mukesh S.
Patel252 PHARMACEUTICS 930202 2 NULL
672 29-Nov-14 HALL - 03 132520808015
PATIWALA
MOHAMMEDSAAD
MOHAMMEDJAM
AL
Design and Development of
Atomoxetine HCl Sustained Release
Tablet
Dr. Mukesh R.
Patel252 PHARMACEUTICS 930202 2 NULL
673 29-Nov-14 HALL - 03 132520808016
PRAJAPATI
DIXITKUMAR
KESHAVLAL
Design and Development of
Cefuroxime axetil Floating Tablet
Dr Mukesh S.
Patel252 PHARMACEUTICS 930202 2 NULL
674 29-Nov-14 HALL - 03 132520808017
RAMANI
AVANIBEN
JAYANTILAL
Design and Development of
Lansoprazole Mucoadhesive Buccal
Tablet
Dr. Kanu R.
Patel252 PHARMACEUTICS 930202 2 NULL
675 29-Nov-14 HALL - 03 132520808018SHAH SIDDHIBEN
VIRENDRAKUMAR
Development of Functionality Added
Materials for Tablet Formulations
Dr. Sanjay S.
Patel252 PHARMACEUTICS 930202 2 NULL
676 29-Nov-14 HALL - 03 132520812002RAJPUT SWAPNIL
KISHOR
Design and Development of Erodible
Pulsatile Drug Delivery of Salbutamol
Sulphate
Dr. Kanu R.
Patel252
INDUSTRIAL
PHARMACY930208 2 NULL
Pulsatile Drug
Delivery
677 29-Nov-14 HALL - 03 132520812003UPADHYAY KHYATI
SHAILESHKUMAR
Development of Levetiracetam
Controlled Release Dosage
Formulation.
Dr. Sanjay S
Patel252
INDUSTRIAL
PHARMACY930208 2 NULL
678 29-Nov-14 HALL - 03 132610808002Hiral Bharatkumar
Brahmbhatt
FORMULATION AND
CHARACTERIZATION OF FLOATING
DRUG DELIVERY SYSTEM
mR. jITENDRA
k. pATEL261 PHARMACEUTICS 930202 3
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
679 29-Nov-14 HALL - 03 132660808007LATHIYA CHIRAG
JINABHAI
FORMULATION EVALUATION &
OPTIMIZATION OF NANO
SUSPENSION CONTAINING
ANTIHYPERTENSIVE DRUG
CHINTAN
JOBANPUTRA266 PHARMACEUTICS 930202 4
NANO
SUSPENSION/EMULSI
ON, SEDDS, LIPID
BASED DDS
680 29-Nov-14 HALL - 03 132240808015GOHIL JAYDIPSINH
MAHENDRASINH
Formulation, Development and
Evaluation of Diclofenac Sodium,
Paracetamol and Chlorzoxazone
Bilayer Tablet
Pranit B. Patel 224 PHARMACEUTICS 930202 1 MISCELANEOUS
681 29-Nov-14 HALL - 04 132240808008patel shivani
jayesh
FORMULATION AND EVALUATION OF
GASTRORETENTIVE MUCOADHESIVE
TABLETs OF VERAPAMIL
HYDROCHLORIDE
Mrs. Sejal M.
Solanki224 PHARMACEUTICS 930202 1
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
682 29-Nov-14 HALL - 04 132240808021
PATEL PARTH
KUMAR
MAHENDRAKUMA
R
Formulation and Evaluation of
Gastroretentive Mucoadhesive
Tablets of levofloxacin hemihydrate
keyur patel 224 PHARMACEUTICS 930202 1
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
683 29-Nov-14 HALL - 04 132440808001
BHAGAT
KHUSHBOO
ATULBHAI
FORMULATION AND EVALUATION OF
TOPICAL NANOEMULGEL OF
ADAPALENE
m. rahil g.
bhura244 PHARMACEUTICS 930202 3
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
684 29-Nov-14 HALL - 04 132440808003PATEL GOPIBEN
MUKESHBHAI
FORMULATION AND EVALUATION OF
AZELASTINE OCULAR IN-SITU GELmehul b. vyas 244 PHARMACEUTICS 930202 3
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
685 29-Nov-14 HALL - 04 132520808003
PARGI
TARUNKUMAR
ARVINDBHAI
DEvelopment and Assessment of
High Functionality Co-Processed
Material For Tablet.
Dr. Sanjay S
Patel252 PHARMACEUTICS 930202 2
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
686 29-Nov-14 HALL - 04 132520808013
CHARAN
MEHULKUMAR
KIRITSINH
Design and Development of
Immediate Release Tablet of
Paroxetine Hydrocloride Factorial
Design
Dr. Alpesh D.
Patel252 PHARMACEUTICS 930202 2
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
687 29-Nov-14 HALL - 04 132610808004PANCHAL JIGAR
MUKESHBHAI
Formulation and evaluation of buccal
patch.
Mr. Jitendra K.
Patel261 PHARMACEUTICS 930202 3
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
688 29-Nov-14 HALL - 04 132660808004
DABHI
ANKITKUMAR
DEVRAJBHAI
FORMULATION AND EVALUATION OF
EMULGEL CONTAINING AN
ANTIFUNGAL AGENT
SUNIL
KARDANI266 PHARMACEUTICS 930202 4
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
689 29-Nov-14 HALL - 04 132660808011Tilwani Jayesh
Mangatram
FORMULATION AND EVALUATION OF
transdermal drug delivery of
triamcino;one acetonide
DR. H. M.
TANK266 PHARMACEUTICS 930202 4
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
690 29-Nov-14 HALL - 04 132660808012VAGHANI MANISH
NARSHIBHAI
FORMULATION AND EVALUATION OF
mucoadhesive BI-LAYER tablet of anti-
inflamatory drug
SUNIL
KARDANI266 PHARMACEUTICS 930202 4
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
691 29-Nov-14 HALL - 04 132660808019PARMAR JIGNESH
NARSHIBHAI
FORMULATION development AND
EVALUATION OF clinidipine
transdermal patch
DR. H. M.
TANK266 PHARMACEUTICS 930202 4
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
692 29-Nov-14 HALL - 05 132440808004
PATEL
NIHARIKABEN
BHULABHAI
COMPARATIVE STUDY OF DIFFERENT
SOLUBILITY ENHANCEMENT
TECHNIQUES ON DISSOLUTION RATE
OF ZALTOPROFEN
m. rahil g.
bhura244 PHARMACEUTICS 930202 3
OTHER (KINDLY
SPECIFY)
Solubility
enhancement
techniques
693 29-Nov-14 HALL - 05 132610808503Patel Kinjal
jayantibhai
FORMULATION DEVELOPMENT AND
EVALUATION OF FLOATING BILAYER
TABLET OF KETOROLAC
TROMETHAMINE.
Mr. Hitesh jain 261 PHARMACEUTICS 930202 3
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
694 29-Nov-14 HALL - 05 132610808507
CHAUHAN
BHAVIKKUMAR
ROHITBHAI
Formulation and evaluation of
sustained release matrix tablet
mr. jitendra k.
patel261 PHARMACEUTICS 930202 3
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
695 29-Nov-14 HALL - 05 132610808508
GOHEL
MILLINKUMAR
RAMNIKBHAI
FORMULATION DEVELOPMENT AND
EVALUATION OF SUSTAINED RELEASE
TABLET OF PREGABALIN
Mr. Hitesh jain 261 PHARMACEUTICS 930202 3
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
696 29-Nov-14 HALL - 05 132610808510SHAH BHAUMIK
KISHORBHAI
Formulation and Evaluation of
Floating Matrix Tablet of
Antibacterial agent
Mr. Jigar Vyas 261 PHARMACEUTICS 930202 3
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
697 29-Nov-14 HALL - 05 132524808001MS. PAYALBEN G.
DAMOR
FORMULATION AND EVALUATION OF
MOUTH DISSOLVING OF
MALETRACEN HCL
DR. ALPESH D.
PATEL252 PHARMACEUTICS 930202 2
ORAL CONTROL DRUG
DELIVERY SYSTEM
698 29-Nov-14 HALL - 05 132524808002
MR.
CHETANKUMAR R.
PATEL
FORMULATION AND IN-VITRO
EVALUATION OF FAST
DISINTEGRATING INDAPAMIDE
TABLET
DR. MUKESH
R. PATEL252 PHARMACEUTICS 930202 2
ORAL CONTROL DRUG
DELIVERY SYSTEM
699 29-Nov-14 HALL - 05 132524808003MR. LAVESH I.
PATEL
FORMULATION AND EVALUATION OF
IMMEDIATE RELEASE OF
LORNOXICAM TABLET
DR. MUKESH S.
PATEL252 PHARMACEUTICS 930202 2
ORAL CONTROL DRUG
DELIVERY SYSTEM
700 29-Nov-14 HALL - 05 132524808004MS. KRISHNA D.
KANSARA
DESIGN AND DEVELOPMENT OF
ZAFIRLEUKAST FAST DISSOLVING
ORAL FILMS
DR. KANU R.
PATEL252 PHARMACEUTICS 930202 2
ORAL CONTROL DRUG
DELIVERY SYSTEM
701 29-Nov-14 HALL - 05 132524808005MR. MEHULBHAI
RATILAL PATEL
DESIGN AND DEVELOPMENT OF
NICORANDIL SUSTAINED RELEASE
TABLET BASED ON MICROSPONGE
TECHNOLOGY
DR. SANJAY S.
PATEL252 PHARMACEUTICS 930202 2
ORAL CONTROL DRUG
DELIVERY SYSTEM
702 29-Nov-14 HALL - 05 132524808006MR. CHIRAG Y.
SOLANKI
FORMULATION AND IN-VITRO
EVALUATION OF ZALTROPROFEN
MICROEMULSION BASED HYDROGEL
DR. ALPESH D.
PATEL252 PHARMACEUTICS 930202 2
ORAL CONTROL DRUG
DELIVERY SYSTEM
703 29-Nov-14 HALL - 06 132610808005Patel Krishna
Bankimchandra
Formulation and Evaluation Of
Sustained Release Matrix Tablet Of
Anti-diabetic Drug
Mr. Jigar Vyas 261 PHARMACEUTICS 930202 3
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
704 29-Nov-14 HALL - 06 132610808501
CHAUHAN
NIMISHA
PRAVINKUMAR
Formulation and evaluation of
extended release tablet mr. jigar vyas 261 PHARMACEUTICS 930202 3
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
705 29-Nov-14 HALL - 06 132610810001Makwana Priti
Kanjibhai
Formulation And Evaluation of
Bilayered sustained release Tablet Mr. Jigar Vyas 261
PHARMACEUTICA
L TECHNOLOGY930202 3
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
706 29-Nov-14 HALL - 06 132660808003
chothani
pritibahen
bipinbhai
DESIGN DEVELOPMENT &
EVALUATION OF GASTRORETENTIVE
TABLET OF PROTON PUMP
INHIBITOR
DR. H. M.
TANK266 PHARMACEUTICS 930202 4
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
707 29-Nov-14 HALL - 06 132660808005DANKHARA RAVI
MANJIBHAI
FORMULATION AND EVALUATION OF
FLOATING MICROBEADS OF
CARDIOVASCULAR DRUG
SUNIL
KARDANI266 PHARMACEUTICS 930202 4
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
708 29-Nov-14 HALL - 06 132660808006GABANI RITUL
BHAGAVANBHAI
DEVELOPMENT AND EVALUATION OF
EXTENDED RELEASE BI-LAYER
TABLETS OF BACLOFEN
SUNIL
KARDANI266 PHARMACEUTICS 930202 4
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
709 29-Nov-14 HALL - 06 132660808009PATEL HARDIK
GOKULBHAI
formulation and evaluation of colon
targeted drug delivery system of
antiinflammatory drug
bansi
zalavadiya266 PHARMACEUTICS 930202 4
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
710 29-Nov-14 HALL - 06 132660808013VASANI CHIRAG
MANSUKHBHAI
FORMULATION AND EVALUATION OF
gastroretentive drug delivery system
of amoxicillin
CHINTAN
JOBANPUTRA266 PHARMACEUTICS 930202 4
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
gastroretentive
711 29-Nov-14 HALL - 06 132660808015
BHESANIYA
GOPALBHAI
MAHESHBHAI
FORMULATION AND EVALUATION OF
controlled porosity osmotic tablet of
cardiovascular drug
DR. H. M.
TANK266 PHARMACEUTICS 930202 4
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
controlled
release
712 29-Nov-14 HALL - 06 132610808001Chaudhary Kartik
Bharatbhai
Formulation and Evaluation of
compressed coated tablet for colon
targeting
Mr. Jigar Vyas 261 PHARMACEUTICS 930202 3
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
713 29-Nov-14 HALL - 06 132610808008
PATEL
SHIVAMKUMAR
KUMUDCHANDRA
FORMULATION DEVELOPMENT AND
EVALUATION OF MATRIX TABLET FOR
COLON TARGETED DRUG DELIVERY
OF ACECLOFENAC
Mr. Hitesh jain 261 PHARMACEUTICS 930202 3
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
714 29-Nov-14 HALL - 07 132440808005
RAOLJI
RANVEERSINH
TAKHATSINH
FORMULATION, EVALUATION AND
TASTE MASKING OF FAST
DISSOLVING FILM OF TAPENTADOL
m. rahil g.
bhura244 PHARMACEUTICS 930202 3
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
715 29-Nov-14 HALL - 07 132440808006
SHAH
SUNNYKUMAR
BAKULKUMAR
DEVELOPMENT AND
CHARACTERIZATION OF MELT IN
MOUTH TABLET OF DIURETIC
mehul b. vyas 244 PHARMACEUTICS 930202 3
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
716 29-Nov-14 HALL - 07 132610808003KACHHELA PRATIK
RAMESHBHAI
Formulation and evaluation of fast
dissolving tablet
mr. jitendra k.
patel261 PHARMACEUTICS 930202 3
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
717 29-Nov-14 HALL - 07 132610808502
DHARA
SURESHKUMAR
PATEL
ENHANCEMENT OF DISSOLUTION
RATE OF POORLY SOLUBLE DRUG BY
LIQUISOLID TECHNIQUE
Mr. Hitesh jain 261 PHARMACEUTICS 930202 3
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
718 29-Nov-14 HALL - 07 132660808010SONANI KEVAL
JAYSUKHBHAI
formulation development and
optimization of orodispersible dosage
form of anti-migraine agent
SUNIL
KARDANI266 PHARMACEUTICS 930202 4
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
719 29-Nov-14 HALL - 07 132660808014
AGRAVAT
MAYURKUMAR
HARSHADRAY
studies on solubility and dissolution
enhancement by liquid solid
technique and development of fast
dissolving tablet of piroxicam
DR. H. M.
TANK266 PHARMACEUTICS 930202 4
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
720 29-Nov-14 HALL - 07 132660808021RAM KISHORBHAI
BACHUBHAI
FORMULATION AND EVALUATION OF
mouth dissolving dosage form of
pantoprazole sesquihydrate
DR. H. M.
TANK266 PHARMACEUTICS 930202 4
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
mouth
dissolving
721 29-Nov-14 HALL - 07 132660808022SHEKHAT SWETA
CHIMANBHAI
FORMULATION AND EVALUATION OF
mouth dissolving tablet of tacrine
DR. H. M.
TANK266 PHARMACEUTICS 930202 4
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
mouth
dissolving
722 29-Nov-14 HALL - 07 132660808024
VORA
KHUSHALIBEN
PRAVINCHANDRA
design and evaluation of
orodispersible tablet of levosulpiride
DR. H. M.
TANK266 PHARMACEUTICS 930202 4
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
723 29-Nov-14 HALL - 08 132520804002
BRAHMBHATT
PARASKUMAR
MAHESHBHAI
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHOD FOR
SIMULTANEOUS ESTIMATION OF
CILOSTAZOL AND IMIPRAMINE IN
BULK AND COMBINED DOSAGE
FORM
Mr M. l.
Kharodiya252
QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
724 29-Nov-14 HALL - 08 132520804006
TRIVEDI
FORAMBEN
PANKAJBHAI
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHOD FOR
SIMULTANEOUS ESTIMATION OF
SUCRALFATE AND OXETACAINE IN
BULK AND COMBINED DOSAGE
FORM
Dr. A. K. Joshi 252QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
725 29-Nov-14 HALL - 08 132520804008
MAHERIYA
PRAVINKUMAR
HARIBHAI
ANALYTICAL METHOD
DEVELOPMENT AND VALIDATION
FOR SIMULTANEOUS ESTIMATION
OF METRONIDAZOLE & DILOXANIDE
FUROATE AND IN BULK AND
PHARMACEUTICAL FORMULATION
DR. L. M.
Prajapati252
QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
726 29-Nov-14 HALL - 08 132520804011
PATEL
TVINKALKUMARI
PRAVINBHAI
DEVELOPMENT AND VALIDATION
OF ANALYTICAL METHOD FOR
SIMULTANEOUS ESTIMATION OF
ACETYL CYSTEINE AND
ACEBROPHYLLINE IN BULK AND
PHARMACEUTICAL FORMULATION
DR. L. M.
Prajapati252
QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
727 29-Nov-14 HALL - 08 132560804008
KANZARIYA
JIGNESH
JASMATBHAI
Stability indicating HPLC method for
development and validation of
METOCLORPAMIDE AND
PARACETAMOL in combined
pharmaceutical dosage form.
MEETA a.
jiladia256
QUALITY
ASSURANCE930204 1 STABILITY STUDIES
728 29-Nov-14 HALL - 08 132610804004MODI JENISHA
DILIPBHAI
STABILITY INDICATING aNALYTICAL
METHOD DEVELOPMENT AND
VALIDATION FOR ESTIMATION OF
Azelnidipine
MS. shreya r
shah261
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
729 29-Nov-14 HALL - 08 132610804008PATEL ZALAK
NITINBHAI
ANALYTICAL METHOD
DEVELOPMENT AND VALIDATION
FOR SIMULTANEOUS ESTIMATION OF
ESCITALOPRAM OXALATE AND
BUPROPION HYDROCHLORIDE
Ms. Grishma h
patel261
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
730 29-Nov-14 HALL - 08 132610804012Thakkar Virali
Narayankumar
ANALYTICAL METHOD
DEVELOPMENT AND VALIDATION OF
LORCASERIN HYDROCHLORIDE.
mr. prasanna
Ku. Pradhan261
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
731 29-Nov-14 HALL - 08 132610804508Patel Rudra
Bharatbhai
Process Validation of Tramadol in
Capsule Dosage Form
Dr. nazneen
Surti261
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
732 29-Nov-14 HALL - 08 132610804512PANDYA MINAL
NIKETANKUMAR
method development and validation
of ibuprofen, paracetamol and
caffeine in tablet dosage form
dr. umesh u
upadhyay261
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
733 29-Nov-14 HALL - 08 132610804001Dhanga Nehal
Kishorsinh
SIMULTANEOUS ESTIMATION OF
MUPIROCIN AND BECLOMETHASONE
DIPROPIONATE IN PHARMACEUTICAL
DOSAGE FORM BY HPLC
Dr. nazneen
Surti261
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
734 29-Nov-14 HALL - 09 132440804008PATEL PRIYANKA
RAJNIKANT
ANALYTICAL METHOD
DEVELOPMENT AND VALIDATION
FOR SIMULTANEOUS ESTIMATION OF
NEBIVOLOL HYDROCHLORIDE AND
CILNIDIPINE IN COMBINED DOASGE
FORM
Ms. Nilam
Patel244
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
735 29-Nov-14 HALL - 09 132440804010PATEL RUCHABEN
KIRTIKUMAR
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHOD FOR
SIMULTANEOUS ESTIMATION OF
FERROUS ASCORBATE AND FOLIC
ACID IN THEIR COMBINED DOSAGE
FORM
Ms. Nilam
Patel244
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
736 29-Nov-14 HALL - 09 132520804001BHATT DHAVAL
AMRUTLAL
DEVELOPMENT AND VALIDATION OF
CHROMATOGRAPHY AND
SPECTROPHOTOMETRIC METHOD
FOR SIMULTANEOUS ESTIMATION OF
CEFIPIME HYDROCHLORIDE AND
AMIKACIN SULPHATE IN BULK AND
DOSAGE FORM COMBINED DOSAGE
FORM
DR. L. M.
Prajapati252
QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
737 29-Nov-14 HALL - 09 132520804003
PANCHAL
ANKITABEN
KIRITKUMAR
ANALYTICAL METHOD
DEVELOPMENT AND VALIDATION
FOR SIMULTANEOUS ESTIMATION
OF DOXOFYLLINE AND TERBUTALINE
SULPHATE IN BULK AND COMBINED
DOSAGE FORM
Mr M. l.
Kharodiya252
QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
738 29-Nov-14 HALL - 09 132520804004PATEL ANJALIBEN
JASHVANTBHAI
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHOD FOR
SIMULTANEOUS ESTIMATION OF
CEFEPIME HCL AND SULBACTUM
SODIUM IN BULK AND COMBINED
DOSAGE FORM
Dr. A. K. Joshi 252QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
739 29-Nov-14 HALL - 09 132520804007
FANEJA
MITTALBEN
DHIRUBHAI
ANALYTICAL METHOD
DEVELOPMENT AND VALIDATION
FOR SIMULTANEOUS ESTIMATION
OF CILNIDIPINE AND
CHLORTHALIDONE IN BULK AND
PHARMACEUTICAL FORMULATION
Dr. A. K. Joshi 252QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
740 29-Nov-14 HALL - 09 132520804009
MAKADIYA
ASHISHKUMAR
SURESHBHAI
DEVLOPMENT & VALIDATION OF
ANALYTICAL METHODS FOR
ESTIMATION OF RACECADOTRIL
AND OFLOXACIN IN BULK &
COMBINED DOSAGE FORM
Dr. A. K. Joshi 252QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
741 29-Nov-14 HALL - 09 132520804010PATEL CHANDANI
MAHESHKUMAR
ANALYTICAL METHOD
DEVELOPMENT AND VALIDATION
FOR SIMULTANEOUS ESTIMATION
OF IBUPROFEN AND CARISOPRODOL
IN BULK AND PHARMACEUTICAL
FORMULATION
Mr M. l.
Kharodiya252
QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
742 29-Nov-14 HALL - 09 132610804003
KATHIRIYA
PARASBHAI
RAMESHBHAI
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHOD FOR
ESTIMATION OF DICLOFENAC
SODIUM AND PANTOPRAZOL
SODIUM SEQUEHYDRATE IN ITS
COMBINED DOSAGE FORM
mr. prasanna
Ku. Pradhan261
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
743 29-Nov-14 HALL - 09 132610804005PARIKH NAMRATA
NILESHKUMAR
ANALYTICAL METHOD
DEVELOPMENT AND VALIDATION
FOR SIMULTANEOUS ESTIMATION OF
DIPHENHYDRAMINE
HYDROCHLORIDE AND NAPROXEN
SODIUM IN ITS COMBINED DOSAGE
FORM.
ms. shreya r
shah261
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
744 29-Nov-14 HALL - 09 132610804007PATEL PARTH
KAUSHIKBHAI
DEVELOPMENT AND VALIDATION OF
UV AND HPLC METHOD FOR
SIMULTANEOUS ESTIMATION OF
ALPHA LIPOIC ACID AND
METFORMIN IN TABLETS.
Ms. Grishma h
patel261
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
745 29-Nov-14 HALL - 09 132610804011
SHAIKH SIPAI
MOHAMMEDSALA
UDDIN
ABDULALEEM
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHOD FOR
ESTIMATION OF CILNIDIPINE AND
METOPROLOL SUCCINATE
mr. prasanna
Ku. Pradhan261
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
746 29-Nov-14 HALL - 10 132440804002
BHATT
RADHIKABEN
VISHNUBHAI
DEVELOPMENT AND VALIDATION OF
STABILITY INDICATING HPLC
METHOD FOR ESTIMATION OF
ANTIDEPRESSANT DRUG AND ITS
RELATED SUBSTANCES FROM
CAPSULE DOSAGE FORM
nilam patel 244QUALITY
ASSURANCE930204 3 STABILITY STUDIES
747 29-Nov-14 HALL - 10 132440804003
CHAVDA
NIRMABEN
VAJESINH
DEVELOPMENT OF STABILITY
INDICATING HPLC METHOD FOR
DETERMINATION OF CILNIDIPINE
AND OLMESARTAN IN BULK AND
PHARMACEUTICAL DOSAGE FORM
Ms. Payal
Chauhan244
QUALITY
ASSURANCE930204 3 STABILITY STUDIES
748 29-Nov-14 HALL - 10 132440804011
PRAJAPATI
KIRALBEN
MANOJBHAI
STABILITY INDICATING
CHROMATOGRAPHIC METHOD FOR
ILAPRAZOLE AND DOMPERIDONE IN
PHARMACEUTICAL FORMULATION
Ms. Payal
Chauhan244
QUALITY
ASSURANCE930204 3 STABILITY STUDIES
749 29-Nov-14 HALL - 10 132440804012
SHARMA
MAITRIBEN
VIJAYKUMAR
DEVELOPMENT AND VALIDATION OF
STABILITY INDICATING
CHROMATOGRAPHIC METHOD FOR
SIMULTANEOUS ESTIMATION OF
KETOROLAC AND
FLUOROMETHOLONE IN OPTHALMIC
FORMULATION
Ms. Payal
Chauhan244
QUALITY
ASSURANCE930204 3 STABILITY STUDIES
750 29-Nov-14 HALL - 10 132560804006
CHAVDA
GAURANG
NARENDRABHAI
Analytical method development and
validation for simultaneous
estimation of DICLOMINE WITH
LOPERAMIDE in pharmaceutical
formulation.
MEETA a.
jiladia256
QUALITY
ASSURANCE930204 1
SIMULTENEOUS
ESTIMATION
751 29-Nov-14 HALL - 10 132660804001
DHAMECHA
MILAN
ARVINDBHAI
Development and validation of
stability indicating method for
estimation of benzthiazide and
trimetrene in pharmaceutical dosage
form by rp hplc
riddhi madhu 266QUALITY
ASSURANCE930204 4
SIMULTENEOUS
ESTIMATION
752 29-Nov-14 HALL - 10 132660804003
DUNGRANI
MUKESH
GHANSHYAMBHAI
development and validation of
analytical method for simultaneous
estimation of Metoprolol succinate
and nifedipine in their synthetic
mixture
riddhi madhu 266QUALITY
ASSURANCE930204 4
SIMULTENEOUS
ESTIMATION
753 29-Nov-14 HALL - 10 132610804013PATEL PRIYANKA
BHUPENDRABHAI
ANALYTICAL METHOD
DEVELOPMENT AND VALIDATION
FOR SIMULTANEOUS ESTIMATION OF
KETOROLAC AND PHENYLEPHRINE.
Ms. Grishma h
patel261
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
754 29-Nov-14 HALL - 10 132610804504
HEMANGI
DATTATRAY
VAIDYA
ANALYTICAL METHOD
DEVELOPMENT AND VALIDATION OF
Diloxanide Furoate AND Ornidazole
IN ITS COMBINED DOSAGE FORM
Dr. nazneen
Surti261
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
755 29-Nov-14 HALL - 10 132610804511
MAKWANA
CHINTANKUMAR
JAGDISHCHANDRA
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHODS FOR
SIMULTANEOUS ESTIMATION OF
DIETHYLCARBAMAZINE AND
DOXYCYCLINE IN THEIR SYNTHETIC
MIXTURE.
Dr. u. m.
upadhyay261
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
756 29-Nov-14 HALL - 10 132610804514
SABHADIYA
VISHAL
HARESHBHAI
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHOD FOR
ESTIMATION OF NIFEDIPINE AND
LIDOCAINE IN PHARMACEUTICAL
DOSAGE FORM
dr. umesh u
upadhyay261
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
757 29-Nov-14 HALL - 11 132440804006PANDYA RUTU
NIMESHKUMAR
STABILITY INDICATING ASSAY
METHOD DEVELOPMENT AND
VALIDATION FOR RAMIPRIL AND
CHLORTHALIDONE IN BULK AND
PHARMACEUTICAL DOSAGE FORM
Ms. Payal
Chauhan244
QUALITY
ASSURANCE930204 3 STABILITY STUDIES
758 29-Nov-14 HALL - 11 132440804007
PATEL
KRUPALIBEN
YOGESHKUMAR
DEVELOPMENT AND VALIDATION OF
STABILITY INDICATING ASSAY
METHOD FOR SIMULTANEOUS
ESTIMATION OF MONTELUKAST
SODIUM AND DESLORATADINE IN
BULK AND COMBINED
PHARMACEUTICAL DOSAGE FORM
Ms. Payal
Chauhan244
QUALITY
ASSURANCE930204 3 STABILITY STUDIES
759 29-Nov-14 HALL - 11 132610804002 Kabita Singh
DEVELOPMENT AND VALIDATION OF
STABILITY INDICATING METHOD OF
DIFLUPREDNATE AND GATIFLOXACIN
IN ITS COMBINED DOSAGE FORM
Dr. nazneen
Surti261
QUALITY
ASSURANCE930204 3 STABILITY STUDIES
760 29-Nov-14 HALL - 11 132610804009 SAJJAD M PATHAN
STABILITY INDICATING METHOD FOR
CHLORTHALIDONE AND clonidine IN
ITS PHARMACEUTICAL DOSAGE
FORM
Ms. Grishma h
patel261
QUALITY
ASSURANCE930204 3 STABILITY STUDIES
761 29-Nov-14 HALL - 11 132610804516PATEL PARITOSH
DASHRATHBHAI
DEVELOPMENT AND VALIDATION OF
STABILITY INDICATING METHOD FOR
MINOXIDIL AND FINASTERIDE IN ITS
PHARMACEUTICAL DOSAGE FORM.
Dr. nazneen
Surti261
QUALITY
ASSURANCE930204 3 STABILITY STUDIES
762 29-Nov-14 HALL - 11 132660804004HADIYA PARESH
ANANDBHAI
development and validation of
stability indicating hptlc method for
estimation of meclizine in tablet
dosage form
riddhi madhu 266QUALITY
ASSURANCE930204 4 STABILITY STUDIES
763 29-Nov-14 HALL - 11 132660804006MANIYA MANISH
GOVINDBHAI
development and validation of
stability indicating method for
estimation of imipramine hcl and
alprazolam in pharmaceutical dosage
form by rp hplc
riddhi madhu 266QUALITY
ASSURANCE930204 4 STABILITY STUDIES
764 29-Nov-14 HALL - 11 132660804008RATHOD BIPIN
SOMABHAI
development and validation of
stability indicating method for
estimation of diloxanide furoate and
ornidazole in pharmaceutical dosage
form by rp hplc
riddhi madhu 266QUALITY
ASSURANCE930204 4 STABILITY STUDIES
765 29-Nov-14 HALL - 11 132660804011
SHINGALA
CHIRAGKUMAR
DILIPBHAI
STABILITY INDICATING METHOD FOR
ESTIMATION OF CLONIDINE HCL AND
HYDROCHLOROTHIAZIDE IN
PHARMACEUTICAL DOSAGE FORM
BY RP HPLC
riddhi madhu 266QUALITY
ASSURANCE930204 4 STABILITY STUDIES
766 29-Nov-14 HALL - 11 132660804017
THUMMAR
MANISHKUMAR
AMARSHIBHAI
DEVELOPMENT AND VALIDATION OF
STABILITY INDICATING METHOD FOR
ESTIMATION OF METOPROLOL
SUCCINATE AND CLINIDIPINE IN
PHARMACEUTICAL DOSAGE FORM
BY RP HPLC
riddhi madhu 266QUALITY
ASSURANCE930204 4 STABILITY STUDIES
767 29-Nov-14 HALL - 11 132610804507
PATEL
BHAVINKUMAR
ARVINDBHAI
DEVELOPMENT AND VALIDATION OF
STABILITY INDICATING METHOD FOR
FLUOROMETHOLONE AND
KETOROLAC IN ITS
PHARMACEUTICAL DOSAGE FORM
mr. prasanna
Ku. Pradhan261
QUALITY
ASSURANCE930204 3 STABILITY STUDIES
768 29-Nov-14 HALL - 12 132440804001
BARUA
PUNITKUMAR
SANTOSHKUMAR
PROCESS VALIDATION OF
AMOXICILLIN (500 MG) AND
POTASSIUM CLAVULANATE (125 MG)
TABLET
Payal Chauhan 244QUALITY
ASSURANCE930204 3 PROCESS VALIDATION
769 29-Nov-14 HALL - 12 132440804004JAM TEJASKUMAR
TARUNBHAI
PROCESS VALIDATION OF
OXYTETRACYCLINE 12.5 V/V
INJECTION
Ms. Payal
Chauhan244
QUALITY
ASSURANCE930204 3 PROCESS VALIDATION
770 29-Nov-14 HALL - 12 132560804004TUVAR JAYDIPSINH
JAMSHANGBHAI
Quantitative estimation of
GLYCYRRHETNIC ACID from
polyherbal marketed formulation by
chromatographic method.
MEETA a.
jiladia256
QUALITY
ASSURANCE930204 1 HERBAL
771 29-Nov-14 HALL - 12 132660804007RAMOLIYA VIMAL
BHIKHABHAI
process validation of omeprazole
delayed release capsule uspriddhi madhu 266
QUALITY
ASSURANCE930204 4 PROCESS VALIDATION
772 29-Nov-14 HALL - 12 132660804009
SAVANI
CHIRAGBHAI
KANUBHAI
PROCESS VALIDATION OF OFLOXACIN
TABLET USP 200 MGriddhi madhu 266
QUALITY
ASSURANCE930204 4 PROCESS VALIDATION
773 29-Nov-14 HALL - 12 132560804010
LAKHANI
VAISHALIBEN
JAYNTIBHAI
ANALYTICAL METHOD DEVLOPMENT
AND VALIDATION OF METFORMIN
HYDROCHLORIDE AND ALPHA LIPOIC
ACID IN THEIR COMBINED
PHARMACEUTICAL DOSAGE FORM
MEETA a.
jiladia256
QUALITY
ASSURANCE930204 1
OTHER (KINDLY
SPECIFY)
774 29-Nov-14 HALL - 12 132560804012
SATAPARA
BHADRESH
RAJESHBHAI
Development and validation of a
stability indicating HPLC method for
ALPRAZOLAM AND IMIPRAMINE in
pharmaceutical dosage form.
MEETA a.
jiladia256
QUALITY
ASSURANCE930204 1 STABILITY STUDIES
775 29-Nov-14 HALL - 12 132560804013SHUKLA NIYATI
ARUNKUMAR
STABILITY INDICATING HPLC
METHOD DEVLOPMENT AND
VALIDATION FOR SIMULTANEOUS
ESTIMATION OF DICYCLOMINE HCL
AND TRAMADOL IN
PHARMACEUTICAL DOSAGE FORM
MEETA a.
jiladia256
QUALITY
ASSURANCE930204 1 STABILITY STUDIES
776 29-Nov-14 HALL - 13 132440804005MIRZA SAIDABANU
SIKANDARBAIG
DEVELOPMENT AND VALIDATION OF
STABILITY INDICATING METHOD FOR
SIMULTANEOUS ESTIMATION OF
BRIMONIDINE TARTRATE AND
TIMOLOL MALEATE IN OPHTHALMIC
FORMULATION
Ms. Payal
Chauhan244
QUALITY
ASSURANCE930204 3 STABILITY STUDIES
777 29-Nov-14 HALL - 13 132440804009PATEL RADHIKA
KAUSHIKBHAI
A STABILITY INDICATING HPLC
METHOD FOR THE ESTIMATION OF
ETIZOLAM AND ESCITALOPRAM IN
PHARMACEUTICAL DOASGE FORM.
Ms. Nilam
Patel244
QUALITY
ASSURANCE930204 3 STABILITY STUDIES
778 29-Nov-14 HALL - 13 132610804501Barot Darshna
Kaushikbhai
PROCESS VALIDATATION OF
AMOXYCILLIN TRIHYDRATE AND
POTASSIUM CLAVULLINATE ORAL
SUSPENSION
mr. prasanna
Ku. Pradhan261
QUALITY
ASSURANCE930204 3 PROCESS VALIDATION
779 29-Nov-14 HALL - 13 132660804014
SHAH
TUSHARKUMAR
PRAKASHCHANDR
A
method development and validation
of formulated fast dissolving tablet of
sildenafil citrate by rp hplc
riddhi madhu 266QUALITY
ASSURANCE930204 4
OTHER (KINDLY
SPECIFY)
method
development
780 29-Nov-14 HALL - 13 132660804015
SINHA
RANJANKUMAR
SANJAYKUMAR
STUDY OF CRITICAL QUALITY
ATTRIBUTES OF SOLID DOSAGE
FORM
riddhi madhu 266QUALITY
ASSURANCE930204 4
OTHER (KINDLY
SPECIFY)
QUALITY
ATTRIBUTES
781 29-Nov-14 HALL - 13 132560804007
DUDHAREJIYA
VISHALKUMAR
MOHANDAS
Development and validation of a
stability indicating HPLC method for
HYDROCHLORTHIAZIDE AND
CLONIDINE HCL in pharmaceutical
dosage form.
MEETA a.
jiladia256
QUALITY
ASSURANCE930204 1 BABE
782 29-Nov-14 HALL - 13 132560804009
KANZARIYA
SURESH
GANGARAMBHAI
Quantitative estimation of
CURCUMIN,CYPERUS ROTUNDUS
AND URSOLIC ACID from ocimum
sanctum 2% in polyherbal marketed
formulation by chromatographic
method.
MEETA a.
jiladia256
QUALITY
ASSURANCE930204 1 HERBAL
783 24-Nov-14 HALL - 01 132120808003
BHADANI
DARSHAN
LABHUBHAI
Formulation and Evaluation Of
Oxyconazole Nitrate Emulgel for the
Treatment of Topical Fungal
Infections
Dr.
M.M.Soniwala212 PHARMACEUTICS 930202 4
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
784 24-Nov-14 HALL - 01 132120808007JIKADRA VIPUL
VINUBHAI
Vardenafil Hydrochloride:
Formulation and Evaluation Of
Unidirectional Mucoadhesive Tablet
Dr.
M.M.Soniwala212 PHARMACEUTICS 930202 4
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
785 24-Nov-14 HALL - 01 132280802001
CHAUDHARI
KHUSHBUBEN
GANJIBHAI
Design and Development of
buccoadhesive controlled release
dosage form of Mirtazapine
Mrs. Hiral
Koradia228
PHARMACEUTICA
L TECHNOLOGY
AND
PHARMACEUTICS
930202 1
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
786 24-Nov-14 HALL - 01 132280802006PHATAK SACHIN
KALYAN
Formulation and evaluation of
modified release mucoadhesive
buccal film of combination of
Atenolol and Nifedipine
Dr. R.K.Parikh 228
PHARMACEUTICA
L TECHNOLOGY
AND
PHARMACEUTICS
930202 1
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
787 24-Nov-14 HALL - 01 132350808001Jinjala Priya
Narendrabhai
FORMULATION AND EVALUATION OF
pH-TRIGGERED IN SITU GEL OF
LOTEPREDNOL FOR OPHTHALMIC
DELIVERY
Mrs. Dipti
Gohil235 PHARMACEUTICS 930202 3
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
788 24-Nov-14 HALL - 01 132350808002 KASTURI
FORMULATION AND DEVELOPMENT
OF IN SITU GEL OF RALOXIFENE FOR
NASAL DRUG DELIVERY.
Dr. Samip Shah 235 PHARMACEUTICS 930202 3
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
789 24-Nov-14 HALL - 01 132500808013Sidapara Milan
Ghelabhai
studies on formulation development
of micro-emulsion based gel of
ornidazole for topical application.
mr. krunal
joshi250 PHARMACEUTICS 930202 4
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
790 24-Nov-14 HALL - 01 132600810001
MALANI
NAVANEETKUMAR
MADHAVJIBHAI
Formulation design and optimization
of mouth dissolving tablets of
tolperisone hydrochloride
Dr. bhavesh s.
nayak260
PHARMACEUTICA
L TECHNOLOGY930202 1
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
791 24-Nov-14 HALL - 01 132550810004PATEL JALPABEN
VISHNUBHAI
Formulation development &
Evaluation of Fast Dissolving Buccal
Film of Anticholinergic Drug
Vijay K Patel 255PHARMACEUTICA
L TECHNOLOGY930202 2
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
Therapeutic
evaluation of
various
formulation
792 24-Nov-14 HALL - 01 132280802004Palaria Chitra
Ganeshbhai
FORMULATION,DEVELOPMENT AND
EVALUATION OF SUSTAINED RELEASE
MATRIX TABLET OF VENLAFAXINE
HYDROCHLORIDE
DR.DHAVAL
MADAT228
PHARMACEUTICA
L TECHNOLOGY
AND
PHARMACEUTICS
930202 1
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
793 24-Nov-14 HALL - 02 132350808004
Chaudhari
Hirenkumar
Pravinbhai
FORMULATION DEVELOPMENT AND
EVALUATION OF GASTRORETENTIVE
DRUG DELIVERY SYSTEM OF
PROCHLORPERAZINE.
Dr. Samip Shah 235 PHARMACEUTICS 930202 3
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
794 24-Nov-14 HALL - 02 132500808001
Anilkumar
Lakhamanbhai
Mathiya
studies on formulation development
of floating tablet of ilaprazole.mr. krunaljoshi 250 PHARMACEUTICS 930202 4
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
795 24-Nov-14 HALL - 02 132500808002
bhavdip
mansukhbhai
vaghasiya
STUDIES ON FORMULATION
DEVELOPMENT OF PROBIOTICS
ASSISTED COLON TARGETED DRUG
DELIVERY SYSTEM.
dr. rishad
jivani250 PHARMACEUTICS 930202 4
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
Colon targeted
drug delivery
system
796 24-Nov-14 HALL - 02 132500808003
BHOOT
DIPAKKUMAR
RAGHAVJIBHAI
formulation and evaluation of
floating tablet of ofloxacin.
mr rajan
kothari250 PHARMACEUTICS 930202 4
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
797 24-Nov-14 HALL - 02 132500808004
Dadhania
Priyeshkumar
Kalidas
formulation and evaluation of gel
beads of amoxycillin trihydrate for
gastro retentive drug delivery.
mr. rajan
kothari250 PHARMACEUTICS 930202 4
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
gel beads for
gastro retentive
drug delivery
798 24-Nov-14 HALL - 02 132500808008MORI RAHUL
VIRABHAI
formulation and evaluation of cost
effective sustained release tablet of
nifedipine.
mr. rajan
kothari250 PHARMACEUTICS 930202 4
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
799 24-Nov-14 HALL - 02 132510808002
BHINGARADIYA
NUTANBEN
HIMMATLAL
formulation and evaluation of oral
controlled release organogel of
methimazole.
dr. tushar a.
gohil251 PHARMACEUTICS 930202 4
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
800 24-Nov-14 HALL - 02 132510808005TRIVEDI SARVARI
CHANDRESHBHAI
Formulation and evaluation of
extended release tablet of nifedipine
using natural gum.
dr. tushar a.
gohil251 PHARMACEUTICS 930202 4
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
801 24-Nov-14 HALL - 02 132600808004MAHAUR
KAMLESH RAMDAS
Formulation and evaluation of
enteric coated pellets of lansoprazole
Dr. jignesh
modi260 PHARMACEUTICS 930202 1
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
802 24-Nov-14 HALL - 02 132600808005
RAI
PAWANKUMAR
ANIRUDH
formulation and characterization of
sustained release dosage form of
zaltoprofen
dr. kunal n.
patel260 PHARMACEUTICS 930202 1
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
803 24-Nov-14 HALL - 03 132350808007
Shah
Rushabhkumar
Nalinkumar
DESIGN AND DEVELOP NAPROXEN
ORODISPERSIBLE TABLET BY
IMPROVISING ITS SOLUBILITY
Dr. Shridhar
Pandya235 PHARMACEUTICS 930202 3
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
804 24-Nov-14 HALL - 03 132500808005GAJJAR CHARMY
BAKULBHAI
studies on formulation development
of mouth dissolving film of clozapine.
Ms.jalpa
sanandia250 PHARMACEUTICS 930202 4
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
805 24-Nov-14 HALL - 03 132500808006
GANGANI
CHANDRESHKUMA
R LALLUBHAI
formulation and development of poly-
herbal chewable tablet.
mr. krunal
joshi250 PHARMACEUTICS 930202 4
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
806 24-Nov-14 HALL - 03 132500808017ARDESANA JIGAR
NAVINCHANDRA
STUDIES ON FORMULATION
DEVELOPMENT OF DOXAZOSIN
MESYLATE FAST DISSOLVING TABLET
DR. RISHAD
JIVANI250 PHARMACEUTICS 930202 4
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
807 24-Nov-14 HALL - 03 132510808004
KABARIYA
SEJALBEN
DINESHBHAI
formulation, evaluation and
characterization of sublingual film of
asenapine maleate by using novel
biodegradable polymer.
Mr. Ashvin
Mathasoliya251 PHARMACEUTICS 930202 4
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
808 24-Nov-14 HALL - 03 132510808006
VAISHNAV
HETALBEN
NAVINBHAI
formulation, development and
optimization of rapimelts containing
metoclopramide hcl using natural
super disintegrant.
dr. tushar a.
gohil251 PHARMACEUTICS 930202 4
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
809 24-Nov-14 HALL - 03 132550810003PATEL HARDIK
JAGDISHBHAI
Formulatio n, development &
evaluation of oral Fast dissolving Film
of Antihistaminic Drug.
Dr. Arvind
ratilal shah255
PHARMACEUTICA
L TECHNOLOGY930202 2
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
GMP
810 24-Nov-14 HALL - 03 132600808002MODI KINJAL
PANKAJKUMAR
development and optimization of
melt in mouth tablets of
PALONOSETRON hydrochloride
dr. kunal n.
patel260 PHARMACEUTICS 930202 1
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
811 24-Nov-14 HALL - 03 132670810005AGARIYA ISMAIL
JAKUB
FORMULATION OF DISPERSIBLE
TABLETS OF NATEGLINIDE BY
SOLUBILITY ENHANCEMENT USING
SOLID DISPERSION TECHNIQUE
Prof. dr. g.
vidyasagar and
mr. ishab
kumar
267PHARMACEUTICA
L TECHNOLOGY930202 4
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
812 24-Nov-14 HALL - 03 132280802002DAVE NEEL
KHODIDAS
FormulATION,DEVELOPMENT AND
EVALUATION OF FAST RELEASE
TABLET OF ROSUVASTATIN CALCIUM
DR.YAMINI
SHAH228
PHARMACEUTICA
L TECHNOLOGY
AND
PHARMACEUTICS
930202 1
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
813 24-Nov-14 HALL - 04 132120808013
PARMAR
BHAVINKUMAR
BALUBHAI
Design, OPTIMIZATION and
evaluation of Lurasidone
Hydrochloride Nanocrystals
Dr sunny r
shah212 PHARMACEUTICS 930202 4
NANO
SUSPENSION/EMULSI
ON, SEDDS, LIPID
BASED DDS
814 24-Nov-14 HALL - 04 132120808015PATEL NANDAN
SARTANBHAI
Formulation, Development and
Characterisation of Soluble Calcium
Tablets
Dr ramesh d
parmar212 PHARMACEUTICS 930202 4
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
815 24-Nov-14 HALL - 04 132120808016Rathod Rajan
Mahendrakumar
Formulation and Evaluation Of Taste
Masked Fast Dissolving Tablet Of
Cefuroxime Axetil
Dr Jaydeep m
patel212 PHARMACEUTICS 930202 4
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
816 24-Nov-14 HALL - 04 132350808003MARU JATIN
SUBHASHBHAI
Comparatively evaluation of natural
super DISINTEGRants to design
venlafaxine fast dissolving tablet.
Dr. Atanu
Kumar Behera235 PHARMACEUTICS 930202 3
CO PROCESSED, DC,
TABLET/CAPSULE
EXCIPIENTS AND
ATTRIBUTES
817 24-Nov-14 HALL - 04 132500808007LATHIYA NIKHIL
BHARATBHAI
studies on formulation development
of nano-suspension of nebivolol.
dr. rishad
jivani250 PHARMACEUTICS 930202 4
NANO
SUSPENSION/EMULSI
ON, SEDDS, LIPID
BASED DDS
818 24-Nov-14 HALL - 04 132120808008PAREKH KHYATI
KAMLESHKUMAR
Formulation and Evaluation Of
Nanosuspension To Improve
Solubility and Dissolution Of
Diacerein
Ms Jalpa s
paun212 PHARMACEUTICS 930202 4
NANO
SUSPENSION/EMULSI
ON, SEDDS, LIPID
BASED DDS
819 24-Nov-14 HALL - 04 132120808009
KOTADIYA
SANDIPKUMAR
JERAMBHAI
Formulation and Evaluation of
Lornoxicam Loaded Self Nano
Emulsifying Drug Delivery System
Dr Dhaval V
Patel212 PHARMACEUTICS 930202 4
NANO
SUSPENSION/EMULSI
ON, SEDDS, LIPID
BASED DDS
820 24-Nov-14 HALL - 04 132120808010MAKWANA SAROJ
VALAJIBHAI
Formulation and Characterisation Of
Sublingual Tablet Containing
Nicardipine Hydrochloride By
Complexation Method
mr Kalpesh A
Patel212 PHARMACEUTICS 930202 4
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
821 24-Nov-14 HALL - 04 132120808011
MALVIYA
RASHMITA
GIRDHARBHAI
preparation and Evaluation Of
Asenapine Maleate Loaded
MICROEMULSION for Inranasal
delivery
Dr ramesh d
parmar212 PHARMACEUTICS 930202 4
NANO
SUSPENSION/EMULSI
ON, SEDDS, LIPID
BASED DDS
822 24-Nov-14 HALL - 04 132120808012MEGHANI JYOTI
BABUBHAI
Formulation and Evaluation of
Microemulsion Containing Anti-
migraine Agent For Intranasal
Delivery
Dr. Chetan H
Borkhataria212 PHARMACEUTICS 930202 4
NANO
SUSPENSION/EMULSI
ON, SEDDS, LIPID
BASED DDS
823 24-Nov-14 HALL - 05 132500808010RASHIYA ASHISH
KANJIBHAI
studies on formulation development
of poly-herbal antacid suspension.
mr. krunal
joshi250 PHARMACEUTICS 930202 4
OTHER (KINDLY
SPECIFY)suspension
824 24-Nov-14 HALL - 05 132500808014Siddhpara Divyesh
Amrutlal
studies on formulation development
of probiotic assisted colon targeted
drug delivery.
mr. krunal
joshi250 PHARMACEUTICS 930202 4
OTHER (KINDLY
SPECIFY)
colon targeted
drug delivery
system
825 24-Nov-14 HALL - 05 132500808023PATEL VIRAL
MAHENDRABHAI
STUDIES ON FORMULATION
DEVELOPMENT OF SATRANIDAZOLE
INSERTS FOR TREATMENT OF
PERIODONTITIS.
DR. RISHAD
JIVANI250 PHARMACEUTICS 930202 4
OTHER (KINDLY
SPECIFY)inserts
826 24-Nov-14 HALL - 05 132500808026SORATHIYA MONA
VINUBHAI
STUDIES ON FORMULATION
DEVELOPMENT OF TRANSLABIAL
DELIVERY OF RIPAGLINAIDE.
DR. RISHAD
JIVANI250 PHARMACEUTICS 930202 4
OTHER (KINDLY
SPECIFY)
TRANSLABIAL
DELIVERY
827 24-Nov-14 HALL - 05 132500808027VEKARIA LALJIBHAI
DURLABHJIBHAI
FORMULATION DEVELOPMENT OF
MECLOFENAMATE EMULGEL
MS. JALPA
SANANDIA250 PHARMACEUTICS 930202 4
OTHER (KINDLY
SPECIFY)EMULGEL
828 24-Nov-14 HALL - 05 132510808001
BHARAD
ANKITABEN
RAMNIKBHAI
formulation, evaluation and
optimization of lafutidine tablets by
liquisolid technique.
mr. ashvin
mathasoliya251 PHARMACEUTICS 930202 4
OTHER (KINDLY
SPECIFY)
solubility
enhancement
TECHNIQUE
829 24-Nov-14 HALL - 05 132510808003
DHADHAL
SNEHABEN
MAHENDRABHAI
formulation, evaluation and
optimization of biphasic drug
DELIVERY system of rizatriptan
benzoate using compressed mini
tablet.
dr. tushar a.
gohil251 PHARMACEUTICS 930202 4
OTHER (KINDLY
SPECIFY)
biphasic drug
DELIVERY
system
830 24-Nov-14 HALL - 05 132600808003PATEL ZALAK
RAJENDRAKUMAR
comparison of solubility
enhancement of lacidipine by various
techniques
dr. kunal n.
patel260 PHARMACEUTICS 930202 1
OTHER (KINDLY
SPECIFY)
Solubility
enhancement
831 24-Nov-14 HALL - 05 132670810001
BHANUSHALI
SHEETAL
RAMJIBHAI
FORMULATION AND EVALUATION OF
MUCOADHESIVE BUCCAL TABLETS
COTAINING CARVEDILOL AS MODEL
DRUG
Prof. dr. g.
vidyasagar and
mr. ishab
kumar
267PHARMACEUTICA
L TECHNOLOGY930202 4 NULL NULL
832 24-Nov-14 HALL - 05 132670810002GOR AKSHITA
VINODKUMAR
FORMULATION AND EVALUATION
OF CAPTOPRIL FLOATING
MICROSPHERE FOR THE
TREATMENT OF HYPERTENSION
Prof. dr. g.
vidyasagar and
mr. ishab
kumar
267PHARMACEUTICA
L TECHNOLOGY930202 4 NULL NULL
833 24-Nov-14 HALL - 05 132670810003PATEL SHEETAL
BHARATBHAI
FORMULATION AND EVALUATION OF
FLOATING MATRIX TABLET OF
METFORMIN HCL FOR TREATMENT
OF DIABETES
Prof. dr. g.
vidyasagar and
mr. ishab
kumar
267PHARMACEUTICA
L TECHNOLOGY930202 4 NULL NULL
834 24-Nov-14 HALL - 05 132670810004PATEL TANVIBEN
BABULAL
FORMULATION AND EVALUATION OF
GASTRORETENTIVE MATRIX TABLET
OF AMOXICILLIN TRIHYDRATE FOR
TREATMENT OF HELICOBACTER
PYLORI INFECTION
Prof. dr. g.
vidyasagar and
mr. ishab
kumar
267PHARMACEUTICA
L TECHNOLOGY930202 4 NULL NULL
835 24-Nov-14 HALL - 06 132120808001
ANGHAN
JIGNESHBHAI
MULJIBHAI
Formulation and Evaluation Of
Stomach Specific Multiparticulate
Drug Delivery Of Tizanidine
Hydrochloride
Dr.
M.M.Soniwala212 PHARMACEUTICS 930202 4 MULTIPARTICULATE
836 24-Nov-14 HALL - 06 132120808018 saurabh sharma
Formulation and Evaluation
of Multiparticulate Pulsatile Release
drug delivery System of Valsartan
dR JAYANT R
CHAVDA212 PHARMACEUTICS 930202 4 MULTIPARTICULATE
837 24-Nov-14 HALL - 06 132350808005Chavda Pooja
Chandulal
FORMULATION EVALUATION AND
CHARACTERIZATION OF
MUCOADHESIVE MICROPARTICLE OF
ARTEMETHER BY SPRAY DRYING.
Dr. Atanu
Kumar Behera235 PHARMACEUTICS 930202 3 MULTIPARTICULATE
838 24-Nov-14 HALL - 06 132500808011
SACHANI
RAJESHKUMAR
KANUBHAI
FORMULATION AND EVALUATION OF
pH TRIGGERED IN-SITU OPHTHALMIC
GEL OF CHLORAMPHENICOL.
DR. RISHAD
JIVANI250 PHARMACEUTICS 930202 4
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
839 24-Nov-14 HALL - 06 132500808012
SARDHARA
JIGNESHKUMAR
NATUBHAI
formulation and evaluation of
mucoadhesive in-situ gel of
dolasetron hydrochloride for nasal
delivery.
Mr. rajan
kothari250 PHARMACEUTICS 930202 4
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
840 24-Nov-14 HALL - 06 132500808018
JADEJA
HEMAKSHIBA
GIRIRAJSINH
FORMULATION AND EVALUATION OF
PULSATILE RELEASE COATED TABLET
OF ANTIHYPERTENSIVE DRUG.
MR. RAJAN
KOTHARI250 PHARMACEUTICS 930202 4
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
841 24-Nov-14 HALL - 06 132500808021MAKWANA NILESH
KALYANJIBHAI
formulation and evaluation of
compressed coated tablets.
dr. rishad
jivani250 PHARMACEUTICS 930202 4
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
842 24-Nov-14 HALL - 06 132550810001 PATEL JAYSHRI
BHAILALBHAI
Enhancement of solubility of
Lornoxicam using novel Liquisolid
techniques
MR. Ketan J
Patel255
PHARMACEUTICA
L TECHNOLOGY930202 2 MULTIPARTICULATE
Controlled
release tablet
843 24-Nov-14 HALL - 06 132600808001Arpita Jagdishlal
Patel
formulation and evaluation of orally
disintegrating tablets of aripiprazole
mrs. bhavana
a. patel260 PHARMACEUTICS 930202 1
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
844 24-Nov-14 HALL - 06 132550810006VYAS POOJABEN
RAJIVKUMAR
Enhancement of Solubility of
Itraconazole using novel liquisolid
technique
MR. Ketan J
Patel255
PHARMACEUTICA
L TECHNOLOGY930202 2 MULTIPARTICULATE
Controlled
release tablet
845 24-Nov-14 HALL - 06 132120808004
BHOI
UMANGKUMAR
AMRUT BHAI
Formulation and Evaluation of
Multiparticulate Extended Release
Pellets in Management of
Hypertension
Dr Jayant R
Chavda212 PHARMACEUTICS 930202 4 MULTIPARTICULATE
846 24-Nov-14 HALL - 06 132120808017
RATHWA
HITENDRAKUMAR
CHAMPAKSINH
Formulation and Evaluation Of
Stomach Specific Chitosan Based
Mucoadhesive Microspheres Of
Lafutidine By Spray Drying
Dr. Sandeep V
Nathwani212 PHARMACEUTICS 930202 4 MULTIPARTICULATE
847 24-Nov-14 HALL - 07 132280802007PRAYAG KEDAR
SHRIDHAR
Design and Development of modified
release dosage form of Mebeverine
Hydrochloride
Dr. R.K.Parikh 228
PHARMACEUTICA
L TECHNOLOGY
AND
PHARMACEUTICS
930202 1
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
848 24-Nov-14 HALL - 07 132280802009Rawal Shruti
Udaykumar
Design and Development of
antihypertensive tablets using
microporous carrier approach
Dr. R.K.Parikh 228
PHARMACEUTICA
L TECHNOLOGY
AND
PHARMACEUTICS
930202 1OTHER (KINDLY
SPECIFY)
849 24-Nov-14 HALL - 07 132550810002
PANDYA
KRUPABEN
RAKESHKUMAR
Formulation development and
evaluation of Fast Dissolving Tablet
of Anti Hypertensive Drug.
MR. JITENDRA
L PATEL255
PHARMACEUTICA
L TECHNOLOGY930202 2
VESICULAR DRUG
DELIVERY SYSTEM
FAST
DISSOLVING
DOSAGE FORMS
850 24-Nov-14 HALL - 07 132550810005PATEL RADHIKA
VINUBHAI
Formulation and characterization of
PEGylated liposomes containing
Antibacterial drug
C D Modi 255PHARMACEUTICA
L TECHNOLOGY930202 2
VESICULAR DRUG
DELIVERY SYSTEM
transdermal
drug delivery
system
851 24-Nov-14 HALL - 07 132120808002BARAIYA PIYUSH
SHAMJI
Formulation and Evaluation Of
Pulsatile Drug Delivery System Of
Trimetazidine Hydrochloride For
Chronomodulated Therapy
Dr. Dipen
Bhimani212 PHARMACEUTICS 930202 4
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
852 24-Nov-14 HALL - 07 132120808006
DIYORA
ASHISHKUMAR
KANJIBHAI
Formulation and Evaluation Of
Controlled Porosity Osmotic Tablet
Of Antiviral Agent
Mr Dhaval d
mori212 PHARMACEUTICS 930202 4
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
osmotic tablets
853 24-Nov-14 HALL - 07 132120808014PATEL ANKITABEN
VINODBHAI
Studies in self nano emulsifying
system for colonic delivery of
curcumin
Dr Jayant R
Chavda212 PHARMACEUTICS 930202 4
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
SNEDDS colonic
drug delivery
854 24-Nov-14 HALL - 07 132280802003
JAYSWAL
KAVITABEN
HARESHKUMAR
Formulation, Development and
Evaluation of Paediatric friendly
Dosage Forms of Montelukast
sodium
Ms. Radhika
Pandya228
PHARMACEUTICA
L TECHNOLOGY
AND
PHARMACEUTICS
930202 1OTHER (KINDLY
SPECIFY)
PAEDIATRIC
FRIENDLY
DOSAGE FORMS
855 24-Nov-14 HALL - 07 132280802005Patel Vrunda
Umeshbhai
Formulation, Development and
CharacteriZation of Parentral Depot
containing Hormone
MR. NAYAN
RATNAKAR228
PHARMACEUTICA
L TECHNOLOGY
AND
PHARMACEUTICS
930202 1OTHER (KINDLY
SPECIFY)
PARENTRAL
DEPOT SYSTEM
856 24-Nov-14 HALL - 07 132280802008RANA TEJALBAHEN
SHANKARBHAI
Preparation and Evaluation of novel
co-processed excipient for extended
release dosage form
mR.tushar
patel228
PHARMACEUTICA
L TECHNOLOGY
AND
PHARMACEUTICS
930202 1
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
857 24-Nov-14 HALL - 08 132120804015PATEL HIRAJ
RAMESHBHAI
Bioanalytical method development
and validation of METHYL
PREDNISOLONE in K3edta human
plasma by HPLC-ESI-MS/MS.
DR. AMIT J.
VYAS212
QUALITY
ASSURANCE930204 4 BIOANALYTICAL
BIOANALYTICAL
METHOD
DEVELOPMENT
858 24-Nov-14 HALL - 08 132120804018Patel Unnati
Vinodbhai
Method development and validation
of oxybutynine hydrochloride in
human plasma by LC-MS/MS
DR. NILESH
PATEL212
QUALITY
ASSURANCE930204 4 BIOANALYTICAL
METHOD
DEVELOPMENT
859 24-Nov-14 HALL - 08 132120804019
PATELIYA
DINESHKUMAR
BHOLABHAI
Bioanalytical method development
and validation of KETOPROFEN in
K3edta human plasma by HPLC-ESI-
MS/MS.
DR. AMIT J.
VYAS212
QUALITY
ASSURANCE930204 4 BIOANALYTICAL
BIOANALYTICAL
METHOD
DEVELOPMENT
860 24-Nov-14 HALL - 08 132120804021SINGALA PRAGNA
PANNALAL
Bioanalytical method development
and validation of LABETALOL in
K3edta human plasma by UPLC-ESI-
MS/MS.
DR. AMIT J.
VYAS212
QUALITY
ASSURANCE930204 4 BIOANALYTICAL
BIOANALYTICAL
METHOD
DEVELOPMENT
861 24-Nov-14 HALL - 08 132270804010PATEL PRIYABEN
BHARATKUMAR
BIOANALYTICAL METHOD
DEVELOPMENT AND VALIDATION OF
NISOLDIPINE IN HUMAN PLASMA
USING LC-MS/MS
dR.ARVIND
JANGID227
QUALITY
ASSURANCE930204 1 BIOANALYTICAL
862 24-Nov-14 HALL - 08 132280804006
PARMAR
BHARATKUMAR
MULJIBHAI
Development And Validation Of
Analytical Methods For Estimation Of
Tranexamic Acid In Pharmaceutical
Dosage Form.
Dr.
Divyeshkumar
B Doshi
228QUALITY
ASSURANCE930204 1
OTHER (KINDLY
SPECIFY)
ANALYTICAL
METHOD
VALIDATION
863 24-Nov-14 HALL - 08 132500804003
GAJERA
SANDIPKUMAR
RASIKLAL
to develop cleaning validation
method for propofol emulsion in
production area.
mr. gaurav
parmar r250
QUALITY
ASSURANCE930204 4
OTHER (KINDLY
SPECIFY)
cleaning
validation
864 24-Nov-14 HALL - 08 132500804009
SONAIYA
CHIRAGKUMAR
DINESHKUMAR
to develop cleaning validation
method of equipment used in
manufacturing naproxen tablet
750mg.
mr. gaurav
parmar r250
QUALITY
ASSURANCE930204 4
OTHER (KINDLY
SPECIFY)
cleaning
validation
865 24-Nov-14 HALL - 08 132280804001ACHARYA CHITRA
SUDHIRBHAI
TLC-Bioautography Assisted
Screening of Various Plant Extracts
for Potential Anti-microbial
Constituent And its Isolation,
Characterization And Estimation
Using Developed Validated HPTLC
Method.
Dr. Mahesh T.
Chhabria228
QUALITY
ASSURANCE930204 1
OTHER (KINDLY
SPECIFY)
TLC
BIOAUTOGRAP
HY OF PLANT
EXTRACTS
866 24-Nov-14 HALL - 08 132120804013
PATEL
DHAVALKUMAR
RAJUBHAI
Bioanalytical method development
and validation using HPLC-ESI-MS/MS
for the estimation of Rufinamide in
K3EDTA Human Plasma
dr. ashok b.
patel212
QUALITY
ASSURANCE930204 4 BIOANALYTICAL
BIOANALYTICAL
METHOD
DEVELOPMENT
867 24-Nov-14 HALL - 09 132270804006MAJITHIA RUCHI
HASMUKHRAY
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHOD FOR
ESTIMATION OF ANAGLIPTINE AND
ITS IMPURITY IN FINISHED DOSAGE
FORM BY RP-HPLC
DR.DHARMIN
JOSHI227
QUALITY
ASSURANCE930204 1 IMPURITY PROFILING
868 24-Nov-14 HALL - 09 132270804009Patel Hetu
Narendrabhai
BIOEQUIVALENCE STUDY OF
ARTEMETHER AND LUMEFANTRINE
TABLET USING LC-MS/MS
MR.PARESH
MISTRY227
QUALITY
ASSURANCE930204 1 BABE
869 24-Nov-14 HALL - 09 132350804001BIJENDRA
SHARMA
ANALYTICAL METHOD
DEVELOPMENT AND METHOD
VALIDATION OF LEVONORGESTROL
TABLET BY TLC AND U.V. METHOD.
Dr. Dhananjay
Mesharm235
QUALITY
ASSURANCE930204 3 PROCESS VALIDATION
870 24-Nov-14 HALL - 09 132350804002
INAMDAR
PRIYALBEN
MAYANKKUMAR
ANALYTICAL METHOD
DEVELOPMENT AND VALIDATION OF
EPTIFIBATIDE IN INJECTABLE DOSAGE
FORM
Dr. Dhananjay
Mesharm235
QUALITY
ASSURANCE930204 3 PROCESS VALIDATION
871 24-Nov-14 HALL - 09 132350804003Jamdar Preya
Pradip
ANALYTICAL METHOD
DEVELOPMENT AND VALIDATION
FOR THE SIMULTANEOUS
ESTIMATION OF NEOSTIGMINE
METHYL SULPHATE AND
GLYCOPYRROLATE IN INJECTABLE
DOSAGE FORM
Dr. Dhananjay
Mesharm235
QUALITY
ASSURANCE930204 3 PROCESS VALIDATION
872 24-Nov-14 HALL - 09 132350804004Patel Mihir
Kamleshbhai
ANALYTICAL METHOD
DEVELOPMENT AND METHOD
VALIDATION OF TRAMADOL
HYDROCHLORIDE AND
ACETOMINOPHEN IN COMBINED
DOGE TABLET BY HTLC AND HPLC
METHOD.
Dr. Dhananjay
Mesharm235
QUALITY
ASSURANCE930204 3 PROCESS VALIDATION
873 24-Nov-14 HALL - 09 132350804006PATEL PINAL
KISHORBHAI
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHODS FOR
SIMULTANEOUS ESTIMATION OF
ALFUZOSIN HYDROCHLORIDE AND
FINASTERIDE IN COMBINED DOSAGE
FORM
Mrs. Dhara
Patel235
QUALITY
ASSURANCE930204 3 PROCESS VALIDATION
874 24-Nov-14 HALL - 09 132500804008MASHRU RAVI
HASMUKHBHAI
to study concurrent process
validation of spironolactone tablet
mr. gaurav
parmar r250
QUALITY
ASSURANCE930204 4 PROCESS VALIDATION
875 24-Nov-14 HALL - 09 132270804007ODEDRA HARITA
KHIMJIBHAI
ANALYTICAL METHOD
DEVELOPMENT AND VALIDATION OF
RESIDUAL SOLVENTS IN IMATINIB
MESYLATE BY GAS
CHROMATOGRAPHY
MR.HITESH
JADAV227
QUALITY
ASSURANCE930204 1 IMPURITY PROFILING
876 24-Nov-14 HALL - 09 132270804506MALIK TANJILA
YAVARHUSEN
ANALYTICAL METHOD
DEVELOPMENT AND VALIDATION OF
EXEMESTANE & ITS RELATED
IMPURITIES IN PHARMACEUTICAL
DOSAGE FORM BY RP-HPLC
MR.JIGNESH
PANOT227
QUALITY
ASSURANCE930204 1 IMPURITY PROFILING
877 24-Nov-14 HALL - 10 132120804001AMRIN ASIFBHAI
MEGHANI
Analytical method development and
validation of Atropine sulphate and
prednisolone in Ophthalmic
preparation.
Mr .ajay I.
Patel212
QUALITY
ASSURANCE930204 4
SIMULTENEOUS
ESTIMATION
878 24-Nov-14 HALL - 10 132120804006KOTADIYA DILIP
MADHUBHAI
Development and validation of a
reversed-phase HPLC method for
simultaneous estimation of
HYDROCODONE and IBUPROFEN in
tablet dosage form
DR. AMIT J.
VYAS212
QUALITY
ASSURANCE930204 4
SIMULTENEOUS
ESTIMATION
RP-HPLC
METHOD
DEVELOPMENT
AND
VALIDATION
879 24-Nov-14 HALL - 10 132120804011Padiya Rikeeta
Jitendrabhai
Analytical method development and
validation of stability indicating
method for Cyclandelate capsule
dosage form and in bulk drug by
HPLC.
Mr .ajay I.
Patel212
QUALITY
ASSURANCE930204 4
SIMULTENEOUS
ESTIMATION
880 24-Nov-14 HALL - 10 132120804003
CHAUHAN
VIPULABEN
BHIMABHAI
Analytical method development and
validation for simultaneous
estimation of
trithioparamethoxyphenylpropene
(Anethole trithione) and
chlorpheniramine maleate in
pharmaceutical formulation
Mr .ajay I.
Patel212
QUALITY
ASSURANCE930204 4
SIMULTENEOUS
ESTIMATION
881 24-Nov-14 HALL - 10 132500804001AMRUTIYA PAYAL
VARSHESHBHAI
Analytical method development and
validation of Pyrantel pamoate and
invermectin in its pharmaceutical
daosageform using hplc
Ms. Foram
vagadia250
QUALITY
ASSURANCE930204 4
SIMULTENEOUS
ESTIMATION
882 24-Nov-14 HALL - 10 132500804002
BHUT
SAGARKUMAR
DHIRAJLAL
Spectrophotometric and
chromatographic method
development and validation of
pseudoephedrine hcl and ambroxol
in its pharmaceutical dosageform
Mr. gaurav
parmar r250
QUALITY
ASSURANCE930204 4
SIMULTENEOUS
ESTIMATION
883 24-Nov-14 HALL - 10 132500804004GHADIYA DILIP
GOVINDBHAI
simultaneous estimation of
metformin hcl and pioglitazone hcl in
bulk and pharmaceutical dosageform
by spectrophotometric method.
ms. foram
vagadia250
QUALITY
ASSURANCE930204 4
SIMULTENEOUS
ESTIMATION
884 24-Nov-14 HALL - 10 132500804005VAGHANI ASHISH
NANJIBHAI
simultaneous estimation of
cilostazole and imipramine in bulk
and pharmaceutical dosage form by
hplc.
ms. Foram
vagadia250
QUALITY
ASSURANCE930204 4
SIMULTENEOUS
ESTIMATION
885 24-Nov-14 HALL - 10 132500804006BHATIYA DHAVAL
ASHWINKUMAR
analytical method development and
validation for simultaneous
estimation of levocloperastine&
chlorpheniramine malate in its
pharmaceutical dosageform.
mr. gaurav
parmar r250
QUALITY
ASSURANCE930204 4
SIMULTENEOUS
ESTIMATION
886 24-Nov-14 HALL - 10 132120804023VYAS EKTABEN
BHARATBHAI
Development and validation of a
reversed-phase HPLC method for
simultaneous estimation of
SERTACONAZOLE NITRATE and
BECLOMETHASONE DIPROPIONATE
in topical dosage form
DR. AMIT J.
VYAS212
QUALITY
ASSURANCE930204 4
SIMULTENEOUS
ESTIMATION
RP-HPLC
METHOD
DEVELOPMENT
AND
VALIDATION
887 24-Nov-14 HALL - 11 132120804008MANDALIYA
VIDHI DINESHBHAI
Quantitative estimation of Curcumin
in Marketed herbal formulations.
Mr .ajay I.
Patel212
QUALITY
ASSURANCE930204 4 HERBAL
888 24-Nov-14 HALL - 11 132120804002
CHAUDHARI
VIJAYKUMAR
MUKESHBHAI
Chromatographic evaluation of
synthetic drug adulteration in
selected anti-arthritic herbal
formulations
Dr. nilesh patel 212QUALITY
ASSURANCE930204 4 HERBAL
Method
Development
889 24-Nov-14 HALL - 11 132280804003 KRUNAL KOTHARI
Isolation, Characterization &
Estimation of Active Constituents
from Achyranthes aspera, linn plant.
Dr. Sindhu B
Ezhava228
QUALITY
ASSURANCE930204 1 HERBAL
890 24-Nov-14 HALL - 11 132280804004MODI MANSI
DEVENDRAKUMAR
Isolation, Characterization &
Estimation of Active Constituents
from Limonia acidissima plant.
Ms. Vanita M
Lasan228
QUALITY
ASSURANCE930204 1 HERBAL
891 24-Nov-14 HALL - 11 132500804007
KOTADIYA
JITENDRA
JAYANTILAL
method development and validation
for determination of related
substance in isoniazide active
pharmaceutical ingredient.
mr. gaurav
parmar r250
QUALITY
ASSURANCE930204 4 IMPURITY PROFILING
892 24-Nov-14 HALL - 11 132550804001KAD MAYUR
VAJUBHAI
Development and validation of RP-
HPLC method for determination of
Fusidic acid and Halobetasole
Propionate and
preservative(Chlorocresol) in cream.
Dr. Saurabh S
Pandya255
QUALITY
ASSURANCE930204 2 HERBAL Bioanalyticals
893 24-Nov-14 HALL - 11 132550804004PATEL RISHIKA
JITUBHAI
Development and validation of RP
HPLC method for determination of
Clobetasole Propionate , terbinafine,
ornidazole, ofloxacin, and
preservatives(Methyl Paraben,Propyl
Paraben) in cream
Dr. Saurabh S
Pandya255
QUALITY
ASSURANCE930204 2 HERBAL Bioanalyticals
894 24-Nov-14 HALL - 11 132550804005
VAISHNAV
AVANIBEN
RAJENDRAPRASAD
Development and validation of RP
HPLC method for determination of
Halobetasole Propionate and
preservatives(Methyl Paraben and
Propyl Paraben) in lotion.
Dr. Saurabh S
Pandya255
QUALITY
ASSURANCE930204 2 HERBAL Bioanalyticals
895 24-Nov-14 HALL - 12 132120804009Miyatra sejal
devjibhai
Building a registration dossier
following CTD Registration guidelines
DR. NILESH
PATEL212
QUALITY
ASSURANCE930204 4 REGULATORY AFFAIRS CTD
896 24-Nov-14 HALL - 12 132120804012PARMAR SUMIT
YASHVANTSINH
Process validation of rosuvastatin
tablets
DR. NILESH
PATEL212
QUALITY
ASSURANCE930204 4 REGULATORY AFFAIRS
Product
development
897 24-Nov-14 HALL - 12 132120804022TALAVIYA MIRA
HARSHADBHAI
Building a registration dossier
following UEMOA Registration
guidelines
DR. NILESH
PATEL212
QUALITY
ASSURANCE930204 4 REGULATORY AFFAIRS
UEMOA
REGISTRATION
898 24-Nov-14 HALL - 12 132270804015
SOYANTAR
KHUSHBU
DHIRAJKUMAR
ANALYTICAL METHOD
DEVELOPMENT AND VALIDATION
FOR SIMULTANEOUS ESTIMATION OF
DEXMEDETOMIDINE AND ITS
RELATED IMPURITIES IN
PHARMACEUTICAL DOSAGE FORM
BY RP-HPLC METHOD
MR.SAMIR
SHAH227
QUALITY
ASSURANCE930204 1 IMPURITY PROFILING
899 24-Nov-14 HALL - 12 132280804007
RATHVA
SUMITRABEN
RAMSINGBHAI
Comparative In-vitro Dissolution
Study of Different Brands of
Tapentadol HCL Tablet & its
Combined Dosage Form.
Dr. Sindhu B
Ezhava228
QUALITY
ASSURANCE930204 1 DISSOLUTION STUDIES
900 24-Nov-14 HALL - 12 132350804007
SAIYED
NAZNINBANU
MAHAMMEDALI
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHODS FOR
SIMULTANEOUS ESTIMATION OF
ALFUZOSIN HYDROCHLORIDE AND
SOLIFENACIN SUCCINATE IN
COMBINED DOSAGE FORM
Mrs. Dhara
Patel235
QUALITY
ASSURANCE930204 3 PROCESS VALIDATION
901 24-Nov-14 HALL - 12 132350804008
TALSANIYA
VIBHUTIBEN
LALITKUMAR
TO DEVELOP AND VALIDATE
ANALYTICAL METHOD FOR
SIMULTANEOUS ESTIMATION OF
BETAMETHASON VALERATE AND
NEOMYCIN SULPHATE IN
PHARMACEUTICAL DOSAGE FORM
Ms. Minal
Rohit235
QUALITY
ASSURANCE930204 3 PROCESS VALIDATION
902 24-Nov-14 HALL - 12 132350804009VAZIR JELAM
BHAGYESHBHAI
TO DEVELOP AND VALIDATE
ANALYTICAL METHOD FOR
ESTIMATION OF METRONIDAZOLE
AND NORFLOXACIN IN BULK AND
COMBINED DOSAGE FORM
Ms. Minal
Rohit235
QUALITY
ASSURANCE930204 3 PROCESS VALIDATION
903 24-Nov-14 HALL - 12 132350804010Mishra Priyanka
Ravindra
DEVELOPMENT AND VALIDATION of
ANALYTICAL METHOD FOR
ESTIMATION OF Alcaftadine IN bulk
drug
Dr. Dhananjay
Mesharm235
QUALITY
ASSURANCE930204 3 PROCESS VALIDATION
904 24-Nov-14 HALL - 12 132350804011PATEL TWINKLE
KHANDUBHAI
ANALYTICAL METHOD
DEVELOPMENT AND VALIDATION
FOR MEFENAMIC ACID,
PARACETAMOL AND DICYCLOMINE
HCL IN TABLET DOSAGE FORM
Dr. Dhananjay
Mesharm235
QUALITY
ASSURANCE930204 3 PROCESS VALIDATION
905 24-Nov-14 HALL - 13 132120804010nisha roshel
aranha
Formulation, Evaluation and Stability
studies of Aminoglycosides
DR. NILESH
PATEL212
QUALITY
ASSURANCE930204 4 STABILITY STUDIES
Formulation
evaluation
906 24-Nov-14 HALL - 13 132120804020
RATHVA
ANKITKUMAR
BACHUBHAI
Analytical method devlopment and
validation of stability indicating RP-
HPLC method of AMOXAPINE tablets
dosage form.
dr. ashok b.
patel212
QUALITY
ASSURANCE930204 4 STABILITY STUDIES
STABILITY
INDICATING
ASSAY METHOD
DEVELOPMENT
907 24-Nov-14 HALL - 13 132270804016YADAV PRIYANKA
DESHRAJ
DEVELOPMENT AND VALIDATION OF
STABILITY INDICATING METHOD FOR
ESTIMATION OF LEUCOVORIN
CALCIUM IN PHARMACEUTICAL
DOSAGE FORM
MR.BHAVESH
PATEL227
QUALITY
ASSURANCE930204 1 STABILITY STUDIES
908 24-Nov-14 HALL - 13 132270804501Haran Avani
Ashokbhai
DEVELOPMENT AND VALIDATION OF
STABILITY INDICATING METHOD FOR
ESTIMATION OF CILNIDIPINE AND
CHLORTHALIDONE IN
PHARMACEUTICAL DOSAGE FORM
BY RP-HPLC
MS.SUMAN
ACHARYA227
QUALITY
ASSURANCE930204 1 STABILITY STUDIES
909 24-Nov-14 HALL - 13 132270804504VADAVIYA NEHAL
RAMESHCHANDRA
DEVELOPMENT AND VALIDATION OF
STABILITY INDICATING METHOD FOR
ESTIMATION OF METHOCARBAMOL
AND MELOXICAM IN
PHARMACEUTICAL DOSAGE FORM
BY RP-HPLC
MR.BHUPEND
RA PATEL227
QUALITY
ASSURANCE930204 1 STABILITY STUDIES
910 24-Nov-14 HALL - 13 132280804008SHAH SHAIVAL
NAIMESH
Development & Validation of Stability
Indicating Analytical Method for
Naftopidil
Dr. Sindhu B
Ezhava228
QUALITY
ASSURANCE930204 1 STABILITY STUDIES
911 24-Nov-14 HALL - 13 132280804002
CHHUNCHHA
KHUSHBUBEN
ATULKUMAR
Development and validation of
stability indicating assay method for
creatine in bulk and its nutritional
supplements.
Dr.
Divyeshkumar
B Doshi
228QUALITY
ASSURANCE930204 1 STABILITY STUDIES
912 24-Nov-14 HALL - 13 132280804005PARIKH RONAK
CHANDRAKANT
Development And Validation Of
Stability Indicating Method For
Vilazodone.
Dr. Mahesh T
Chhabria228
QUALITY
ASSURANCE930204 1 STABILITY STUDIES
913 24-Nov-14 HALL - 13 132120804005Disha Hirjibhai
Vadadoriya
Development and validation of
stability indicating method for
determination of Lurasidone in bulk
drug by HPLC.
Mr .ajay I.
Patel212
QUALITY
ASSURANCE930204 4 STABILITY STUDIES
914 24-Nov-14 HALL - 14 132270804004Dixit Dhara
Kaushalbhai
DEVELOPMENT AND VALIDATION OF
STABILITY INDICATING METHOD FOR
ESTIMATION OF TRANEXAMIC ACID
IN PHARMACEUTICAL DOSAGE FORM
MR.BHAVESH
PATEL227
QUALITY
ASSURANCE930204 1 STABILITY STUDIES
915 24-Nov-14 HALL - 14 132270804510VALU DISHA
DAMJIBHAI
DEVELOPMENT AND VALIDATION OF
STABILITY INDICATING METHOD FOR
ESTIMATION OF MIFEPRISTONE IN
PHARMACEUTICAL DOSAGE FORM
BY RP-HPLC
MR.RAKESH
BHAGAT227
QUALITY
ASSURANCE930204 1 STABILITY STUDIES
916 24-Nov-14 HALL - 14 132280804009Mohammad Bashir
Ahmadi
Simultaneous Estimation OF Cefixime
And Ornidazole By HPTLC Method.
Dr.
Divyeshkumar
B Doshi
228QUALITY
ASSURANCE930204 1
SIMULTENEOUS
ESTIMATION
917 24-Nov-14 HALL - 14 132350804005PATEL NIVEDITA
RAMESHBHAI
ANALYTICAL METHOD
DEVELOPMENT AND VALIDATION for
simultaneous estimation of
paracetamo land oxycodone
hydrochloride in talet dosage form.
Dr. Dhananjay
Mesharm235
QUALITY
ASSURANCE930204 3
SIMULTENEOUS
ESTIMATION
918 24-Nov-14 HALL - 14 132270804001BAROT HINESHA
SANJAYKUMAR
DEVELOPMENT AND VALIDATION OF
STABILITY INDICATING RP-HPLC
METHOD FOR ESTIMATION OF
DEFERIPRONE IN PHARMACEUTICAL
DOSAGE FORM
MR.DARSHIL
SHAH227
QUALITY
ASSURANCE930204 1 STABILITY STUDIES
919 24-Nov-14 HALL - 14 132120804007MAKWANA NIRAV
NAGARBHAI
Stability indicating assay method
development and validation for
estimation of NEBIVOLOL and
VALSARTAN in pharmaceutical
dosage form by RP-HPLC.
DR. AMIT J.
VYAS212
QUALITY
ASSURANCE930204 4 STABILITY STUDIES
STABILITY
INDICATING
ASSAY METHOD
DEVELOPMENT
920 24-Nov-14 HALL - 14 132120804017
PATEL
NIKUNJKUMAR
JESANGBHAI
Analytical method development and
validation of stability indicating RP-
HPLC method of CILNIDIPIN and
CHLORTHALIDONE in tablet dosage
form
dr. ashok b.
patel212
QUALITY
ASSURANCE930204 4 STABILITY STUDIES
STABILITY
INDICATING RP-
HPLC
921 24-Nov-14 HALL - 14 132120804024YADAV SHIKHA
MAHENDRA
DEVELOPMENT AND VALIDATION OF
STABILITY INDICATING METHOD OF
PERAMPANEL IN BULK USING
ANALYTICAL INSTRUMENT
dr. ashok b.
patel212
QUALITY
ASSURANCE930204 4 STABILITY STUDIES
STABILITY
INDICATING
METHOD
development
922 25-Nov-14 HALL - 01 132060808006PATEL DHAVAL
HARISHBHAI
Formulation and Development of Self
Emulsifying Drug Delivery System of
Fenofibrate
Mr. Hardeep
banwait206 PHARMACEUTICS 930202 1
NANO
SUSPENSION/EMULSI
ON, SEDDS, LIPID
BASED DDS
923 25-Nov-14 HALL - 01 132070808001BHATI MANISHA
PRASHANTSINH
STUDIES ON DESIGN AND
DEVELOPMENT OF
CHRONOPHARMACEUTICAL DRUG
DELIVERY SYSTEM OF LOSARTAN
POTASSIUM
DR. MOIN. K.
MODASIYA207 PHARMACEUTICS 930202 2 NULL NULL
924 25-Nov-14 HALL - 01 132070808002
Bhovaniya
Kanijfatema
Akabarali
FORMULATION AND EVALUATION OF
BENZOCAINE IN-SITU PERIODONTAL
GEL
DR A S
SOLANKI207 PHARMACEUTICS 930202 2 NULL NULL
925 25-Nov-14 HALL - 01 132070808003
CHAUDHARY
DHARA
JESHINGBHAI
FORMULATION AND EVALUATION OF
DELAYED ONSET EXTENDED RELEASE
TABLET OF OLMESARTAN
MEDOXOMIL
DR V M PATEL 207 PHARMACEUTICS 930202 2 NULL NULL
926 25-Nov-14 HALL - 01 132070808005
IMAM
MEHZABEEN
AHEMEDHUSSAIN
FORMULATION AND
CHARACTERIZATION OF MOUTH
DISSOLVING DOSAGE FORM FOR
FESOTERODINE FUMARATE
ANAND K
PATEL207 PHARMACEUTICS 930202 2 NULL NULL
927 25-Nov-14 HALL - 01 132420808001
KHUSHAL
HASMUKHBHAI
VALDORIYA
Development and evaluation of
bilayer sustained release tablets of
Alprazolam and Fluoxetin
Mr hiren n
khatri 242 PHARMACEUTICS 930202 2
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
Sustain RELEASE
drug delivery
928 25-Nov-14 HALL - 01 132420808005PATEL VIPUL
BABUBHAI
Formulation and evaluation of gastro
retentive films of Ketorolac
Tromethamine
Mr hiren n
khatri 242 PHARMACEUTICS 930202 2
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
929 25-Nov-14 HALL - 01 132420808008
MUKDIWALA
MOHMADAZAZ
MOHMAD YUNUS
Formulation and evaluation of
floating in-situ gel of Tizanidine HCl
Dr Riddhi M
Dave242 PHARMACEUTICS 930202 2
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
930 25-Nov-14 HALL - 01 132420808012PATHAN MIRAN
ABDURRAUFKHAN
Formulation and Evaluation of
sustained release matrix tablets of
Faropenem using natural and
synthetic polymers
Dr Riddhi M
Dave242 PHARMACEUTICS 930202 2
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
931 25-Nov-14 HALL - 01 132080808006NINAMA UTKARSH
KUMARPAL
FORMULATION AND EVALUATION OF
SUSTAINED RELEASE LIPID MATRIX
TABLET OF NICORANDIL
DR. SUNITA
CHAUDHARY208 PHARMACEUTICS 930202 1
NANO
SUSPENSION/EMULSI
ON, SEDDS, LIPID
BASED DDS
NA
932 25-Nov-14 HALL - 02 132080808008
PATADIYA
HITARTH
RAJUBHAI
Microemulsion based nasal to brain
delivery of drug acting on cns
dr.sunita
chaudhary208 PHARMACEUTICS 930202 1
OTHER (KINDLY
SPECIFY)microemulsion
933 25-Nov-14 HALL - 02 132060808001BHESANIA HARESH
NATVARLAL
Formulation, Optimization and in-
vitro Evaluation of Cilnidipine
LiquiSolid Tablet
MR. NISHITH
PATEL206 PHARMACEUTICS 930202 1
OTHER (KINDLY
SPECIFY)
LIQUI-SOLID
Compact
934 25-Nov-14 HALL - 02 132060808004
PANARA
JATINKUMAR
RAJESHBHAI
Formulation and Development of
Microemulsion based Solid Dosage
Form of Atrovastatine calcium
MR. NISHITH
PATEL206 PHARMACEUTICS 930202 1
OTHER (KINDLY
SPECIFY)
935 25-Nov-14 HALL - 02 132060808005patel bhavinkumar
kiritbhai
Formulation, Development and
Evaluation of Ibuprofen and
Femotidine in Combined Dosage
Form
Mr. Hardeep
banwait206 PHARMACEUTICS 930202 1
OTHER (KINDLY
SPECIFY)
Combination
Dosage form
936 25-Nov-14 HALL - 02 132060808009VANIYA DEVANG
DHANJIBHAI
A Study on solubility enhancement
methods of poorly water soluble
drug perphenazine
Mr. Hardeep
banwait206 PHARMACEUTICS 930202 1
OTHER (KINDLY
SPECIFY)
SOLUBILITY
ENHANCEMENT
937 25-Nov-14 HALL - 02 132060808013SHAH HARSHIL
MINESHBHAI
ENHANCEMENT OF SOLUBILITY OF
POORLY SOLUBLE DRUG TINIDAZOLE
BY VARIOUS TECHNIQUES
mr. hardeep
banvait206 PHARMACEUTICS 930202 1
OTHER (KINDLY
SPECIFY)
Solubility
Enhancement
tech
938 25-Nov-14 HALL - 02 132080808013
RANA
KARIMAEHAMAD
ANVARAEHAMAD
study of co-solvency for improve
solubility of glipizide in osmotic drug
delivery system
BHAVIN
BHIMANI208 PHARMACEUTICS 930202 1
OTHER (KINDLY
SPECIFY)
osmotic drug
delivery system
939 25-Nov-14 HALL - 02 132420808013
POKAR
AKASHKUMAR
VASANTBHAI
Formulation and evaluation of
Cinnarizine lozenges
Mr hiren n
khatri 242 PHARMACEUTICS 930202 2
CO PROCESSED, DC,
TABLET/CAPSULE
EXCIPIENTS AND
ATTRIBUTES
940 25-Nov-14 HALL - 03 132080808004
BALOTIYA
NARESHKUMAR
NATHURAM
formulation and evaluation of
clobetasol emulgel FOR TOPICAL
DRUG DELIVERY
KINGAL
SANGHVI208 PHARMACEUTICS 930202 1
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
941 25-Nov-14 HALL - 03 132080808009PATEL DEVAL
RAMESHCHANDRA
FORMULATION AND EVALUATION OF
BIOADHESIVE BILAYER BUCCAL
TABLET OF ESOMEPRAZOLE
DR.UPENDRA
PATEL208 PHARMACEUTICS 930202 1
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
NA
942 25-Nov-14 HALL - 03 132080808010PATEL DHARABEN
CHETANKUMAR
DEVELOPMENT AND
CHARACTERIZATION OF
TRANSDERMAL PATCH OF
RASAGILINE MESYLATE.
MRS .KINJAL
SANGHAVI208 PHARMACEUTICS 930202 1
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
943 25-Nov-14 HALL - 03 132080808016YOGI DIVYESH
BHARATBHAI
FORMULATION AND EVALUATION OF
AMLEXANOX MOUTH ULCER GEL.
MR.GANSHYA
M PATEL208 PHARMACEUTICS 930202 1
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
NA
944 25-Nov-14 HALL - 03 132080808017YOGI JIGAR
NARENDRABHAI
FORMULATION AND EVALUATION OF
MICROEMULSION-BASED DRUG
DELIVERY SYSTEM FOR
TRANSDERMAL ADMINISTRATION OF
DIACEREIN.
DR. SUNITA
CHAUDHARY208 PHARMACEUTICS 930202 1
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
NA
945 25-Nov-14 HALL - 03 132080808019SHAH PREXA
PARAGBHAI
FORMULATION AND EVALUATION OF
CHEWABLE TABLET CONTAINING
RAFT FORMING SYSTEM OF
RABEPRAZOLE.
MR. BHAVIN
BHIMANI208 PHARMACEUTICS 930202 1
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
NA
946 25-Nov-14 HALL - 03 132250808006
PATEL
KULDIPKUMAR
RANCHHODBHAI
FORMULATION AND EVALAUTION OF
BUCCAL TABLET CONTAINING
METRONIDAZOLE
DR.HEMANGI
PATEL225 PHARMACEUTICS 930202 2
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
947 25-Nov-14 HALL - 03 132250808011MAURYA POOJA
RADHESHYAM
FORMULATION AND EVALUATION OF
TRANSDERMAL PATCH CONTAINING
ANTI HYPERTENSIVE DRUG
DR.HEMANGI
PATEL225 PHARMACEUTICS 930202 2
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
948 25-Nov-14 HALL - 03 132250808013
PANCHAL
KINJALBEN
VINODBHAI
DEVELOPMENT AND OPTIMIZATION
OF TRANSDERMAL patch
CONTAINING ANTI-PARKINSON DRUG
Dr.Rajesh
Keraliya225 PHARMACEUTICS 930202 2
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
949 25-Nov-14 HALL - 03 132080808018PATEL RIPAL
SURESHBHAI
FORMULATION & EVALUATION OF
TRANSDERMAL PATCH OF
NISOLDIPINE.
MRS. HIRAL
SHAH208 PHARMACEUTICS 930202 1
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
NA
950 25-Nov-14 HALL - 04 132070808007PANCHAL PALAK
HASMUKHBHAI
FORMULATION DEVELOPMENT AND
EVALUATION OF CEFPODOXIME
PROXETIL BY SOLID LIPID
NANOPARTICLES
Dr D A SHAH 207 PHARMACEUTICS 930202 2 NULL NULL
951 25-Nov-14 HALL - 04 132070808008
PATEL
CHINTALBEN
PRAVINBHAI
DESIGN DEVELOPMENT AND
EVALUATION OF LANSOPRAZOLE
SOLID ORAL SUSPENSION
DR A S
SOLANKI207 PHARMACEUTICS 930202 2 NULL NULL
952 25-Nov-14 HALL - 04 132070808011Patel Urjasvi
Harishbhai
FORMULATION AND EVALUATION OF
ORAL FAST DISINTEGRATING TABLET
OF CEFPODOXIME PROXETIL USING
SMEDDS AS SOLUBLIZING METHOD
DR A S
SOLANKI207 PHARMACEUTICS 930202 2 NULL NULL
953 25-Nov-14 HALL - 04 132070808012RAVAL PALAKBEN
AJITBHAI
DEVELOPMENT AND OPTIMIZATION
OF FAST DISSOLVING TABLET OF
NICORANDIL
DR V M PATEL 207 PHARMACEUTICS 930202 2 NULL NULL
954 25-Nov-14 HALL - 04 132070808014
SUDANI
MILANKUMARI
SAVJIBHAI
FORMULATION AND EVALUTION OF
SUSTAINED RELEASE MICROSPHERES
OF ZOLPIDEM TARTRATE
DR A S
SOLANKI207 PHARMACEUTICS 930202 2 NULL NULL
955 25-Nov-14 HALL - 04 132080808001
DABHI
VINESHKUMAR
CHIMANLAL
FORMULATION AND EVALUATION OF
INSITU OPHTHALMIC GEL FOR
CONTROLLED RELEASE OF TIMOLOL
MALEATE USING TEMPERATURE
SENSITIVE POLYMER
MR. BHAVIN
BHIMANI208 PHARMACEUTICS 930202 1
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
956 25-Nov-14 HALL - 04 132080808002NAYAK MEHUL
BALVENTKUMAR
FORMULATION AND EVALUATION OF
PRESS COATED PULSATILE TABLET OF
NEBIVOLOL FOR
CHRONOPHARMACOTHERAPY OF
HYPERTENSION
DR. UPENDRA
PATEL208 PHARMACEUTICS 930202 1
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
NA
957 25-Nov-14 HALL - 04 132080808005DESAI VISHWA
URJITBHAI
FORMULATION AND EVALUATION OF
OF IN-SITU FLOATING GEL
CONTAINING PIOGLITAZONE HCL
AND METFORMIN HCL FOR
DIABETES
DR. UPENDRA
PATEL208 PHARMACEUTICS 930202 1
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
NA
958 25-Nov-14 HALL - 04 132080808007PAL JAGATRAM
BHARATSINH
FORMULATION AND EVALUATION OF
FLOATING IN SITU GEL OF
TRAMADOL HYDROCHLORIDE
MRS. HIRAL
SHAH208 PHARMACEUTICS 930202 1
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
NA
959 25-Nov-14 HALL - 04 132080808501ZALA PARTH
HARISHKUMAR
FORMULATION AND EVALUATION OF
CONTROLLED POROSITY OSMOTIC
PUMP TABLET OF PREGABALIN
MR.GANSHYA
M PATEL208 PHARMACEUTICS 930202 1
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
NA
960 25-Nov-14 HALL - 05 132070808009
PATEL
DHARABAHEN
VINODBHAI
DESIGN DEVELOPMENT AND
EVALUATION OF SUSTAINED
RELEASE METFORMIN WITH
IMMEDIATE RELEASE LINAGLIPTIN
TABLETS
Dr D A SHAH 207 PHARMACEUTICS 930202 2
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
961 25-Nov-14 HALL - 05 132070808016
MANSURI
MOHNISHALI
RAFIKBHAI
FORMULATION AND EVALUATION OF
VOGLIBOSE ORO-DISPERSIBLE
TABLETS
Dr D A SHAH 207 PHARMACEUTICS 930202 2
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
962 25-Nov-14 HALL - 05 132070808017
PATEL
JASMINKUMAR
DINESHBHAI
TO FORMULATE AND EVALUATE
DOMPERIDONE LOADED SOLID LIPID
NANOPARTICLES
Dr D A SHAH 207 PHARMACEUTICS 930202 2
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
963 25-Nov-14 HALL - 05 132080808003
VAHANI
HASMUKHBHAI
SAVASHIBHAI
DESIGN AND CHARACTERIZATION OF
SUSTAINED RELEASE MATRIX
PELLETS OF STAVUDINE
DR. SUNITA
CHAUDHARY208 PHARMACEUTICS 930202 1 MULTIPARTICULATE NA
964 25-Nov-14 HALL - 05 132420808002LEUVA VINAYAK
RAMANBHAI
Formulation and evaluation of
Azithromycin emulgel for topical
delivery
Dr Dhaval J
Patel242 PHARMACEUTICS 930202 2
BUCO/MUCOADHESIV
E, TDDS, TOPICAL,
HYDROGELS NASAL
TOPICAL
DELIVERY
965 25-Nov-14 HALL - 05 132420808003
PATEL
MINESHKUMAR
GHANASHYAMBHA
I
Design and Development of mouth
dissolving films of Amlodipine
Besylate and Nebivolol
Hydrochloride
Dr Shrenik K
Shah242 PHARMACEUTICS 930202 2
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
966 25-Nov-14 HALL - 05 132420808004PATEL NIRAV
KUBERBHAI
Formulation and evaluation of
sublingual tablets of Paliperidone
Dr Shrenik K
Shah242 PHARMACEUTICS 930202 2
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
QUick dissolving
drug delivery
967 25-Nov-14 HALL - 05 132420808007RAWAL KAPILDEV
SATISHKUMAR
Formulation and evaluation of fast
disintegrating tablets for Deflazcort
Dr Dhaval J
Patel242 PHARMACEUTICS 930202 2
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
968 25-Nov-14 HALL - 05 132080808011PATEL DHRUVI
RASIKBHAI
FORMULATION AND EVALUATION OF
FAST DISSOLVING TABLET OF
MIRTAZAPINE
DR.UPENDRA
PATEL208 PHARMACEUTICS 930202 1
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
NA
969 25-Nov-14 HALL - 05 132080808014
SHRIMALI
CHINMAY
DILIPKUMAR
FORMULATION AND EVALUATION OF
FAST DISSOLVING ORAL FILM OF
MELOXICAM
MR.GHANSHY
AM PATEL208 PHARMACEUTICS 930202 1
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
NA
970 25-Nov-14 HALL - 06 132250808002DABHI VIRPALSINH
GHANSHYAMSINH
DEVELOPMENT and optimization OF
FAST DISSOLVING TABLET
CONTAINING ANTIHYPERTENSIVE
DRUG.
Dr.Rajesh
Keraliya225 PHARMACEUTICS 930202 2
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
971 25-Nov-14 HALL - 06 132250808005Patel Hardikkumar
Shaileshbhai
FORMUATION AND EVALUATION OF
ARTEMETHER AND LUMEFANTRINE
DISPERSIBLE TABLET
Dr.Chirag Patel 225 PHARMACEUTICS 930202 2
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
972 25-Nov-14 HALL - 06 132250808007
Prajapati
jayminkumar
baldevbhai
DEVELOPMENT AND OPTIMIZATION
OF DEXTROMETHORPHAN FAST
DISSOLVING FILM
DR.HEMANGI
PATEL225 PHARMACEUTICS 930202 2
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
973 25-Nov-14 HALL - 06 132250808008Prajapati parth
vinodkumar
FORMUATION AND EVALUATION OF
FAST DISSOLVING TABLET OF ANTI-
HISTAMINE DRUG
Dr.Chirag Patel 225 PHARMACEUTICS 930202 2
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
974 25-Nov-14 HALL - 06 132250808015
PATEL
MAULIKKUMAR
UPENDRABHAI
FORMULATION AND EVALUATION OF
venlafaxine HCL FAST DISSOLVING
TABLET
DR.HEMANGI
PATEL225 PHARMACEUTICS 930202 2
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
975 25-Nov-14 HALL - 06 132250808016
PATEL
PRATIKKUMAR
JETHABHAI
FORMULATION, development of fast
dissolving tablet of iloperidone
Dr.Rajesh
Keraliya225 PHARMACEUTICS 930202 2
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
976 25-Nov-14 HALL - 06 132420808009PATEL BHUNESH
ARVINDBHAI
Formulation and evaluation of
Etodolac fast dissolving tablets
Dr Dhaval J
Patel242 PHARMACEUTICS 930202 2
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
977 25-Nov-14 HALL - 06 132420808010
PATEL
BRIJESHKUMAR
BABUBHAI
Formulation and evaluation of
mirtazepine buccal films
Mr hiren n
khatri 242 PHARMACEUTICS 930202 2
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
978 25-Nov-14 HALL - 06 132420808011
PATEL
RONAKKUMAR
SHASHIKANTBHAI
Physicochemical characterization and
in–vitro dissolution enhancement of
Irbesartan HP-ß-CD complex
Dr Dhaval J
Patel242 PHARMACEUTICS 930202 2
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
979 25-Nov-14 HALL - 06 132420808014YADAV RAJESH
GHAMANI SINGH
Studies on solubility and dissolution
rate enhancement of Roxithromycin
using hydrophilic carriers.
Dr Shrenik K
Shah242 PHARMACEUTICS 930202 2
IR, ODT, DT,
SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
NG
980 25-Nov-14 HALL - 07 132070808015BHATT NAZNIN
MUSTAKBHAI
FORMULATION AND EVALUATION OF
ORAL FAST DISSOLVING FILM OF
DESLORATADINE
Dr D A SHAH 207 PHARMACEUTICS 930202 2 NULL NULL
981 25-Nov-14 HALL - 07 132070808018
PRAJAPATI
RAVIKUMAR
DILIPKUMAR
FORMULATION AND EVALUATION OF
FLOATING PULSATILE
MICROSPHERES OF RAMIPRIL
DR V M PATEL 207 PHARMACEUTICS 930202 2 NULL NULL
982 25-Nov-14 HALL - 07 132070808020NINAMA PRITIBEN
RAJESHBHAI
DEVELOPMENT AND EVALUATION OF
SUSTAINED RELEASE MICROSPHERE
OF LORATADINE
DR A S
SOLANKI207 PHARMACEUTICS 930202 2 NULL NULL
983 25-Nov-14 HALL - 07 132070808021
CHAUDHARY
ROSHANIBEN
AMRUTBHAI
FORMULATION DEVELOPMENT AND
EVALUATION OF FAST DISSOLVING
TABLET OF DAPSONE
DR V M PATEL 207 PHARMACEUTICS 930202 2 NULL NULL
984 25-Nov-14 HALL - 07 132250808001
CHAUHAN
DIGVIJAYSINH
AJITSINH
DEVELOPMENT AND OPTIMIZATION
OF SUSTAINED RELEASE TABLET OF
DALFAMPRINE
mS.zIL p.pATEL 225 PHARMACEUTICS 930202 2
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
985 25-Nov-14 HALL - 07 132250808003PATEL BHOOMI
PRAVINBHAI
FORMUATION, EVALUATION AND
COMPARISION OF COLON TARGETED
ANTI CANCER DRUG
Dr.Chirag Patel 225 PHARMACEUTICS 930202 2
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
986 25-Nov-14 HALL - 07 132250808009
BHABHOR
HARSADKUMAR
LALLUBHAI
FORMULATION AND EVALUATION OF
ORNIDAZOLE FLOaTING INSITU GELmS.zIL p.pATEL 225 PHARMACEUTICS 930202 2
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
987 25-Nov-14 HALL - 07 132250808010
GAJJAR
SANGAMITRA
SYAMKUMAR
DESIGN AND EVALUATION OF
FLOATING IN-SITU GEL FOR
SUCRALFATE
DR.HEMANGI
PATEL225 PHARMACEUTICS 930202 2
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
988 25-Nov-14 HALL - 07 132250808012NAYEE RONAK
SURESHKUMAR
FORMULATION AND EVALUATION OF
NASAL INSITU GEL FOR
CYPROHEPATIDINE
DR.HEMANGI
PATEL225 PHARMACEUTICS 930202 2
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
989 25-Nov-14 HALL - 07 132250808014
PATEL
JAIMINKUMAR
RATILAL
FORMULATION, EVALUATION AND
OPTIMIZATION OF PULSATILE DRUG
DELIVERY SYSTEM PREPARED USING
RUPTURABLE AND ERODIBLE
POLYMERS
Dr.Rajesh
Keraliya225 PHARMACEUTICS 930202 2
DELAYED/EXTENDED
RELEASE, FLOATING,
INSITU
990 25-Nov-14 HALL - 08 132070804002
LALA
AYESHABANU
RAFIKAHMED
PROCESS VALIDATION OF TABLET
FORMULATION OF PARACETAMOL
AND NIMESULIDE
NAYAK PRATIK
P207
QUALITY
ASSURANCE930204 2 NULL NULL
991 25-Nov-14 HALL - 08 132070804004
PATEL
HIRALBAHEN
MUKUNDBHAI
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHOD FOR
SIMULTANEOUS ESTIMATION OF
AMOXICILLIN AND CARBOCISTEINE IN
FORMULATION.
NAYAK PRATIK
P207
QUALITY
ASSURANCE930204 2 NULL NULL
992 25-Nov-14 HALL - 08 132070804006
PATEL
KRUNALKUMAR
BHARATBHAI
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHOD FOR
SIMULTANEOUS ESTIMATION OF
ALISKIREN AND VALSARTAN IN
FORMULATION
PATEL SNEHAL
V207
QUALITY
ASSURANCE930204 2 NULL NULL
993 25-Nov-14 HALL - 08 132070804007
PRAJAPATI
HETALBAHEN
BHARATBHAI
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHOD FOR
SIMULTANEOUS ESTIMATION OF
BUPRENORPHINE AND NALOXONE IN
FORMULATION
PATEL SNEHAL
V207
QUALITY
ASSURANCE930204 2 NULL NULL
994 25-Nov-14 HALL - 08 132070804008
VANKAR
RAHULKUMAR
RAMJIBHAI
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHOD FOR
SIMULTANEOUS ESTIMATION OF
FOSINOPRIL SODIUM AND
HYDROCHLORTHIAZIDE IN
FORMULATION
NAYAK PRATIK
P207
QUALITY
ASSURANCE930204 2 NULL NULL
995 25-Nov-14 HALL - 08 132070804009
RATHOD
RACHANABEN
PURUSHOTTAMBH
AI
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHOD FOR
SIMULTANEOUS ESTIMATION OF
BUPROPION AND NALTREXONE IN
FORMULATION
RAJESH R
PARMAR207
QUALITY
ASSURANCE930204 2 NULL NULL
996 25-Nov-14 HALL - 08 132420809006PATEL JAYMIN
GHANSHYAMBHAI
Development and validation of
analytical method for simultaneous
estimation of Methylcobalamine and
Duloxetine HCl in tablet
Dr. Ankit B.
Chaudhary242
PHARMACEUTICA
L QUALITY
ASSURANCE
930204 2SIMULTENEOUS
ESTIMATION
997 25-Nov-14 HALL - 08 132420804020SHAH RINAL
RAKESHKUMAR
Development and validation of
analytical method for simultaneous
estimation of Betamethasone
valtrate, Chloramphenicol and
Lignocaine HCl in ear drop
Ms. MItali
Shrimankar242
QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
998 25-Nov-14 HALL - 08 132420809004RANA JAYDIP
DASHRATHLAL
Development and validation of
analytical method for
SIMULTANEOUS estimation of
Dicyclomine hydrochloride and
tramadol in Pharmaceutical dosage
form
Dr. Ankit B.
Chaudhary242
PHARMACEUTICA
L QUALITY
ASSURANCE
930204 2SIMULTENEOUS
ESTIMATION
999 25-Nov-14 HALL - 09 132060804016PATEL KOMALBEN
VISHNUBHAI
ANALYTICAL METHOD
DEVELOPMENT AND VALIDATION
FOR SIMULTANEOUS ESTIMATION OF
TRIFLUOPERAZINE,
CHLORDIAZEPOXIDE AND
TRIHEXIPHENIDYL IN ITS
PHARMACEUTICAL DOSAGE FORM
BY RP-HPLC
DR. MANDEV
B. PATEL206
QUALITY
ASSURANCE930204 1
OTHER (KINDLY
SPECIFY)
method
development
and validation
1000 25-Nov-14 HALL - 09 132060804017PATEL NAMRATA
CHHAGANBHAI
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHODS FOR
ESTIMATION OF LEUCOVORIN
CALCIUM IN ITS MARKETED DOSAGE
FORM
MS. BHUMIKA
D. SAKHRELIYA206
QUALITY
ASSURANCE930204 1
OTHER (KINDLY
SPECIFY)
method
development
and validation
1001 25-Nov-14 HALL - 09 132070804003Modi Nikee
Rajeshbhai
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHOD FOR
SIMULTANEOUS ESTIMATION OF
IMIPENEM AND CILASTATIN SODIUM
IN FORMULATION.
RAJESH R
PARMAR207
QUALITY
ASSURANCE930204 2 BABE
1002 25-Nov-14 HALL - 09 132420809001CHAUHAN BHAVIK
KISHORBHAI
Development and validation of
analytical method for simultaneous
estimation of mephenesin,
methylnicotine and capsicum
oleoresin in pharmaceutical dosage
form
Ms. Shweta M.
Bhadani242
PHARMACEUTICA
L QUALITY
ASSURANCE
930204 2SIMULTENEOUS
ESTIMATION
1003 25-Nov-14 HALL - 09 132420809002Maheta Ashaben
Jagdishbhai
Development and validation of
analytical method for simultaneous
estimation of Tramadol HCl and
Aceclofenac in tablet
Ms. Komal P.
Patel242
PHARMACEUTICA
L QUALITY
ASSURANCE
930204 2SIMULTENEOUS
ESTIMATION
1004 25-Nov-14 HALL - 09 132420809003
PATEL
NIHARIKABEN
ARVINDBHAI
Development and validation of
analytical method for simultaneous
estimation of Doxylamine Succinate
and Pyridoxine HCl in tablet
Ms. Komal P.
Patel242
PHARMACEUTICA
L QUALITY
ASSURANCE
930204 2SIMULTENEOUS
ESTIMATION
1005 25-Nov-14 HALL - 09 132420809005
MORISWALA
FAUZIYA
ALTAFAHMED
Bioanalytical method development
and validation for estimation of
Methenamine in human plasma by LC-
MS/MS
Dr. Ankit B.
Chaudhary242
PHARMACEUTICA
L QUALITY
ASSURANCE
930204 2OTHER (KINDLY
SPECIFY)bioanalytical
1006 25-Nov-14 HALL - 09 132420809007SHIROYA SNEHA
KANUBHAI
Bioanalytical method development
and validation for estimation of
Valsartan in human plasma by LC-
MS/MS
Dr. Ankit B.
Chaudhary242
PHARMACEUTICA
L QUALITY
ASSURANCE
930204 2OTHER (KINDLY
SPECIFY)bioanalytical
1007 25-Nov-14 HALL - 09 132240804003Jetwani Soniya
Manojkumar
ANALYTICAL METHOD
DEVELOPMENT AND VALIDATION;
DRUG-EXCIPIENT COMPATIBILITY
STUDY; DEGRADATION KINETIC
STUDY AND DISSOLUTION STUDY
FOR VILAZODONE HYDROCHLORIDE
IN PHARMACEUTICAL DOSAGE
FORM.
Smita H Joshi 224QUALITY
ASSURANCE930204 1
OTHER (KINDLY
SPECIFY)
dRUG-
EXCIPIENT
COMPATIBILITY
STUDY; KINETIC
STUDY
1008 25-Nov-14 HALL - 09 132240804011TRIVEDI DHRUTI
ARUNBHAI
simultaneous estimation AND
METHOD VALIDATION OF ENALAPRIL
AND AMLODIPINE in pharmaceutical
FORMULATION.
Smita H Joshi 224QUALITY
ASSURANCE930204 1
SIMULTENEOUS
ESTIMATION
1009 25-Nov-14 HALL - 09 132240804012
CHAUDHARY
SUCHITA
SOHANVIRSINGH
Analytical method development and
validation for simultaneous
estimation of DILOXANIDE FUROATE
AND ORNIDAZOLE in pharmaceutical
dosage form.
Smita H Joshi 224QUALITY
ASSURANCE930204 1
SIMULTENEOUS
ESTIMATION
1010 25-Nov-14 HALL - 10 132060804005mehta shachi
ajaykumar
DEVELOPMENT AND VALIDATION OF
STABILITY INDICATING ANALYTICAL
METHOD FOR ESTIMATION OF
GRISEOFULVIN IN TABLET DOSAGE
FORM
mrs. KOmal
Trivedi206
QUALITY
ASSURANCE930204 1 STABILITY STUDIES
1011 25-Nov-14 HALL - 10 132060804014JAIN PINKI
SANTOSHKUMAR
DEVELOPMENT AND VALIDATION OF
STABILITY INDICATING RP-HPLC
METHOD FOR SIMULTANEOUS
ESTIMATION OF ILAPRAZOLE AND
DOMPERIDONE IN THEIR COMBINED
DOSAGE FORM
DR. MANDEV
B. PATEL206
QUALITY
ASSURANCE930204 1 STABILITY STUDIES
1012 25-Nov-14 HALL - 10 132420804018
RACHIT BANA S/O
ARUN KUMAR
BANA
Development and validation of
analytical methods for simultaneous
estimation of Ketorolac
tromethamine and Phenylephrine
hydrochloride
Ms. Shweta M.
Bhadani242
QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
1013 25-Nov-14 HALL - 10 132420804019SHAH FRENNY
ATULKUMAR
Development and validation of
analytical method for simultaneous
estimation of Ivermectin and
Fenbendazole in tablet
Ms. Komal P.
Patel242
QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
1014 25-Nov-14 HALL - 10 132420804021
SHAH
NIKHILKUMAR
CHINUBHAI
analytical method development and
validation for simultaneous
estimation of beclomethasone
dipropionate and mupirocine in its
Pharmaceutical dosage form
Dr. Riddhi M.
Dave242
QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
1015 25-Nov-14 HALL - 10 132420804023
PATEL
POOJABAHEN
CHANDRAKANT
Development and validation of
analytical method for simultaneous
estimation of tinidazole, miconazole
nitrate and clotrimazole in tablet
Dr. Ankit B.
Chaudhary242
QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
1016 25-Nov-14 HALL - 10 132420804024PATEL KRUTI
DILIPKUMAR
Development and validation of
analytical method for simultaneous
estimation of Paracetamol,
Diclofenac potassium and
Serratiopeptidase in tablet dosage
form
Dr. Dhaval J.
Patel242
QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
1017 25-Nov-14 HALL - 10 132240804008Shastri Devanshi
Pareshkumar
DEVELOPMENT AND VALIDATION OF
STABILITY INDICATING ASSAY
METHOD FOR DETERMINATION OF
GABAPENTIN AND NORTRIPTYLINE
HYDROCHLORIDE IN
PHARMACEUTICAL DOSAGE FORM.
Sagar D solanki 224QUALITY
ASSURANCE930204 1 STABILITY STUDIES
1018 25-Nov-14 HALL - 10 132240804009SWETA
MAROTHIYA
STABILITY INDICATING
CHROMATOGRAPHIC METHOD
DEVELOPMENT AND VALIDATION
FOR SIMULTANEOUS ESTIMATION OF
KETOROLAC TROMETHAMINE AND
FLUOROMETHOLONE IN COMBINED
PHARMACEUTICAL DOSAGE FORM.
HARESHKUMA
R R.
CHAUDHARY
224QUALITY
ASSURANCE930204 1 STABILITY STUDIES
1019 25-Nov-14 HALL - 10 132240804010TRIVEDI AMI
JAYESHBHAI
DEVELOPMENT AND VALIDATION OF
STABILITY INDICATING ASSAY
METHOD FOR SIMULTANEOUS
ESTIMATION OF CEFIXIME AND
OFLOXACIN IN PHARMACEUTICAL
DOSAGE FORM.
parul K Parmar 224QUALITY
ASSURANCE930204 1 STABILITY STUDIES
1020 25-Nov-14 HALL - 10 132240804018VAGHELA DIPABEN
JAYANTIBHAI
ANALYTICAL METHOD
DEVELOPMENT AND VALIDATION OF
STABILITY INDICATING ASSAY
METHOD FOR CILNIDIPINE AND
CHLORTHALIDONE IN COMBINED
PHARMACEUTICAL DOSAGE FORM.
parul K Parmar 224QUALITY
ASSURANCE930204 1 STABILITY STUDIES
1021 25-Nov-14 HALL - 11 132060804001
BHUNATAR
NILESHKUMAR
RAMANBHAI
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHODS FOR
SIMULTANEOUS ESTIMATION OF
LIDOCAINE AND CLOTRIMAZOLE IN
THEIR COMBINED MARKETED
DOSAGE FORM
MS. BHUMIKA
D. SAKHRELIYA206
QUALITY
ASSURANCE930204 1
SIMULTENEOUS
ESTIMATION
1022 25-Nov-14 HALL - 11 132060804002CHAUDHARI
KEYURI UMEDBHAI
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHODS FOR
SIMULTANEOUS ESTIMATION OF
CILOTAZOLE AND TELMISARTAN IN
THEIR COMBINED DOSAGE FORM
MS. BHUMIKA
D. SAKHRELIYA206
QUALITY
ASSURANCE930204 1
SIMULTENEOUS
ESTIMATION
1023 25-Nov-14 HALL - 11 132060804003Chauhan Vishal
Mukeshkumar
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHODS FOR
SIMULTANEOUS ESTIMATION OF
ORNIDAZOLE AND DILOXANITE IN
THEIR COMBINED DOSAGE FORM
MS. DIVYA G.
THAKKAR206
QUALITY
ASSURANCE930204 1
SIMULTENEOUS
ESTIMATION
1024 25-Nov-14 HALL - 11 132060804004MAKWANA NEHA
VINODBHAI
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHODS FOR
SIMULTANEOUS ESTIMATION OF
LEVOCLOPERASTINE AND
CLORPHENIRAMINE MALEATE IN
THEIR COMBINED DOSAGE FORM
DR. MANDEV
B. PATEL206
QUALITY
ASSURANCE930204 1
SIMULTENEOUS
ESTIMATION
1025 25-Nov-14 HALL - 11 132060804006patel abhilasha
bhaveshbhai
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHODS FOR
SIMULTANEOUS ESTIMATION OF
NIFTOPIDIN AND DUTASTERIDE IN
THEIR COMBINED DOSAGE FORM
MS. BHUMIKA
D. SAKHRELIYA206
QUALITY
ASSURANCE930204 1
SIMULTENEOUS
ESTIMATION
1026 25-Nov-14 HALL - 11 132420804009SHETH VIDHI
ROHITKUMAR
Analytical method development and
validation for simultaneous
estimation of Mefenamic acid and
Tizanidine HCl in tablet dosage form
Dr. Ankit B.
Chaudhary242
QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
1027 25-Nov-14 HALL - 11 132420804010 Yadav Zimmy
Development and validation of
analytical method for simultaneous
estimation of Roxithromycin and
Serratiopeptidase in tablet dosage
form
Ms. Mitali V.
Shrimanker242
QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
1028 25-Nov-14 HALL - 11 132420804011BHAVSAR RISHAB
NIRANJANBHAI
Development and validation of RP-
HPLC method for simultaneous
estimation of Cefixime trihydrate,
Cloxacillin sodium and Clavulanate
potassium in Pharmaceutical dosage
form
Dr. Ankit B.
Chaudhary242
QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
1029 25-Nov-14 HALL - 11 132420804012
CHAUDHARY
ASHABEN
JAYNTIBHAI
Development and validation of
analytical methods for simultaneous
estimation of Diclofenac sodium and
Cholestyramine in capsule
Dr. Ankit B.
Chaudhary242
QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
1030 25-Nov-14 HALL - 11 132420804014
JAYSWAL
ANKITABAHEN
PRAVINKUMAR
Development and validation of
analytical method for simultaneous
estimation of Fluorometholone and
Neomycin sulphate in eye drop
Ms. Komal P.
Patel242
QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
1031 25-Nov-14 HALL - 12 132060804008PATEL JUHI
KIRITKUMAR
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHODS FOR
SIMULTANEOUS ESTIMATION OF
LORNOXICAM, PARACETAMOL AND
SERRATIOPEPTIDASE IN THEIR
COMBINED DOSAGE FORM
MS. DIVYA G.
THAKKAR206
QUALITY
ASSURANCE930204 1
SIMULTENEOUS
ESTIMATION
1032 25-Nov-14 HALL - 12 132060804009
PATEL
SANKETKUMAR
NITESHBHAI
ANALYTICAL METHOD
DEVELOPMENT AND VALIDATION
FOR SIMULTANEOUS ESTIMATION OF
CILOSTLZOLE AND IMIPRAMINE BY
RP HPLC
MS. DIVYA G.
THAKKAR206
QUALITY
ASSURANCE930204 1
SIMULTENEOUS
ESTIMATION
1033 25-Nov-14 HALL - 12 132060804010PATEL YOGESH
NANDUBHAI
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHODS FOR
SIMULTANEOUS ESTIMATION OF
GABAPENTIN AND NORTRIPTYLINE IN
THEIR COMBINED DOSAGE FORM
DR. MANDEV
B. PATEL206
QUALITY
ASSURANCE930204 1
SIMULTENEOUS
ESTIMATION
1034 25-Nov-14 HALL - 12 132060804013
BHATIA
ABHISHEKH
DINESHCHANDRA
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHODS FOR
SIMULTANEOUS ESTIMATION OF
ETHINYLESTRADIOL AND
CYPROTERON ACETATE IN THEIR
COMBINED DOSAGE FORM
mrs. KOmal
Trivedi206
QUALITY
ASSURANCE930204 1
SIMULTENEOUS
ESTIMATION
1035 25-Nov-14 HALL - 12 132060804015PANCHAL ROHAN
SUNILKUMAR
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHODS FOR
SIMULTANEOUS ESTIMATION OF
CLONIDINE HYDROCHLORIDE AND
CHLORTHALIDONE IN THEIR
COMBINED DOSAGE FORM
MS. DIVYA G.
THAKKAR206
QUALITY
ASSURANCE930204 1
SIMULTENEOUS
ESTIMATION
1036 25-Nov-14 HALL - 12 132240804001
CHAUDHARY
KHUSHBUBEN
MANILAL
Analytical method development and
validation for simultaneous
estimation of Fluticasone and
Mupirocin in pharmaceutical dosage
form.
Smita H Joshi 224QUALITY
ASSURANCE930204 1
SIMULTENEOUS
ESTIMATION
1037 25-Nov-14 HALL - 12 132240804004KUNJADIYA JIGAR
MANJIBHAI
Analytical method development and
validation for simultaneous
estimation of Ciprofloxacin
Hydrochloride, Ofloxacin, Tinidazole,
Ornidazole and Metronidazole by RP-
HPLC.
Smita H Joshi 224QUALITY
ASSURANCE930204 1
SIMULTENEOUS
ESTIMATION
1038 25-Nov-14 HALL - 12 132240804006
RAVAL
VINAYKUMAR
BHADRESHKUMAR
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHODS FOR
SIMULTANEOUS ESTIMATION OF
CILOSTAZOL AND IMIPRAMINE
HYDROCHLORIDE IN PARENTRAL
DOSAGE FORM.
Sagar D solanki 224QUALITY
ASSURANCE930204 1
SIMULTENEOUS
ESTIMATION
1039 25-Nov-14 HALL - 12 132240804014
PUROHIT
PRAKASHKUMAR
CHUNILAL
ANALYTICAL METHOD
DEVELOPMENT AND VALIDATION
FOR SIMULTANEOUS ESTIMATION OF
LEVOSULPIRIDE, AMBROXOL
HYDROCHLORIDE AND
GUAIPHENESIN IN PHARMACEUTICAL
DOSAGE FORM.
Sagar D solanki 224QUALITY
ASSURANCE930204 1
SIMULTENEOUS
ESTIMATION
1040 25-Nov-14 HALL - 12 132240804007Ravi Bhikhubhai
Pandit
STABILITY INDICATING HPLC
METHOD FOR SIMULTANEOUS
ESTIMATION OF MINOXIDIL AND
FINASTERIDE IN PHARMACEUTICAL
DOSAGE FORM
parul K Parmar 224QUALITY
ASSURANCE930204 1
SIMULTENEOUS
ESTIMATION
1041 25-Nov-14 HALL - 13 132240804002
ENGINEER
GRISHMA
KIRITKUMAR
DEVELOPMENT AND VALIDATION OF
STABILITY INDICATING ANALYTICAL
METHOD FOR ATORVASTATIN AND
METHYLCOBALAMIN IN COMBINED
PHARMACEUTICAL DOSAGE FORM.
HARESHKUMA
R R.
CHAUDHARY
224QUALITY
ASSURANCE930204 1 STABILITY STUDIES
1042 25-Nov-14 HALL - 13 132240804013PATEL PRIYAL
ASHOKKUMAR
STABILITY INDICATING HPLC
METHOD FOR SIMULTANEOUS
ESTIMATION OF BECLOMETHASONE
AND MUPIROCIN IN
PHARMACEUTICAL DOSAGE FORM
HARESHKUMA
R R.
CHAUDHARY
224QUALITY
ASSURANCE930204 1 STABILITY STUDIES
1043 25-Nov-14 HALL - 13 132240804016SHAH HIMANI
JAYVADAN
stability indicating chromatographic
method development and validation
for simultaneous estimation of
rosiglitazone and glimepiride.
Sagar D solanki 224QUALITY
ASSURANCE930204 1 STABILITY STUDIES
1044 25-Nov-14 HALL - 13 132420804005PATEL DIMPALBEN
RAJANIKANT
Development and validation of
analytical methods for simultaneous
estimation of Cilnidipine and
Nebivolol HCl in tablet
Ms. Komal P.
Patel242
QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
1045 25-Nov-14 HALL - 13 132420804006
PATEL
JANKIBAHEN
ANILBHAI
Analytical method development and
validation for simultaneous
estimation of Clonidine HCl and
Hydrochlorothiazide in tablet
Dr. Ankit B.
Chaudhary242
QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
1046 25-Nov-14 HALL - 13 132420804007PATEL ZALAKBEN
KIRITBHAI
Development and validation of
analytical method for simultaneous
estimation of Ibuprofen, Paracetamol
and chlorzoxazone
Dr. Riddhi M.
Dave242
QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
1047 25-Nov-14 HALL - 13 132420804008Shah Chintal
Mukeshbhai
Development and validation of
analytical method for simultaneous
estimation of Bromhexine HCl,
Guaiphenesin and Chlorpheniramine
maleate in tablet
Ms. Shweta M.
Bhadani242
QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
1048 25-Nov-14 HALL - 13 132420804015MEHTA MANTHAN
YOGESHBHAI
prospective Process validation of
Bupropion HCl tablet
Dr. Riddhi M.
Dave242
QUALITY
ASSURANCE930204 2 PROCESS VALIDATION
1049 25-Nov-14 HALL - 13 132420804022VAGHELA PRIYA
VIJAYSINH
prospective Process validation of
Hydroxychloroquine sulphate tablet
Dr. Dhaval J.
Patel242
QUALITY
ASSURANCE930204 2 PROCESS VALIDATION
1050 25-Nov-14 HALL - 13 132240804005PATEL VIVIDHA
ISHVARBHAI
Development and validation of
STABILITY INDICATING ASSAY
METHOD FOR AVANAFIL AND
DEPOXETINE.
Dr. Sagar d
solanki224
QUALITY
ASSURANCE930204 1 STABILITY STUDIES
1051 25-Nov-14 HALL - 14 132060804012SONI NIRAV
RAJENDRAKUMAR
BIOANALYTICAL METHOD
DEVELOPMENT AND VALIDATION OF
METAXALONE IN HUMAN PLASMA
BY LC-MS/MS
DR. MANDEV
B. PATEL206
QUALITY
ASSURANCE930204 1 BIOANALYTICAL
1052 25-Nov-14 HALL - 14 132070804001
CHHABHAIYA
PRITIBAHEN
ASHVINKUMAR
Analytical method development and
validation for estimation of
trifluoperazine and chlordiazepoxide
in pharmaceutical dosage form.
RAJESH R
PARMAR207
QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
1053 25-Nov-14 HALL - 14 132070804005PATEL JIGISHA
KANTILAL
DEVELOPMENT AND VALIDATION OF
ANALYTICAL METHOD FOR
SIMULTANEOUS ESTIMATION OF
RABEPRAZOLE SODIUM AND
MOSAPRIDE CITRATE IN COMBINED
PHARMACEUTICAL FORMULATION.
RAJESH R
PARMAR207
QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
1054 25-Nov-14 HALL - 14 132420804001
CHAUDHARI
HIRENKUMAR
JAGUBHAI
Development and validation of
analytical method for simultaneous
estimation of Etoricoxib and
Serratiopeptidase in tablet
Ms. Shweta M.
Bhadani242
QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
1055 25-Nov-14 HALL - 14 132420804002GOSAI BHARTI
ASHOKBHAI
Development and validation of
analytical method for simultaneous
estimation of Etizolam and
Propranolol hydrochloride in tablet
Ms. Mitali
Shrimankar242
QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
1056 25-Nov-14 HALL - 14 132420804003 HEMANGINI PATEL
Development and validation of
analytical method for simultaneous
estimation of Rifampicin, Isoniazide
and Piperine in capsule
Ms. Mitali V.
Shrimanker242
QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
1057 25-Nov-14 HALL - 14 132420804004Patel Dhavalkumar
Manubhai
Development and validation of
analytical method for simultaneous
estimation of Aceclofenac,
Paracetamol and Serratiopeptidase in
tablet
Ms. Komal P.
Patel242
QUALITY
ASSURANCE930204 2
SIMULTENEOUS
ESTIMATION
1058 25-Nov-14 HALL - 14 132420804017
PATEL
KUNDANKUMAR
GOVINDBHAI
Development and validation of
stability indicating HPLC method for
Epalrestat and Methylcobalamine in
tablet dosage form
Ms. Shweta M.
Bhadani242
QUALITY
ASSURANCE930204 2 STABILITY STUDIES
1059 25-Nov-14 HALL - 14 132420809008
SHAH
HARDIKKUMAR
PANKAJKUMAR
Development and validation of
stability indicating assay method of
Olmesartan and Hydrochlorthiazide
in tablet
Ms. Shweta M.
Bhadani242
PHARMACEUTICA
L QUALITY
ASSURANCE
930204 2 STABILITY STUDIES
1060 26-Nov-14 HALL - 01 132120803004DONGA VIPUL
KARAMSHIBHAI
Bioequivalence study of Pioglitazone
HCl 15mg and metformin HCl 850mg
on fasting condition
Dr. Ravi A.
Manek212 PHARMACOLOGY 930203 4 BABE STUDY
1061 26-Nov-14 HALL - 01 132120803006
GORAKHIYA
RADHIKA
KRUSHNKUMAR
Bioequivalence study of Rasagiline 1
mg tablet, under fasting condition
Dr. Jignesh I.
Patel212 PHARMACOLOGY 930203 4 BABE STUDY
1062 26-Nov-14 HALL - 01 132120803008
KHARADI
RAJESHBHAI
PREMJIBHAI
Bioquivalence study of Esomeprazole
Magnesium delayed release capsule
USP 40 mg under fasting conditions
Dr. Devang B.
Sheth212 PHARMACOLOGY 930203 4 BABE STUDY
1063 26-Nov-14 HALL - 01 132120803013
PATEL
VISHALKUMAR
KIRITBHAI
Bioequivalence study of
Clarithromycin (500mg) extended
release tablet under fasting condition
Dr. Jignesh I.
Patel212 PHARMACOLOGY 930203 4 BABE STUDY
1064 26-Nov-14 HALL - 01 132120803003CHANDRAYEE
BHATTACHARYYA
Bioequivalence study of Divalproex
sodium (500mg) extended release
tablet under fasting condition
Dr. Jignesh I.
Patel212 PHARMACOLOGY 930203 4 BABE STUDY
1065 26-Nov-14 HALL - 01 132280803002bhati kinjal
prakashbhai
Evaluation of influential factors and
treatment given in polycystic ovary
syndrome - A clinical study
Dr Anita A.
Mehta228 PHARMACOLOGY 930203 1
OTHER (KINDLY
SPECIFY)
POLYCYSTIC
OVARY
SYNDROME
1066 26-Nov-14 HALL - 01 132390803001
AHIR
MITESHKUMAR
SUMANBHAI
Epidemiological study of asthma in
school going children of valsad
district
Mr. mittal
dalal239 PHARMACOLOGY 930203 5
PHARMACOEPIDEMIL
OGY
1067 26-Nov-14 HALL - 01 132440803002
KRUTIBEN
MAHESHBHAI
PATEL
EVALUATION OF ANTIUROLITHIATIC
ACTIVITY OF LAWSONIA INERMIS
LINN. IN RATS.
Dr. Samir k.
Shah244 PHARMACOLOGY 930203 3 RENAL DISORDERS
1068 26-Nov-14 HALL - 01 132680803002PATEL NISHA
MAHESHBHAI
exploring in-vivo anti-urolithiatic
effects of polyherbal preparation on
ethylene glycol induced urolithiasis in
rats
mr. vijay b.
lambole268 PHARMACOLOGY 930203 5 RENAL DISORDERS
1069 26-Nov-14 HALL - 01 132280803001 ashok choudary
TO STUDY EFFECT OF CROTOLERIA
BURHIA ON GASTRIC BLEEDING AND
BLOOD COAGULATION PROFILE OF
ASPIRIN + CLOPIDOGREL TREATED
RATS
Dr Parloop A.
Bhatt228 PHARMACOLOGY 930203 1
OTHER (KINDLY
SPECIFY)
GASTRIC
BLEEDING AND
BLOOD
COAGULATION
PROFILE
1070 26-Nov-14 HALL - 01 132280803004DESAI DWITI
DEVENDRAKUMAR
An investigation to determine effect
of Tephrosia purpurea in bleeding
induced by blood thinners
Dr Parloop A.
Bhatt228 PHARMACOLOGY 930203 1
OTHER (KINDLY
SPECIFY)
GASTRIC
BLEEDING WITH
BLOOD
THINNERS
1071 26-Nov-14 HALL - 01 132680803001
DHIMMAR
NIKITABEN
JAYANTIBHAI
evaluation of polyherbal preparation
on high fat diet induced
hyperlipidemia in rats
mr.vipul g.
gajera268 PHARMACOLOGY 930203 5
OTHER (KINDLY
SPECIFY)
HYPERLIPIDEMI
A
1072 26-Nov-14 HALL - 02 132020803001MEHTA GHAZAL
RASHMIN
Neuroprotective role of Sal resin
(shorea robusta gaertn.f.)against
cognitive impairment in rats.
Dr.N. N. Shah 202 PHARMACOLOGY 930203 3 CNS DISORDER
1073 26-Nov-14 HALL - 02 132020803004
PATEL
DIVYESHKUMAR
MAHENDRABHAI
Evaluation of neuropharmacological
activity of Dioscorea bulbifera using
various experimental models.
dr.v.j.galani 202 PHARMACOLOGY 930203 3 CNS DISORDER
1074 26-Nov-14 HALL - 02 132020803005
PATEL
VISMABAHEN
JAGDISHBHAI
evaluation of antistress activity of
operculina turpenthum using various
experimental models.
dr.v.j.galani 202 PHARMACOLOGY 930203 3 CNS DISORDER
1075 26-Nov-14 HALL - 02 132120803009
MAKVANA
ANURADHA
GIRDHARBHAI
Evaluation of preventive effect of
ethyl acetate fraction of Cajanus
cajan (L.) Millisp. on experimental
diabetic cataract in Rat
Dr. Ketan P.
Modi212 PHARMACOLOGY 930203 4
METABOLIC DISORDER
( PLEASE SPECIFY
DISORDER)
Diabetic
complications
1076 26-Nov-14 HALL - 02 132280803006KHUMAN VIKAS
PALJIBHAI
Investigation into anti-asthmatic
activity of TLR-4 antagonist in
experimental model of asthma
Dr Anita A.
Mehta228 PHARMACOLOGY 930203 1
RESPIRATORY
DISORDER ( PLEASE
SPECIFY DISORDER OR
DISEASE)
aSTHMA
1077 26-Nov-14 HALL - 02 132280803009
PATEL
PRIYANKABEN
GOVINDBHAI
Metabolic effects and weight gain
regulation by Asenapine and
Iloperidone in hyperlipidemic rats
Dr Sunita S.
Goswami228 PHARMACOLOGY 930203 1
METABOLIC DISORDER
( PLEASE SPECIFY
DISORDER)
DIABETES,
DYSLIPIDEAMIA
AND WEIGHT
GAIN
REGULATION
1078 26-Nov-14 HALL - 02 132390803002 Dave Karan Rajesh
Assessment of neurobehavioral
effect of shankhpushpi & Brahmi in
wistar rats
Mr. mittal
dalal239 PHARMACOLOGY 930203 5 CNS DISORDER
1079 26-Nov-14 HALL - 02 132390803003PATEL POONAM
BALUBHAI
Assessment of neurotoxicity of
phenylethylamine in wistar rats
Dr. arindam
paul239 PHARMACOLOGY 930203 5 CNS DISORDER
1080 26-Nov-14 HALL - 02 132440803004
PATHAN
SOHELKHAN
LIYAKATALIKHAN
EVALUATION OF ANTIOBESITY
ACTIVITY OF GARUGA PINNATA
ROXB. IN HIGH FAT DIET INDUCED
RATS.
Dr. Samir k.
Shah244 PHARMACOLOGY 930203 3
METABOLIC DISORDER
( PLEASE SPECIFY
DISORDER)
obesity
1081 26-Nov-14 HALL - 02 132440803005PATEL HEMAKSHI
DILIPBHAI
EVALUATION OF ANTIASTHMATIC
ACTIVITY OF ALEURITES
MOLUCCANUS IN EXPERIMENTAL
ANIMALS.
Dr. Samir k.
Shah244 PHARMACOLOGY 930203 3
RESPIRATORY
DISORDER ( PLEASE
SPECIFY DISORDER OR
DISEASE)
asthma
1082 26-Nov-14 HALL - 03 132020803003
PITRODA
KHUSHBU
DIPAKBHAI
evalutation of cardioprotective
potentiol of averrhoa carambola fruit
in isoproterenol induced myocardial
infarction in rats.
Dr. P. D.
Sachdeva202 PHARMACOLOGY 930203 3 CVS DISORDER
1083 26-Nov-14 HALL - 03 132130803002KANANI
MILANKUMAR
Effect of Saroglitazar on
isoproterenol induced myocardial
ischemia in rats
Dr. Jitendra
Vaghasiya213 PHARMACOLOGY 930203 3 CVS DISORDER
1084 26-Nov-14 HALL - 03 132280803005
GAMIT
KRUTIKABEN
DIVANBHAI
Effect of statins on lipid dependent
MMP-2 activity in platelets using
experimental model of
atherosclerosis
Dr Anita A.
Mehta228 PHARMACOLOGY 930203 1 CVS DISORDER
ATHEROSCLERO
SIS AND
PLATELET
AGGREGATION
1085 26-Nov-14 HALL - 03 132280803007KONIKA G
ADESARA
Comparative study of various
diuretics in cardiovascular
complications – A clinical study
Dr Anita A.
Mehta228 PHARMACOLOGY 930203 1 CVS DISORDER
CARDIOVASCUL
AR
COMPLICATION
S
1086 26-Nov-14 HALL - 03 132280803008Modi Nirav
Bharatbhai
To study the effectS of Asenapine
and Aripiprazole against
experimentally induced
cardiovascular dysfunction in rats
Dr Sunita S.
Goswami228 PHARMACOLOGY 930203 1 CVS DISORDER
CARDIOVASCUL
AR
COMPLICATION
S
1087 26-Nov-14 HALL - 03 132280803010RAJPUT POOJA
JAYPALSINGH
STUDY ON CARDIOPROTECTIVE
EFFECTS OF ONDANSETRON IN
ANIMAL MODELS OF CARDIAC
HYPERTROPHY
Dr Anita A.
Mehta228 PHARMACOLOGY 930203 1 CVS DISORDER
CARDIAC
HYPERTROPHY
1088 26-Nov-14 HALL - 03 132280803003DARJI HEMANGINI
PRAFULLBHAI
Effect of ACE inhibitors on matrix
metalloproteinase-2 in
atherosclerotic model of rats
Dr Anita A.
Mehta228 PHARMACOLOGY 930203 1 CVS DISORDER
ATHEROSCLERO
SIS AND
PLATELET
AGGREGATION
1089 26-Nov-14 HALL - 03 132130803001
DOBARIYA
HINALBEN
VINODBHAI
Effect of Lettuce (Lactuca Sativa L.)
on renal artery occlusion induced
hypertension in rats
Dr. Jitendra
Vaghasiya213 PHARMACOLOGY 930203 3 CVS DISORDER
1090 26-Nov-14 HALL - 04 132120803010 marsonia yogita
Effect of alcoholic extract of
Adhatoda vasica Nees in chemically
induced inflammatory bowel disease
in rats
Dr. Jignesh I.
Patel212 PHARMACOLOGY 930203 4
G.I. TRACT ( PLEASE
SPECIFY DISORDER OR
DISEASE)
Inflammatory
bowel disease
1091 26-Nov-14 HALL - 04 132120803011PATEL CHANDNI
SHAILESHBHAI###############################
Dr. Ketan P.
Modi212 PHARMACOLOGY 930203 4 BABE STUDY
1092 26-Nov-14 HALL - 04 132120803017sonari sapnaben
ashokbhai
Bioequivalence study of Ranitidine
300 mg capsule under fasting
conditions
Dr. Devang B.
Sheth212 PHARMACOLOGY 930203 4 BABE STUDY
1093 26-Nov-14 HALL - 04 132120803018UPADHYAY NIKHIL
MAHESH
Bioequivalence Assessment of
Azelastine hydrochloride and
Fluticasone propionate 137/50 µg
nasal spray in Human subjects under
fasting conditions through Single-
Dose Design
Dr. Ketan P.
Modi212 PHARMACOLOGY 930203 4 BABE STUDY
1094 26-Nov-14 HALL - 04 132020803002
Patel
Hasmitabahen
Jagdishbhai
to evaluate activity of
thiocolchicoside and Artocarpus
heterophyllus lam.leaves
(jackfruit)on inflammatory bowel
disease using rats as experimental
animal.
dr.naitik.d.triv
edi202 PHARMACOLOGY 930203 3
G.I. TRACT ( PLEASE
SPECIFY DISORDER OR
DISEASE)
1095 26-Nov-14 HALL - 04 132440803001PATEL KINTUBEN
RAJESHBHAI
EVALUATION OF ANTIULCER
ACTIViTY OF CAESALPINIA CRISTA
LINN. IN RATS.
Dr. Samir k.
Shah244 PHARMACOLOGY 930203 3
G.I. TRACT ( PLEASE
SPECIFY DISORDER OR
DISEASE)
Ulcer
1096 26-Nov-14 HALL - 04 132050803001
PATEL VAIDEHI
CHANDRAKANTBH
AI
Preclinical efficacy testing of
designed polyherbal antiurolithiatic
formulation
Dr.Tejal .R.
Gandhi205 PHARMACOLOGY 930203 3
G.I. TRACT ( PLEASE
SPECIFY DISORDER OR
DISEASE)
urolithiasis
1097 26-Nov-14 HALL - 04 132130803004
PATHAK
KHUSHIBEN
ASHISHKUMAR
Investigations into the effects of
Nicardipine on gastric ischemia
reperfusion injury in rats
Mrs.
Sangeetha L.A.
Rajbanshi
213 PHARMACOLOGY 930203 3
G.I. TRACT ( PLEASE
SPECIFY DISORDER OR
DISEASE)
GASTRIC
ISCHEMIA
REPERFUSION
INJURY
1098 26-Nov-14 HALL - 05 132120803005GANDHI PARTH
MANHARBHAI
Screening of some medicinal plants
of Euphorbiaceae family for COX
inhibitory activity
Dr. Devang B.
Sheth212 PHARMACOLOGY 930203 4
OTHER (KINDLY
SPECIFY)Inflammation
1099 26-Nov-14 HALL - 05 132120803014
RUPARELIYA
NILESH
RAMESHBHAI
Evaluation of Antioxidant Activity of
Coumarin and Cinnamic acid
Derivatives
Dr. Ravi A.
Manek212 PHARMACOLOGY 930203 4
OTHER (KINDLY
SPECIFY)oxidative stress
1100 26-Nov-14 HALL - 05 132120803016SOLANKI NIKUNJ
RAMESHBHAI
Screening of some medicinal plants
of Fabaceae family for COX inhibitory
activity
Dr. Devang B.
Sheth212 PHARMACOLOGY 930203 4
OTHER (KINDLY
SPECIFY)Inflammation
1101 26-Nov-14 HALL - 05 132120803007GOSWAMI POOJA
DINESHGIRI
Evaluation of Anti-oxidant and Anti-
coagulant activity of dicoumarol
containing pyrazole aldehyde
derivatives
Dr. Ketan P.
Modi212 PHARMACOLOGY 930203 4
OTHER (KINDLY
SPECIFY)oxidative stress
1102 26-Nov-14 HALL - 05 132120803015
SOLANKI
MITANJALI
MANUBHAI
Evaluation of Antioxidant Activity of
1-Methyl Dihydroquinolin and
Cinnamic acid Derivatives
Dr. Ravi A.
Manek212 PHARMACOLOGY 930203 4
OTHER (KINDLY
SPECIFY)oxidative stress
1103 26-Nov-14 HALL - 05 132440803003
PATEL
NIKITABAHEN
ASHWINBHAI
EVALUATION OF ANTIARTHRITIC
ACTIVITY OF CITRUS AURANTIUM IN
RATS.
Dr. Samir k.
Shah244 PHARMACOLOGY 930203 3
OTHER (KINDLY
SPECIFY)arthrities
1104 26-Nov-14 HALL - 05 132130803003patel hajra
abdullah
Pharmacological evaluation of Spark
capsule (an ayurvedic proprietary
medicine) on reproductive functions
of male rats
Mrs. Deepti K.
Jani213 PHARMACOLOGY 930203 3
OTHER (KINDLY
SPECIFY)
MALE
REPRODUCTIVE
SYSTEM
(SPERMATOGE
NESIS)
1105 26-Nov-14 HALL - 06 132610805002
CHAUDHARI
MINALBEN
PRAKASHBHAI
isolation and characterization of
BOSWELLIC ACID from BOSWELLIA
SERRATA and its quantification in a
polyherbal formulation
DR.U.M.UPAD
HYAY261
PHARMACOGNOS
Y930205 3 HERBAL RESEARCH
PHYTOCHEMIST
RY
1106 26-Nov-14 HALL - 06 132610805001 Rucha Ghode
isolation and characterization of
glycyrrhizin from glycyrrhiza glabra
and its quantification in a polyherbal
formulation
dr.u.m.upadhy
ay261
PHARMACOGNOS
Y930205 3 HERBAL RESEARCH Phytochemistry
1107 26-Nov-14 HALL - 06 132280805002
TEJAL
SHAILESHBHAI
PATEL
Phenylpropanoids from
Stachytarpheta indica and its anti-
acne activity
Dr. Mamta B.
Shah228
PHARMACOGNOS
Y930205 1
OTHER (KINDLY
SPECIFY)
PHYTOCHEMIC
AL
INVESTIGATION
&
PHARMACOLOG
ICAL ACTIVITY
1108 26-Nov-14 HALL - 07 132020814001DESAI PUSHKAL
SANJIVBHAI
synthesis and evaluation of
pyrimidine based phthalimide
derivatives as potential anticancer
agents.
dr. vipul m.
vaghela202
MEDICAL
CHEMISTRY930201 3
MEDICINAL
CHEMISTRY
(ANTICANCER)
1109 26-Nov-14 HALL - 07 132330801003JOSHI MAITREYEE
KIRANKUMAR
Synthesis and biological evaluation of
new triazoles containing prodrug.
Mr. Akhil
Nagar233
PHARMACEUTICA
L CHEMISTRY930201 3
MEDICINAL
CHEMISTRYAnti depressant
1110 26-Nov-14 HALL - 07 132270801001
BHUT
DIPAKKUMAR
MAHESHKUMAR
Synthesis of some new fused Bicyclo
pyrimidines as potential antimicrobial
agents.
mr.rajesh gami 227PHARMACEUTICA
L CHEMISTRY930201 1
MEDICINAL
CHEMISTRY
1111 26-Nov-14 HALL - 07 132270801002CHAVDA HARSHA
NAVNITBHAI
Synthesis and antibacterial activity of
some newer Dihyropyridines and
Barbitones.
Ms. Sweta
patel227
PHARMACEUTICA
L CHEMISTRY930201 1
MEDICINAL
CHEMISTRY
1112 26-Nov-14 HALL - 07 132270801003SHAH MEET
NRUPESHKUMAR
A one pot synthesis of some
Pyranoquinolines and
Pyrano(c)chromenes as biologically
active agents.
Ms. Sweta
patel227
PHARMACEUTICA
L CHEMISTRY930201 1
MEDICINAL
CHEMISTRY
1113 26-Nov-14 HALL - 07 132270801004
ZARMARIYA
SANDHYABEN
MANSUKHBHAI
Synthesis and biological evaluation of
some 2-Amino/Chloromethyl-1H-
benzimidazole derivatives as
antimicrobial agents.
mr.rajesh gami 227PHARMACEUTICA
L CHEMISTRY930201 1
MEDICINAL
CHEMISTRY
1114 26-Nov-14 HALL - 07 132280801001
BOGHARA
PARTHKUMAR
JITENDRABHAI
SYNTHESIS AND PHARMACOLOGICAL
EVALUATION OF SOME NOVEL
AZETINE DERIVATIVES.
Dharmishtha
R. Parmar228
PHARMACEUTICA
L CHEMISTRY930201 1
MEDICINAL
CHEMISTRY
1115 26-Nov-14 HALL - 07 132280801005
MUNSHI
SUNEHANA
NASIMBHAI
SYNTHESIS AND BIOLOGICAL
EVALUATION OF SOME NOVEL IKKß
INHIBITORS.
Dr. Mahesh T.
Chhabria228
PHARMACEUTICA
L CHEMISTRY930201 1
MEDICINAL
CHEMISTRY
(ANTICANCER)
1116 26-Nov-14 HALL - 07 132330801001khushbu samir
shah
Synthesis and biological evaluation of
novel Rhodanine derivativesAkhil Nagar 233
PHARMACEUTICA
L CHEMISTRY930201 3
MEDICINAL
CHEMISTRY
Anti-
Inflammatory
1117 26-Nov-14 HALL - 07 132330801005
PARMAR
KASHYAPI
ASHOKKUMAR
Synthesis and biological screening of
new thiazolidinone derivatives.Ashish Patel 233
PHARMACEUTICA
L CHEMISTRY930201 3
MEDICINAL
CHEMISTRY
Anti-
Inflammatory
1118 26-Nov-14 HALL - 07 132330801006PRAJAPATI HIRAL
VASANTBHAI
Synthesis and pharmacological
evaluation of new medicinally
important thiadiazole derivatives.
Viral Patel 233PHARMACEUTICA
L CHEMISTRY930201 3
MEDICINAL
CHEMISTRY
Anti-
Depressant
1119 26-Nov-14 HALL - 07 132280801003
DARJI
HIRENKUMAR
HARSHADBHAI
SYNTHESIS AND SCREENING OF
NOVEL ADAMANTYLE DERIVATIVES
AS AN ANTI-TUBERCULAR AGENTS
Dr. Mahesh T.
Chhabria228
PHARMACEUTICA
L CHEMISTRY930201 1
OTHER (KINDLY
SPECIFY)
MEDICINAL
CHEMISTRY(AN
TI-TUBERCULAR
AGENTS)
1120 26-Nov-14 HALL - 08 132280801006
PARMAR
DARSHNABEN
VIRABHAI
SYNTHESIS AND ANTIMICROBIAL
SCREENING OF SOME NOVEL
PYRIMIDINE DERIVATIVES.
Dr. Haribhai A.
Rabari228
PHARMACEUTICA
L CHEMISTRY930201 1
MEDICINAL
CHEMISTRY
(ANTIINFECTIVES)
1121 26-Nov-14 HALL - 08 132280801007
RADADIYA
KALPESHKUMAR
RAJNIKANTBHAI
DESIGN, SYNTHESIS AND
ANTIMYCOBACTERIAL ACTIVITY OF
SOME NOVEL QUINOLONE
DERIVATIVES.
Dr. Been R.
Prajapati228
PHARMACEUTICA
L CHEMISTRY930201 1
MEDICINAL
CHEMISTRY
(ANTIINFECTIVES)
1122 26-Nov-14 HALL - 08 132280801008THAKKAR NICKY
JANAKBHAI
DESIGN, SYNTHESIS AND
PHARMACOLOGICAL EVALUATION
OF SOME NOVeL SUBSTITUTED
NITROIMIDAZOLE DERIVATIVES.
Dr. Been R.
Prajapati228
PHARMACEUTICA
L CHEMISTRY930201 1
MEDICINAL
CHEMISTRY
(ANTIINFECTIVES)
1123 26-Nov-14 HALL - 08 132330801002
CHOVATIYA
SUDHIRKUMAR
JIVRAJBHAI
Synthesis and biological evaLuation
of new thiazole derivativesViral Patel 233
PHARMACEUTICA
L CHEMISTRY930201 3
MEDICINAL
CHEMISTRY
(ANTIINFECTIVES)
1124 26-Nov-14 HALL - 08 132330801004KARA RIZWANA
SHABBIRAHMED
Synthesis and biological screening of
new flavanoid derivatives.Ashish Patel 233
PHARMACEUTICA
L CHEMISTRY930201 3
MEDICINAL
CHEMISTRY
(ANTIINFECTIVES)
1125 26-Nov-14 HALL - 08 132540801003VASAVA RICHA
THAKORBHAI
Synthesis of New L-Phenylalanine
Derivatives As Potential Anti-Cancer
AgentS.
DR.M.N.NOOL
VI254
PHARMACEUTICA
L CHEMISTRY930201 5
MEDICINAL
CHEMISTRY
(ANTICANCER)
synthetic
chemistry
1126 26-Nov-14 HALL - 08 132540801005KAKADIYA DIPESH
GORDHANBHAI
Synthesis of new 5- substituted
Oxindole derivatives as potential
anticancer agentS.
DR.M.N.NOOL
VI254
PHARMACEUTICA
L CHEMISTRY930201 5
MEDICINAL
CHEMISTRY
(ANTICANCER)
synthetic
chemistry
1127 26-Nov-14 HALL - 08 132540801001PATEL ARTIBEN
BHARATKUMAR
Synthesis of New Pyrimidine
Derivatives as Potential Anticancer
Agents
DR.M.N.NOOL
VI254
PHARMACEUTICA
L CHEMISTRY930201 5
MEDICINAL
CHEMISTRY
(ANTICANCER)
synthetic
chemistry
1128 26-Nov-14 HALL - 08 132540801002PATEL KIRTI
NARENDRABHAI
Synthesis of new 7- Amino coumarin
derivatives as potential anticancer
agentS.
DR.M.N.NOOL
VI254
PHARMACEUTICA
L CHEMISTRY930201 5
MEDICINAL
CHEMISTRY
(ANTICANCER)
synthetic
chemistry
1129 26-Nov-14 HALL - 08 132540801004GOHIL CHIRAG
JAGDISHCHANDRA
Synthesis of New Diaryl derivatives as
potential Anti Cancer Agents.
DR.M.N.NOOL
VI254
PHARMACEUTICA
L CHEMISTRY930201 5
MEDICINAL
CHEMISTRY
(ANTICANCER)
synthetic
chemistry
1130 26-Nov-14 HALL - 08 132280801002
DAMOR
JIGARKUMAR
CHANDUBHAI
SYNTHESIS AND BIOLOGICAL
SCREENING OF SOME NOVEL 1,2,4-
TRIAZOLE DERIVATIVES AS AN
ANTIMICROBIAL AGENTS.
Dr. Haribhai A.
Rabari228
PHARMACEUTICA
L CHEMISTRY930201 1
MEDICINAL
CHEMISTRY
(ANTIINFECTIVES)
1131 26-Nov-14 HALL - 09 132020806002PATEL MEGHA
SHASHIKANTBHAI
to study treatment pattern,
treatment satisfaction and quality of
life of galactorrheal patient
Dr. n.d.trivedi 202CLINICAL
PHARMACY930206 3
OTHER (KINDLY
SPECIFY)galactorrhea
1132 26-Nov-14 HALL - 09 132020806003
ALGOTAR
HARSHABEN
JODHABHAI
Measurement of quality of life in the
patients on antihypertensive drug
therapy
DR. BHARAT
GAJJAR202
CLINICAL
PHARMACY930206 3 CLINICAL STUDY (CVS)
1133 26-Nov-14 HALL - 09 132020806006
PATEL
SACHINKUMAR
PRAVINBHAI
STUDY TO FIND OUT TREATMENT
PATTERN IN PATIENTS SUFFERING
FROM ALZHEIMER'S DISEASE IN
private set up at ANAND DISTRICT
DR.
ANURADHA
JOSHI
202CLINICAL
PHARMACY930206 3
CLINICAL STUDY, (CNS,
ARTHRITIS, CANCER,
EYES)
1134 26-Nov-14 HALL - 09 132450806001
PATEL
MAULIKKUMAR
PRAVINBHAI
CORRELATION OF RADIATION SIDE
EFFECTS AND PATIENT PROFILE IN
HEAD AND NECK CANCER
DR. I.S.ANAND 245CLINICAL
PHARMACY930206 2 NULL
1135 26-Nov-14 HALL - 09 132450806002
PRAJAPATI
MAULIKKUMAR
GOVINDBHAI
TO EVALUATE SAFETY AND EFFICACY
OF DPP IV INHIBITORS IN TYPE 2
DIABETES
DR.I.S.ANAND 245CLINICAL
PHARMACY930206 2 NULL
Clinical study
(diabetes)
1136 26-Nov-14 HALL - 09 132820806001SONI NISHIT
NILESHKUMAR
Risk of myopathy due to treatment of
type 2diabetic mellitus patient
Dr. upama
trivedi282
CLINICAL
PHARMACY930206 3
PHARMACY PRACTICE
& CLINICAL STUDY
(DIABETES)
1137 26-Nov-14 HALL - 09 132820806004PATEL EVA
AJAYBHAI
Surrogacy: The experience of
Surrogate mother at Akanksha
Infertility Clinic.
Dr. upama
trivedi282
CLINICAL
PHARMACY930206 3
OTHER (KINDLY
SPECIFY)Surrogacy
1138 26-Nov-14 HALL - 09 132820806005
PATEL
PRITESHKUMAR
SATISHBHAI
Quality of life in moderate to severe
psoriasis
Dr. upama
trivedi282
CLINICAL
PHARMACY930206 3
OTHER (KINDLY
SPECIFY)Severe psoriasis
1139 26-Nov-14 HALL - 09 132820806006SHAH KARISHMA
RAJESH
Measurement of Hospital Anxiety
and Depression scale for the males
undergoing infertility treatment.
Dr. upama
trivedi282
CLINICAL
PHARMACY930206 3
OTHER (KINDLY
SPECIFY)
infertility
treatment.
1140 26-Nov-14 HALL - 09 132020806001
JAYNITA
ASHOKKUMAR
PATEL
assessment of the experience of
injection devices used in in-vitro
fertilization treatment
Dr.(Mrs.)
Nirzarini n
shah
202CLINICAL
PHARMACY930206 3
OTHER (KINDLY
SPECIFY)
Gynaecology
and obstetrics
1141 26-Nov-14 HALL - 09 132020806004PATEL MILAN
RAKESHBHAI
effectiveness of dpp-4 inhibitors
versus sulphonylureas in
management of uncontrolled type-2
diabetes mellitus - a comparative
study
dr. punam d.
sachdeva202
CLINICAL
PHARMACY930206 3
PHARMACY PRACTICE
& CLINICAL STUDY
(DIABETES)
1142 26-Nov-14 HALL - 09 132020806005VAGHELA DIPALI
MAGANBHAI
to study prescribing patterns of
antibiotics in dental practice in a
tertiary care teaching hospital.
dr.nazima
mirza202
CLINICAL
PHARMACY930206 3
OTHER (KINDLY
SPECIFY)
ANTIBIOTICS IN
DENTISTRY
1143 26-Nov-14 HALL - 10 132090816001
MALANKIYA
GIRISHKUMAR
KALYANBHAI
regulation aspects of generic drug
registration in brazil and south africa
dr ashish
trivedi209
PHARMACEUTICA
L MANAGEMENT
AND
REGULATORY
AFFAIRS
1931602 3 REGULATORY AFFAIRS
1144 26-Nov-14 HALL - 10 132090816002PATEL SWETA
NARENDRAKUMAR
regulation for packaging materials
used for pharmaceutical products
mrs anveshna
y bhatt209
PHARMACEUTICA
L MANAGEMENT
AND
REGULATORY
AFFAIRS
1931602 3 REGULATORY AFFAIRS
1145 26-Nov-14 HALL - 10 132150816002
SONAR LAUKIK
SUBHASHCHANDR
A
CURRENT REGULATORY
REQUIREMENT FOR REGISTRATION
OF ONCOLOGY PRODUCTS IN PERU.
Mr. RONAK
DEDANIA215
PHARMACEUTICA
L MANAGEMENT
AND
REGULATORY
AFFAIRS
1931602 5 REGULATORY AFFAIRS
1146 26-Nov-14 HALL - 10 132570816001PATEL JANKIBEN
LALITBHAI
COMPARISON OF CLINICAL TRIALS
regulation FOR BIOLOGICALS IN
INDIA AND US
MR. BHUVAN
P. RAVAL257
PHARMACEUTICA
L MANAGEMENT
AND
REGULATORY
AFFAIRS
1931602 2 REGULATORY AFFAIRS
1147 26-Nov-14 HALL - 10 132640816001Roma
Chandracumar
preparation and submission of
dossier of multisourced finished
pharmaceutical product in who ctd
format for obtaining marketing
authorization in zimbabwe (mcaz-
medicine control authority of
zimbabwe)
dr. parula b.
patel264
PHARMACEUTICA
L MANAGEMENT
AND
REGULATORY
AFFAIRS
1931602 4 REGULATORY AFFAIRS
1148 26-Nov-14 HALL - 10 132640816002
KINARIWALA
MISHAL
HEMANTKUMAR
comparative study of hatch waxman
act vs bpci act: a regulatory and
patent perspective
DR. RAMESH b.
parmar264
PHARMACEUTICA
L MANAGEMENT
AND
REGULATORY
AFFAIRS
1931602 4 REGULATORY AFFAIRS
1149 26-Nov-14 HALL - 10 132640816003PANDIT KEDAR
JAYESHKUMAR
submission requirements for
parentral/solid oral in regulated
market
DR. RAMESH b.
parmar264
PHARMACEUTICA
L MANAGEMENT
AND
REGULATORY
AFFAIRS
1931602 4 REGULATORY AFFAIRS
1150 26-Nov-14 HALL - 10 132570816002PATEL KAMINIBEN
DINESHBHAI
design and development of common
dossier preparation strategy for
obtaining marketing AUTHORIZATION
of generic immediate release (ir)
solid oral dosage form in regulated
markets
MR. BHUVAN
P. RAVAL257
PHARMACEUTICA
L MANAGEMENT
AND
REGULATORY
AFFAIRS
1931602 2 REGULATORY AFFAIRS
1151 26-Nov-14 HALL - 10 132150816001GANDHI MITISHA
SANJAYKUMAR
Comparison of advance drug
regulatory structure and its
framework in Europe and United
State with reference to case study of
Furosemide drug in Europe and
United State
Dr.Sanket D.
Gandhi215
PHARMACEUTICA
L MANAGEMENT
AND
REGULATORY
AFFAIRS
1931602 5 REGULATORY AFFAIRS
1152 26-Nov-14 HALL - 11 132090816004
PATEL
KISHANKUMAR
ZAVERBHAI
regulatory aspects of herbal drugs in
india, usa and gulf counteries
dr ashish
trivedi209
PHARMACEUTICA
L MANAGEMENT
AND
REGULATORY
AFFAIRS
1931602 3 REGULATORY AFFAIRS
1153 26-Nov-14 HALL - 11 132090816005PATEL KULDIP
BHARATBHAI
global DEVELOPMENT strategy for
generic medicinal products with
regard to BIO-EQUIVALENCE studies-
special focus on bio-waiver approach
in europe, usa and brazil
dr ashish
trivedi209
PHARMACEUTICA
L MANAGEMENT
AND
REGULATORY
AFFAIRS
1931602 3 REGULATORY AFFAIRS
1154 26-Nov-14 HALL - 11 132090816006
PATEL
PRIYANKABEN
NARENDRABHAI
comparison of post approval
changes/variations filing in europe
and canada
dr bina a shah 209
PHARMACEUTICA
L MANAGEMENT
AND
REGULATORY
AFFAIRS
1931602 3 REGULATORY AFFAIRS
1155 26-Nov-14 HALL - 11 132090816007THAKKAR JINAL
SURESHBHAI
regulation guideline and registration
requirements for herbal products in
europe, india and some african
countries
mrs anveshna
y bhatt209
PHARMACEUTICA
L MANAGEMENT
AND
REGULATORY
AFFAIRS
1931602 3 REGULATORY AFFAIRS
1156 26-Nov-14 HALL - 11 132230816001 Tessy Mathew
Reviewing current regulations for
marketing authorization of finished
pharmaceuticals.
Dr. (Mrs.)
Mrunali R.
Patel
223
PHARMACEUTICA
L MANAGEMENT
AND
REGULATORY
AFFAIRS
1931602 3 REGULATORY AFFAIRS
1157 26-Nov-14 HALL - 11 132230816002KUMARI NEHA
SINGH
Preparation of DRUG MASTER FILE
(DMF) for two different drugs
Clinidipine and Febantel.
Dr. Aliasgar J.
Kundawala223
PHARMACEUTICA
L MANAGEMENT
AND
REGULATORY
AFFAIRS
1931602 3 REGULATORY AFFAIRS
1158 26-Nov-14 HALL - 11 132270816001 DEEPIKA BHAT
DEVELOPMENT OF NEW MARKETING
STRATEGY OF BIOSIMILAR DRUG
BEVACIZUMAB IN INDIA
MR.SUMIT
KUMAR
MADAN
227
PHARMACEUTICA
L MANAGEMENT
AND
REGULATORY
AFFAIRS
1931602 1OTHER (KINDLY
SPECIFY)
MARKETING
AND
MANAGEMENT
1159 26-Nov-14 HALL - 11 132270816002RAVAL ANUSHREE
HARSHADKUMAR
CURRENT SENARIO AND MARKETING
OPPORTUNITY OF METHYL
COBALAMIN AND PREGABALIN IN
NEURO MUSCULAR PAIN
MR.KAUSHIK
DAS GUPTA227
PHARMACEUTICA
L MANAGEMENT
AND
REGULATORY
AFFAIRS
1931602 1OTHER (KINDLY
SPECIFY)
MARKETING
AND
MANAGEMENT
1160 26-Nov-14 HALL - 12 132270815003Jadav Bhargavi
Harshadbhai
REGULATORY REQUIREMENTS FOR
IMPORT AND EXPORT OF
PHARMACEUTICALS IN AFRICAN
COUNTRIES
mr.paresh
patel227
Quality Assurance
and Pharm
Regulatory Affairs
1931502 1 REGULATORY AFFAIRS
1161 26-Nov-14 HALL - 12 132270815005
MISHRA
KETANKUMAR
RAJESHKUMAR
COMPARATIVE STUDY OF
REGULATION ON PEDIATRIC DRUGS
IN US, UK AND EAST AFRICAN UNION
DR.JIGNESH
SHAH227
Quality Assurance
and Pharm
Regulatory Affairs
1931502 1 REGULATORY AFFAIRS
1162 26-Nov-14 HALL - 12 132270815006PARIKH VISHAL
HITENDRA
COMPARATIVE STUDY OF
REGULATORY REQUIREMENTS ON
CARDIOVASCULAR DEVICES IN US,
AUSTRALIA AND SINGAPORE
MS.KRUPA
THULA227
Quality Assurance
and Pharm
Regulatory Affairs
1931502 1 REGULATORY AFFAIRS
1163 26-Nov-14 HALL - 12 132270815007RATHOD DHAVAL
SHANTILAL
REGULATORY REQUIREMENTS FOR
MARKETING APPROVAL OF
GEMCITABINE AND STUDY OF
PHARMACEUTICAL VARIATION IN
PHILLIPPINES
Mr. Nirav Shah 227
Quality Assurance
and Pharm
Regulatory Affairs
1931502 1 REGULATORY AFFAIRS
1164 26-Nov-14 HALL - 12 132270815008
RAVAL
AAKASHDEEP
SURESHKUMAR
DRAFTING REGULATORY
FRAMEWORK FOR ADVANCED
THERAPY MEDICINAL PRODUCTS IN
EUROPE, US AND JAPAN
DR.DILIP
MAHESHWARI227
Quality Assurance
and Pharm
Regulatory Affairs
1931502 1 REGULATORY AFFAIRS
1165 26-Nov-14 HALL - 12 132270815009Rucha Ashokkumar
Patel
PRECISE STUDY OF REGULATORY
ASPECTS OF HAEMOVIGILANCE IN
UK, AUSTRALIA AND INDIA
DR.DILIP
MAHESHWARI227
Quality Assurance
and Pharm
Regulatory Affairs
1931502 1 REGULATORY AFFAIRS
1166 26-Nov-14 HALL - 12 132270815011SHAH DEVAL
KAMRAJBHAI
STUDY OF REGULATORY
REQUIREMENTS OF INHALATION
AND NASAL PRODUCTS IN US AND
EUROPE
MR.DARSHIL
SHAH227
Quality Assurance
and Pharm
Regulatory Affairs
1931502 1 REGULATORY AFFAIRS
1167 26-Nov-14 HALL - 12 132270815013VORA KHUSHBOO
MAYUR
REGULATORY REQUIREMENTS ON
ANNUAL PRODUCT QUALITY REVIEW
OF PHARMACEUTICAL PRODUCT IN
DIFFERENT COUNTRIES
Mr. M.
Sharvan227
Quality Assurance
and Pharm
Regulatory Affairs
1931502 1 REGULATORY AFFAIRS
1168 26-Nov-14 HALL - 12 132270815502KAVI MANSI
KETANKUMAR
REGULATORY REQUIREMENTS AND
COMPARATIVE STUDY OF MEDICAL
FOOD REGULATIONS IN US,
AUSTRALIA AND INDIA
MS.KRUPA
THULA227
Quality Assurance
and Pharm
Regulatory Affairs
1931502 1 REGULATORY AFFAIRS
1169 26-Nov-14 HALL - 13 132270815012
THAKKAR
MURLIKUMAR
LALITKUMAR
ANALYTICAL METHOD
DEVELOPMENT AND VALIDATION
FOR SIMULTANEOUS ESTIMATION OF
GEMCITABINE AND TEMOXIFEN IN
SYNTHETIC MIXTURE
MR.DARSHIL
SHAH227
Quality Assurance
and Pharm
Regulatory Affairs
1931502 1SIMULTENEOUS
ESTIMATION
1170 26-Nov-14 HALL - 13 132270815504PATELPOOJA
BRIJESHKUMAR
COMPARATIVE STUDY OF MEDICAL
DEVICE REGULATIONS IN EUROPE ,
AUSTRALIA AND INDIA AND ITS
MARKETING APPROVAL IN EUROPE
Mr. Sumit
Tripathi227
Quality Assurance
and Pharm
Regulatory Affairs
1931502 1 REGULATORY AFFAIRS
1171 26-Nov-14 HALL - 13 132270815505
PAWARMO.NASIR
UDDIN IQBAL
HUSSAIN
PREPARATION OF DRAFT GUIDANCE
DOCUMENT FOR MARKETING
AUTHORIZATION OF CEFUROXIME
AXETIL ORAL SUSPENSION IN
BOTSWANA
Mr. Nirav Shah 227
Quality Assurance
and Pharm
Regulatory Affairs
1931502 1 REGULATORY AFFAIRS
1172 26-Nov-14 HALL - 13 132270815001Bhargava Nupur
Sunil
STUDY OF REGULATION AND
REGISTRATION REQUIREMENTS OF
PARENTERAL PRODUCT IN US,
AUSTRALIA AND MALAYSIA
Mr. Sumit
Tripathi227
Quality Assurance
and Pharm
Regulatory Affairs
1931502 1 REGULATORY AFFAIRS
1173 26-Nov-14 HALL - 13 132270815004Janagi Parimalam
Reddiar
STUDY OF REGULATORY
FRAMEWORK ON MEDICAL WASTE
MANGEMENT IN US, UK AND INDIA
DR.JIGNESH
SHAH227
Quality Assurance
and Pharm
Regulatory Affairs
1931502 1 REGULATORY AFFAIRS
1174 26-Nov-14 HALL - 13 132270815010SAPARIYA JAYDIP
MANSUKHBHAI
STUDY OF LEGISLATION AND FAST-
TRACK APPROVAL PROCESS FOR
ORPHAN DRUGS IN US, EUROPE
AND JAPAN
MR.RAJESH
GAMI227
Quality Assurance
and Pharm
Regulatory Affairs
1931502 1 REGULATORY AFFAIRS
1175 26-Nov-14 HALL - 13 132270815501
GANDHI PRACHI
SUBHASHCHANDR
A
ESSENTIALS OF REFERENCE LISTED
DRUGS IN GENERIC PRODUCT
DEVELOPMENT.
Mr. M.
Sharvan227
Quality Assurance
and Pharm
Regulatory Affairs
1931502 1 REGULATORY AFFAIRS
1176 26-Nov-14 HALL - 13 132270815503MISTRI RAVI
HARSHADKUMAR
COMPREHENSIVE STUDY AND
COMPARISON OF DRUG
REGULATORY EXCLUSIVITY
STRATEGIES IN US, EUROPE, CANADA
AND JAPAN
mr.paresh
patel227
Quality Assurance
and Pharm
Regulatory Affairs
1931502 1 REGULATORY AFFAIRS
1177 26-Nov-14 HALL - 13 132270815506 TRIVEDI BHAWIN
STUDY OF REGULATORY
REQUIREMENTS OF
BIOTECHNOLOGICALLY DERIVED
PRODUCT AND MARKETING
AUTHORIZATION OF ENOXAPARIN
SODIUM IN EUROPEAN UNION
Mr. Nirav Shah 227
Quality Assurance
and Pharm
Regulatory Affairs
1931502 1 REGULATORY AFFAIRS